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ABSTRACT
Preparation of Enantioenriched Alkyltin Species and Their Application in Stereospecific
Transformations: A Case Study
by
Glenn O. Ralph

Advisor: Doctor Mark Biscoe
Organometallic reagents containing the tin-carbon bond are used extensively in modern synthetic
chemistry for the formation of new bonds to carbon. Over recent decades, transition metal
catalyzed cross coupling reactions between two C(sp2) centers have been widely developed.
However, the introduction of a C(sp3) center complicates the catalytic cycle, and opens
unproductive chemical pathways which lead to isomerization, elimination, and racemization
(Figure 1). Our lab has developed a modified-Stille reaction to combat the deleterious effects of
β-hydride elimination. Our protocol enables unactivated 2° alkyl organotin nucleophiles to
undergo efficient cross coupling reactions with C(sp2) electrophiles, avoiding the drawbacks
commonly associated with such a synthetic approach. Analysis of the final products has shown
our system to be highly stereospecific, which allows for translation of chiral information from
our organometallic nucleophiles to the resulting arylation and acylation products (Figure 2-a,b).
This specificity was also found to exist in an electrophilic halogenation reaction unrelated to the
cross coupling mechanism (Figure 2-c).
This report will focus on our attempt to solve the major bottleneck for broader utility of our
system, the preparation of enantioenriched tin precursors. Until recently, 2° alkyl tin compounds
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were not a synthetically useful species, as the rate of 2° alkyl transfer was simply too slow. With
our nucleophiles exempt from that limitation, we began searching for a proper, general synthetic
method for their preparation. We found that by utilizing a lithium-naphthalide catalyst, a
tricarbastannatrane anion could be prepared from the corresponding chloride. By using this
reagent, we observed the clean inversion of alkyl sulfonates from commercially available
enantioenriched alcohols (Figure 3). No longer tethered to directed lithiation or chiral prepHPLC separations, we were able to expand our library of tin nucleophiles with defined
stereochemistry. This report will cover the development of the tricarbastannatrane anion and a
discussion of the utility of enantioenriched 2° alkyl nucleophiles.

Figure 2
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CHAPTER ONE
Introduction:
By design, the fundamental goal of modern synthetic chemistry will always be just out of
reach. Synthetic chemists worldwide are forever in search of better control of atoms, molecules,
and their behavior. Agriculture, energy, and medicine, the pillar stones of civilization, rely
heavily on our ability to rationally manipulate the chemical space. To achieve forward progress
in these areas, it is essential that our chemistry is always more robust, more selective, more
efficient, and more straightforward.
Organic chemists implement a diverse set of synthetic methods to craft the molecules our
civilization relies upon.

The shape of the carbon framework and selected presence of

heteroatoms dictate the behavior of these compounds. Typically, a given framework will consist
of several hybridization states of carbon, which help define its chemical, physical, and biological
properties. When carbon has bonds to four atoms, the bonds are C(sp3) hybridized, are lowest in
energy, and tend to be most stable. It is well established that as unsaturation increases, to C(sp2),
then C(sp), the bonds get shorter, more reactive, and higher in energy. Hybridization effects
structural orientation as well. C(sp3) hybridized carbon bonds are tetrahedral, meaning they
occupy functional space in all three dimensions. C(sp2) hybridization has been described as
“flat”, occupying space in two dimensions, with C(sp) hybridization occupying only one.1
In the case of a saturated carbon with four unique bonds, some properties are affected by
the “handedness”, or chirality of the molecule. Louis Pasteur first discovered molecular chirality
in the mid-19th century. He noticed portions of conglomerate crystals of tartaric acid salts
appeared to be non-superimposable-mirror-images, and completed the first identification and
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intentional separation of a racemic mixture.2 In his later career exploring fermentation, he
reported that
“...the two tartaric acids, right and left, is subjected to the same method of fermentation,
it is resolved into the right acid which is fermented and left acid which remains intact, in such a
way that the best means of obtaining left tartaric acid I know of today is to resolve paratartaric
acid by fermentation.”2
This is the first published observation of racemate selectivity in a biological process;
meaning one part of the racemate, or an enantiomer, had observable properties in contrast to the
opposite enantiomer.
From the discovery of the Grignard reagent in the 1900’s, to the more sophisticated
transformations of the present, expertise regarding the behavior of carbon during a chemical
reaction is essential to address our synthetic goals. The diversity of carbon bond manipulations
known to modern chemists is, for obvious reasons, too vast to summarize. However, it is
possible to emphasize the importance of direct, rational control of general synthetic methods in
order to attain the molecule of interest. Regardless of specific field, organic synthesis targets
contain a variety of complex carbon states, and the ability to control carbon bond-forming
reactions within a diversity framework is essential. The following is a statement regarding the
impact of modern synthetic methodology on structural diversity.

1.1 Criticisms of a modern approach to synthesis:
In the last decade, there have been several well-written criticisms of the current
implementation of synthetic chemistry for medicinal drug discovery. In 2009, Frank Lovering
published his opinion in the Journal of Medicinal Chemistry, suggesting an “Escape from
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flatland” is needed,1 while Dean J. Brown, in 2015 asks; “Where have all the new reactions
gone?”3 It could be argued that these critiques are relevant in some degree to all forms of
synthesis research. The two reports are related as they both criticize modern developments in
synthetic chemistry for biasing towards less complex, less structurally interesting molecular
scaffolds. Additionally, these reports are evidence that modern complexity-building methods are
not robust or straightforward enough for a broader general utility within the synthetic
community.
Lovering began his argument with the hypothesis that developments in reliability,
versatility, and high throughput capability of C(sp2)-C(sp2) cross coupling reactions are biasing
drug discovery efforts toward targets with less natural product-like character.

To test the

hypothesis, he looked for a correlation between the complexity of a molecule and its ability to
progress through the phases of clinical testing.1 For his study, he approximated the complexity of
a molecule by comparing saturation and chirality. He defined saturation as Fsp3, or the fraction
of Csp3 hybridized carbons over the total number of carbons present in the molecule. For
chirality, he simply observed whether or not the molecule in question contained one or more
chiral centers. Screening these conditions against the clinical testing database of GVK BIO from
1980 onwards, he found a direct correlation between his definition of complexity and progress
through the trial phases. He concluded his work by referencing the diversity-oriented synthesis
movement in synthetic chemistry. The goal of which is to combat flatland with the discovery of
more accessible and reliable methods to increase complexity in molecules.1
Dean J. Brown, who several years later cites Lovering’s work in his own criticism, is also
a proponent of diversity-oriented synthesis. His article is a simple yet thorough analysis of the
historical (1984) and modern (2014) synthetic approaches to medicinal and natural product
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targets. He extracted relevant publications from the Journal of Medicinal Chemistry, the Journal
of the American Chemical Society, and Angewandte Chemie International Edition from each of
the two years, and reviewed the most frequently used chemical reactions (Figure 1.1).3 He found
the most commonly used reactions of 1984 were still the most popular 30 years later, with the
exception of C(sp2)-C(sp2) cross coupling and amide bond formation. He also argues the need to
move away from C(sp2) bond based structures in order to access a new era of
scaffolds.

chemical

Among other things, he proposes expedited integration of modern chemical

methodologies, expansion into less occupied chemical space (i.e., three dimensions), and the
selection of the most appropriate chemical route, not simply the most expeditious.
30 years of impact

Figure 1.1: 30 years of impact. Brown reports the most used chemical reactions from the years
1984 and 2014.3 The arrowed dates refer to the date of discovery, which emphasizes the
popularity and age of the reaction.

4

1.2 Necessity for enantiomerically pure chemical targets:
For the total synthesis of functionalized three-dimensional molecules containing chiral
centers, control of final product stereochemistry is essential. A chiral drug administered as a
racemic mixture can essentially behave as two separate drugs in biological systems. For
example, racemic albuterol is a chiral small molecule drug commonly used for inhalation therapy
of acute airway obstruction. The Merck Manual, Veterinary Manual, describes the difference in
biological activity as follows.
“The R-enantiomer has bronchodilatory and anti-inflammatory effects, and the Senantiomer paradoxically is associated with increased airway hyperreactivity and proinflammatory effects.” 4
For this racemic mixture, the beneficial enantiomer can be used to help treat breathing
problems, while the opposite configuration was shown to exacerbate breathing problems (Figure
1.2-a). This biological selectivity is not the only, or most severe example known. Thalidomide is
an infamous biologically active small molecule drug. Initially developed in Germany,
Thalidomide was released globally in the 1950’s. It was, and to some degree still is, used as a
therapy for a variety of ailments including morning sickness, leprosy, certain cancers, Crohn’s
disease, and HIV.5 Its use to combat morning sickness in the 1950’s led to reports of birth
defects and other pathologies. It took 10 years and 10,000 cases of major birth defects before the
therapy was discontinued. It was then discovered that the (R)-enantiomer was responsible for
the therapeutic effects, while the (S)-enantiomer was responsible for birth defects. Thalidomide
has been considered the largest man-made medical disaster in history (Figure 1.2-b).5
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Figure 1.2: Racemate selectivity in biological processes. The inversion of single point chirality
in biologically active albuterol (a), and thalidomide (b), has drastic changes in physiological
effect.

1.3 Separation:
From a practical standpoint, the three common ways to obtain a single product
enantiomer are racemate separation, asymmetric induction, or stereospecific translation. All
three methodologies have merit. Separation of racemates is effective, but suffers from complex,
sometimes difficult or impossible separation techniques, along with the obvious waste associated
with formation of the opposite enantiomer. Referring back to Louis Pasteur, his painstaking
separation was accomplished by manually separating the two crystal structures from the
6

conglomerate.

This

process

was

solvation/recrystallization/separation cycles.

indeed

tedious,

and

required

multiple

In an achiral environment, enantiomers have

identical chemical and physical properties. The conglomerate crystal mixture Pasteur observed
occurred due to the affinity of an enantiomer to crystalize with itself. Although archaic sounding
by todays standards, the fundamental principal behind the first separation remains the foundation
of modern chiral separation techniques; i.e. enantiomers are non-identical compounds, and can
behave selectively in strictly optimized chemical environments.6
Sohrab Rohani, in 2010 from the University of Western Ontario, reviewed resolution by
crystallization of modern active pharmaceutical ingredients (API).7 The work explains how
enantiomer self-affinity crystallization is unreliable.

Conglomerate crystals from racemic

mixtures of single point chirality APIs are, in large part, inseparable. This is because in nonideal circumstances, crystal lattices can alternate between (R)- and (S)- either orderly, or in a
random distribution. Therefore, common industrial crystallizations rely on pre-derivatization
with a resolving agent to form diastereomers, or non-mirror-image stereoisomers. Often times,
the difference in solubility of diastereomers is conducive to a separation by crystallization. Loss
of yield due to non-essential chemical manipulation and handling, and incompatibility with noncrystalline materials are limitations of this method.
Another modern method for racemate separation is chiral chromatography. This process
utilizes chiral stationary phase interactions to introduce racemate differentiation, even on an
industrial scale. In 2014, The Daicel group by Chiral Technologies Inc. presented their solutions
to some of the problems associated with enantiomer crystallization.8 They argue that practical
chromatography is not the temporary, inelegant solution that conventional wisdom believes it to
be. Their development solution involves the determination of optimum analytical conditions
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based on a thorough method screening. In combination with a loading and stability study, the
process can result in the isolation of megatons of a single enantiomer in flow, or in batch.
Although useful for the large-scale synthesis of complex API molecules, there are serious
limitations for crystallization or chiral chromatography as a technique to obtain enantiopure
products. There is a significant waste associated with the exclusion of the non-target enantiomer.
If late-stage chirality is introduced, the yield of potentially valuable intermediates is then reduced
to a maximum of 50%. Second, if derivatization to diastereomers is required, then non-essential
losses of yield based on further chemical manipulation and handling is incurred. Racemate
separation via crystallization is not appropriate for compounds that do not form lattice structures,
while chiral chromatography adds the additional burden of tedious method screening and
development.

1.4 Induction:
Asymmetric induction, or the selective generation of a stereocenter via catalyst, substrate,
enzyme, or additive control, is an incredibly powerful synthetic methodology that is continually
being developed. Induction via chiral catalyst, of which there are many examples in the
literature, capitalizes on the difference in energy between the transition states of opposing
enantiomer formation. If the energy difference is sufficient, the pro-chiral substrate is oriented
or activated so the desired bond forms one product enantiomer selectively. Many bond-forming
iterations of this technique are used regularly. It must be emphasized that absolute configuration
of the final product is being generated by the reaction of non-chiral or racemic starting materials.
Another method of asymmetric induction, dubbed “deracemization”, must be mentioned
in this context. Deracemization can be thought of as a dynamic equilibrium in the presence of a
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chiral agent. Yue Ji published a great example of this reaction in 2015. In this work, it was
shown that a one-pot redox reaction was capable of producing a single enantiomer from racemic
compounds containing a tetrahydroisoquinoline core.9 By choosing an orthogonal oxidative and
reductive agent pair, and the addition of a chiral ligand, Ji was able to deracemize the title
amines with excellent yields and enantioenrichment (Figure 1.3). A deuterium labeling study
suggested an imine intermediate, and it was proposed that the reduction reaction is selective via
chiral ligated iridium-based hydrogenation. As the equilibrium proceeds, enantiodifferentiation
occurs between the chiral catalyst and proposed imine during hydrogenation, which favors the
formation of a single enantiomer.

Deracemization of tetrahydroisoquinoline core
1% [Ir(cod)Cl]2
2.2% (R) SynPhos (L*)
NH
1.5 eq. NBS
0.55 eq. Na2CO3
DCE, D2 (100 psi)
30 ºC, 36 h

Ph

NH
Ph D

oxidation
(fast)

N
Ph

L*
D Ir
D

reduction
(selective, slow)

NH
Ph D

Figure 1.3: Deracemization of tetrahydroisoquinoline core: Optically active final products
are observed for the redox deracemization of tetrahydroisoquinoline cores using NBS and
iridium based hydrogenation with a chiral ligand (L*).
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There have been many examples in the recent literature that validate asymmetric
induction as a methodology for obtaining enantioenriched final products. However, it has been
shown that small steric or electronic perturbations of the substrate can decrease or erase this
selectivity entirely. It is difficult to predict how strongly these catalyst/substrate interactions will
be, or which orientation will form the desired bond, so this methodology often requires intense
optimization from substrate to substrate. This becomes problematic for SAR studies, for
instance, where targeted diversity among similar scaffolds is essential. Although incredibly
valuable, this approach can suffer from a lack of generality and predictability.

1.5 Translation:
Stereospecific translation of chirality is a valuable approach to diversity-oriented
synthesis.

From the simplest perspective, this can involve bond formation distal to point

chirality, or reaction upon a structural motif that precludes the formation of a racemic mixture,
like epoxide ring opening. Although useful in certain applications, a more elegant approach
involves translation of chirality through bond manipulation at the chiral carbon. Two examples
of these types of transformations involve the utility of formal SN2 mechanisms and transition
metal catalysis.
The benzylic position of a chemical building block, common to many natural and
therapeutic molecules, is of recent interest in synthesis. This position has been known to behave
somewhere between a formal C(sp2) and C(sp3) hybridized carbon, due to α-activation of the
benzene ring. The Kobayashi group accomplished the most recent development involving a
stereospecific translation at this position (Figure 1.4-c).10 This represents a significant evolution
of their work in 2016 regarding the displacement of α-unsaturated diethylphosphate leaving
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groups (Figure 1.4-a).11 They generated a known diarylmethyllithium reagent, and observed
clean inversion of starting material without the use of metal catalysis. By replacing the ethyl
phosphate groups with phenyl, they were able to attack the carbon of interest selectively for 2°
alkyl and saturated carbocyclic substrates (Figure 1.4). This use of a formal SN2 mechanism
was used to translate chirality from enantioenriched starting material to final product with very
good efficiency.

Inversion for chiral translation
(a)

EtO OEt
P
O
O

(Ar)2CH2, n-BuLi

Ar

Ar
OTBS

OTBS THF, -15 ºC, 15-60 min
EtO OEt
P
O
O

(Ar)2CH2, n-BuLi

(b)

THF, -15 ºC, 15-60 min
R1

R1

R2

(Ar)2CH2, n-BuLi, THF
-15 - 0 ºC, 15-60 min

Ar
Et

R2

R = Alkyl, PhO
OPh
cycloalkyl
P
O
O
(c)

Ar

Ar
R1

Ar
R2

Figure 1.4: Inversion for chiral translation. A formal SN2 mechanism is still relevant for the
preparation of useful enantiopure chemical targets. The Kobayashi group reports clean inversion
of an allylic diethyl phosphate (a), but observed predominately by-product with fully saturated
phosphates (b). Replacing the ethyl groups with phenyl, they observed the desired selectivity
(c).

Another example of stereospecific translation requires the use of 2° organometallic
reagents in coupling reactions. Independent of stereocontrol, the modular nature of a coupling
11

reaction has made it a very useful approach to synthesis. Modern research groups have achieved
great success by implementing an enantioenriched organometallic reagent as a coupling partner.
Cross-coupling reactions of this type encompass a wide set of chemical transformations, several
of which will be discussed later in more detail. Due to the many challenges of such an approach,
only a selection of these methods introduce three-dimensional complexity through general,
predictable, stereospecific translations. However, the independence of steric or electronic effects
allow for a more targeted, rational synthetic approach to enantioenriched products.

1.5 Conclusion:
For a modern world with challenging synthetic hurdles in agriculture, energy and
medicine, it is imperative that we continue to develop chemistry to address them. The discovery
and development of C(sp2)-C(sp2) cross coupling technology has been an undeniable boon to
chemical synthesis, but if we rely too heavily on its simplicity and reliability, it may inherently
bias our science. It has been shown that increased molecular complexity can lead to more
efficient and productive chemical solutions, and historically robust manipulations are not
sufficient.
There are many valid synthetic approaches to diverse, complex, and structurally
interesting molecules. Of the most common techniques, each has its utility and limitations. For
constructing complex bonds to carbon, we implement stereospecific translation by combining the
versatility of transition metal catalysis with the robustness of configurationally stable
enantioenriched organometallic nucleophiles. We believe this combination will result in easy
access for the synthetic community to achieve general, rational, complexity in target molecules
without the limitations of current methods.
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CHAPTER TWO
Background:
2.1 Transition metal catalyzed cross-coupling reactions:
The impact of transition metal catalyzed carbon-carbon cross-coupling reactions on
synthetic organic chemistry is well known. The reliability, versatility, and robustness of these
types of reactions allow them to be utilized for all scales of synthesis, from academia to industry.
While the cross coupling of C(sp2)-C(sp2) centers is well established across a wide variety of
catalysts, conditions, and substrates, incorporation of a C(sp3) center still presents challenges.
A forward thinking review published this year, by Campeau and Hazari, chronicle a
history of cross-coupling technology as evidence for their road map of future coupling
techniques.1 Broadly speaking, cross-coupling reactions occur via transition metal catalysis.
This discovery relied on the early observations that homo-coupling of Grignard reagents occur in
the presence of a catalytic amount of first row transition metal salt and an oxidizing agent. This
led to the first example of a formal cross-coupling between alkenyl halides and Grignard
reagents via iron catalysis in 1971.1 From there, the field specialized into the various named
transition metal catalyzed cross-coupling reactions that have greatly impacted how we do
synthesis. This impact is the basis for the criticisms of Lovering and Brown in the last decade.
When cross-coupling two C(sp2) centers, the generic catalytic cycle is invoked to describe the
several fundamental transformations that occur (Figure 2.1). This cyclic mechanism, or subtle
variation thereof, can be applied to several well-known organometallic named reactions. The
most notable are the Suzuki, Negishi, Kumada and Stille reactions. These transformations are
named for the specific metallic handle on the nucleophilic coupling partner. The unifying trait

14

of these reactions is the new C-C bond formed by reductive elimination of the two coupling
partners from the transition metal center.

Catalytic cycle
X

Ar

[LnM1]

R

R
reductive
elimination

oxidative
addition
X
M1 L
R

M1= Pd, Ni
X= I, Br, Cl, OTf

Ar
M1 L n

n

R

ArM2
M2 X
transmetallation

M2 =
MgBr= Kumada
Zn= Negishi
Sn= Stille
B= Suzuki

Figure 2.1: The simplified catalytic cycle. Commonly used to describe the general
transformations observed between transition metal catalyst, a C(sp2) hybridized organic
electrophile, and C(sp2) hybridized organometallic nucleophile.

It is well established that when using a palladium catalyst in a cross-coupling reaction, a
series of oxidative addition, transmetallation, and reductive elimination occur.2 Oxidative
addition can be thought of as a nucleophilic attack of the active palladium catalyst on the
electrophilic coupling partner. The transformation normally involves a pre-coordination of the
metal to the pi system of the electrophile, followed by the insertion event.3 This results in
oxidation of the metal center, which for palladium is typically Pd(0) to a Pd(II) species. The Pd(II)
species is then electrophilic in nature. Transmetallation is the transfer of the nucleophilic
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coupling partner to the electrophilic Pd(II) complex, which results in a second Pd(II) complex,
which bears both of the intended coupling partners.

Mechanisms of transmetallation and

perturbations that impact the transition state will be discussed in a later section. Reductive
elimination is the formal coupling event, in which a new C-C bond is formed, and the metal
center is reduced back to the active state of Pd(0). The catalyst is now free to re-enter the cycle. It
is believed that each catalytic transformation is in dynamic equilibrium, and that a single
perturbation to the system can affect the efficiency of the entire sequence of events. This general
process is commonly limited to the use of C(sp2) coupling partners as attempts to integrate a
C(sp3) coupling partner often results in no reaction or the formation of undesired byproducts.2
It should be mentioned that there are alternative schemes to the traditional cross-coupling
reaction involving an electrophile, nucleophile, and catalyst. Oxidative cross-coupling and crosselectrophile-coupling are both metal catalyzed schemes that couple either two nucleophilic or
two electrophilic reagents. Carbon-carbon and carbon-heteroatom bonds can be formed this way
in a variety of hybridizations. Typically in both schemes, a super-stoichiometric amount of
oxidant or reductant is added to promote the more appropriate reactive state of the transition
metal. Homo-coupling is a common unproductive pathway for these reactions, which is possibly
why they are considered under-investigated. If this topic is of interest, the reader can follow up
with Liu’s review on oxidative cross-coupling from 2011,4 or Everson’s review on crosselectrophile coupling from 2014.5

2.2 Cross-coupling a C(sp3) hybridized reagent:
The addition of C(sp3) coupling partners to the catalytic cycle is becoming more
commonplace, and protocols have been developed for primary, secondary, and to a lesser extent,
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tertiary alkyl transfers.2 With the addition of alkyl systems into cross coupling reactions, it
became possible to transfer selective chirality to the final products. This significant synthetic
accomplishment will be discussed later in more detail.
The primary hurdle to overcome when using palladium and a C(sp3) coupling partner is
related to the transfer rate observed for various coupling groups. Alkynyl substituents typically
transmetallate fastest. This is primarily due to the impact of increased s-character on orbital
overlap with the d-orbital of the transition metal during the transfer event. The rate slows as scharacter decreases in aryl and vinyl systems.6 For C(sp3) systems, the differentiation is more
about sterics.7 A primary system will transfer faster than a secondary system, with a tertiary
system being the slowest. Normally, some form of activation is required to facilitate the transfer
of a C(sp3) center.
Another challenge to overcome in attempting to couple any C(sp3) center is evident by
observing the structure of an alkyl-bearing transition metal complex. When Pd(II) contains an
alkyl group, a thermodynamically competitive mechanism observed is β-hydride elimination.
This phenomenon unlocks a non-productive chain of transformations, which lead to elimination,
isomerization, and racemization of the desired coupling product (Figure 2.2). It has been shown
that β-hydride elimination can be overcome by leveraging strongly activated coupling partners,
or a finely tuned catalyst system. Although there are several methodologies currently under
investigation, they all effectively subvert the β-hydride elimination pathway, and result in
excellent yields of desired products.
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C(sp2) - C(sp3)
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Figure 2.2: Cross-coupling a C(sp3) nucleophile. Describes the additional reactivity pathways
for organometallic complexes that contain a β-hydrogen.

For the sake of completion, it should be mentioned that C(sp3) electrophiles are currently
being investigated in cross-coupling reactions. Editor Yasushi Nishihara reviewed the current use
of alkyl electrophiles in a later section of the book Applied Cross-Coupling Reactions in 2013.3
The section was prefaced with two fundamental complications regarding that approach. First,
there is significant difficulty in promoting the oxidative addition of a carbon electrophile that
does not contain a pi system. With no pre-coordination event, harsher conditions are required to
force the insertion reaction to occur. Second, the newly formed carbon-metal bond is susceptible
to β-hydride elimination.

Several research groups have successfully navigated these

limitations.3, 8, 9 This method is a valid approach to incorporate molecular complexity and was
recently reviewed by Wu in 2018.10
The earliest examples of transmetallation with a C(sp3) nucleophile were published in the
1970’s, and were further developed over the next two decades. These processes incorporated
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alkyl lithium, Grignard, zinc, aluminum, tin and boron reagents.11 The authors were able to avoid
β-hydride elimination for 1° nucleophiles by implementing sufficiently bulky ligands on a nickel
or palladium catalyst.

It was proposed that bulky ligands promote an accelerated rate of

reductive elimination due to forced proximity of the coupling partners (Figure 2.3).
Further developments in the field led to the use of secondary alkyl nucleophiles.
Hayashi et al. reported a system in 1984 that was capable of coupling secondary alkyl zinc and
Grignard reagents with organic halides using a bidentate ferrocene-based ligand system.12 At
roughly the same time, advancements in tin and boron chemistry led to their utility in similar
secondary systems.13

Ligand crowding effect
(a)

(b)
R1

Pd
R2

Pd R1
R2

Figure 2.3: Ligand crowding effect on reductive elimination. Non-bulky ligands are
associated with a decreased rate of reductive elimination (a). Encumbered ligands restrict
substituent mobility around palladium, and accelerate reductive elimination (b).

The push towards tin and boron based nucleophiles was pursued for several reasons. In
the early work with secondary systems, strongly nucleophilic organometallic reagents were
required to achieve transmetallation.

It was found that this limited the functional group

compatibility associated with a useful cross-coupling reaction. Additionally, the instability of
zinc and Grignard nucleophiles lead to messy and inconsistent preparation methods, potentially
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leading to a lack of broad utility. Tin and boron based nucleophiles are more stable, and promote
a wider range of functional group tolerance.

2.3 Enantiospecific cross-coupling of configurationally stable nucleophiles:
When discussing the relative reactivity of the various metallic handles, it is important to
mention the inverse relationship between nucleophilicity and configurational stability.
Nucleophilicity increases along the set as the ionic character of the carbon-metal bond increases.
As ionic character increases, a decrease in configurational stability is typically observed (Figure
2.4).14 This facet is essential for understanding the methodologies associated with enantiospecific
cross-coupling reactions. Strong 2° alkyl nucleophiles are inherently easier to transmetallate, yet
typically lead to racemic products. Alkylboron and alkyltin compounds capable of promoting
transmetallation have been shown to efficiently translate chiral information into final products.

Trends in chemical properties
configurational stability
M = B > Sn > Zn > Mg > Li

R1
M
R2
R3

ionic character
M = B < Sn < Zn < Mg < Li
M = B < Sn < Zn < Mg < Li
nucleophilicity

Figure 2.4: Trends in chemical properties. The general relationship between nucleophilicity
and configurational stability observed for the most common metallic handles.

As of 2015, there are several examples of in situ-generated configurationally stable
lithium, Grignard, and zinc-based organometallic nucleophiles capable of achieving
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enantiospecific translation,15-22 but the processes lack generality and reliability. Additionally,
these methods are limited by functional group compatibility of the substrate. It could also be
argued that isolable and bench-top stable reagents are more conducive to broader utility in the
synthetic community. Another approach includes the preparation and isolation of an
enantioenriched organometallic building block, capable of rational incorporation of selective
chirality at any stage of synthesis.
The Suzuki reaction, developed in 1995 by Akira Suzuki and Norio Miyaura, is the most
widely investigated cross-coupling reaction scheme.23 Suzuki reactions implement an activated
organoboron(ate) for transmetallation. Organoboron compounds are commercially available as a
variety of useful chemical building blocks, and there are multiple reliable synthetic preparation
methods. Jason Rygus and Cathleen Crudden published an incredibly thorough review of modern
Suzuki cross-coupling reactions in 2017.24 They describe the wide variety of isolable
organoboron compounds currently capable of enantiospecific translation. Beginning in the early
2000’s, both the Deng and Gevorgyan groups found that enantioenriched cyclopropyl substrates
were compatible.25, 26 For the next almost two decades, this system inspired work with larger
alicyclic,27-29 benzylic,30 allylic,31,

32

biarylmethyl,33 β- or γ- carbonyl containing,34-39 γ-

hydroxy,40, 41 and α-heteroatom containing40, 42, 43 organoboron reagents (Figure 2.5). It was
found that activating/directing scaffolds were essential for reactivity. The reported
transformations gave rise to systems of iterative Suzuki cross-coupling reactions,44, 45 which
resulted in the invention of an automated “small-molecule synthesizer.”46
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Modern organoboron nucleophiles
BF3K
OH
B(OH)2

BPin

BPin

R

R

R
B(OH)2

BPin

BF3K
R

OBn

O

BPin

R

BPin
R

R
isomerization

Ph

Figure 2.5: Organoboron scaffolds in stereospecific Suzuki reactions. Developments in 2°
organoboron compatibility have led to varied success in un-activated alicyclic systems (left).
Activated systems have delivered great success in stereospecific arylation reactions (right).

There is no doubt that Suzuki chemistry has greatly impacted the field of synthetic
chemistry.

However, enantiospecific Suzuki reactions have multiple limitations. Control

experiments have shown that if activating/directing groups are not present in the organoboron
reagent, a corresponding drop in yield or enantiospecificity is observed.24 This can be explained
by the aforementioned relationship between nucleophilicity and configurational stability. Boron
is the least nucleophilic of the commonly used metallic handles. Therefore, activation within the
alkyl group being transferred is required to promote effective transmetallation. This is a
limitation of the inherent properties of the transfer group of interest, which suggests the
possibility that boronate scaffolds not mentioned will have a lower chance of success.
As of 2017, only one reaction scheme is capable of an enantiospecific Suzuki reaction
that utilizes un-activated reagents that do not contain directing groups (Figure 2.6). The Biscoe
group reported inversion of configuration using enantioenriched sec-butyl boronic acid and
trifluoroborate derivatives with a variety of heteroatom-containing organic electrophiles.47 Their
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system was inspired by the work of Molander and Dreher,27 and utilized a preformed P(t-Bu)3
ligated palladium precatalyst to suppress isomerization and racemization found in earlier
systems.

Enantiospecific arylation of un-activated alkylboron

R
N

5-10% precatalyst, K2CO3 (3eq)
BF3K

Cl

toluene/H2O or benzene/H2O
60-100 °C, 24-48 h

R

(t-Bu)3P Pd NH2
OMs
precatalyst

N

Figure 2.6: First enantiospecific arylation of an un-activated organoboron. The conditions
reported by the Biscoe group, utilizing an enantioenriched alkylboron nucleophile with no
directing or activating groups present in the desired coupling fragment.

Mechanistic impact on stereochemistry
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Figure 2.7: Generic stereospecific mechanism. An SE2 retentive mechanism is associated with
a closed, cyclic transition state (top), while an SE2 invertive mechanism is associated with an
open transition state (bottom).
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Another significant limitation to broad utility of stereospecific Suzuki couplings is the
sensitivity of mechanism reported for the various activating/directing groups. This phenomenon
allows some boron nucleophiles to promote retentive products, while other, structurally similar
nucleophiles promote inversion. Suzuki reactions involving benzylic and α-OBn containing
boron nucleophiles specifically result in retention of configuration.24 This suggests a closed SE2
mechanism.

The remaining activated substrates generally promote invertive products,

suggesting an open SE2 mechanism (Figure 2.7).
The Suginome group reported a synthetically useful example of this dichotomy in 2011.34
They subjected the enantio-invertive cross-coupling of an α-amide alkylboron reagent to
increasingly acidic additives, and reported an optimized 93%ee of retention in the final products.
They propose pre-coordination of the amide carbonyl and the boronic ester prior to
transmetallation results in inversion, while acidic additives disrupt the coordination event, which
led to retention of configuration (Figure 2.8). Although incredibly reliable for a variety of
enantiospecific transformations, the Suzuki reaction is not necessarily the most versatile or the
most general method to integrate controlled complexity into molecules.
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Interrupted carbonyl-directing cross-coupling
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Figure 2.8: Variability in mechanism for enantiospecific Suzuki cross-coupling. The amide
carbonyl promotes an open invertive mechanism via boron activation (top). If an appropriate
Lewis acid is present, the mechanism switches to closed retentive.

2.4 Alkyltin nucleophiles for enantiospecific cross-coupling:
Another method for cross-coupling isolable, configurationally stable organometallic
nucleophiles is the Stille reaction.

Reactions that fall into this category implement an

organostannane nucleophile. The Stille reaction will be discussed more thoroughly due to its
direct relevancy to this dissertation.
Discovered in 1978 by John Stille and David Milstein, the Stille reaction has attracted
considerable development. From a practical standpoint, the utility of the Stille reaction is similar
to that of the Suzuki reaction. Often times, both reactions are valid, reliable approaches to forge
the same chemical bond. However, the Stille reaction is better known for robustness, selectivity,
and mild conditions. It is imperative that these conditions are met in total synthesis. In 2014,
Heravi reviewed the Stille reaction under the lens of application in very complex total synthesis
projects.48 Perhaps the most impressive example reported is the intermediate for synthesis of the
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antibiotic etnangien (Figure 2.9). This relied on the coupling of two late-stage, very functionally
dense components, which was achieved in 70% yield.

Stille coupling in etnangien synthesis
O

OH
O

I

O

O

O

MeO
OH

OMe

(Bu)3Sn
OH

OH
PdCl2(CH3CN),
DMF

O

OH
O

MeO

O
O

OH
OH

OMe

O

70%

OH

Figure 2.9: Stille coupling in etnangein synthesis. The efficient late-stage cross-coupling of
two functionally dense fragments in the total synthesis of the antibiotic etnangien.

When utilizing a C(sp3) hybridized organostannane, there are additional complications to
overcome in addition to those of the Suzuki reaction. Organostannanes typically require four
carbon substituents to reach the level of energy required for transmetallation. For typical C(sp2)
couplings, handles like tri-n-butyl, trimethyl, triethyl, etc. are used as less reactive place-holding
substituents on tin (dummy ligands). The more labile C(sp2) carbon will transfer selectively.
Early success in transferring alkyl groups from tin relied on two methods; either the tetrasubstitution of the desired alkyl group, which inherently wastes three equivalents of potentially
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useful material, or activation of the desired group by one of the methods mentioned previously
(e.g., benzylic, α-heteroatom, etc.). In addition to this, there are very real concerns regarding the
general toxicity of organostannane reagents.49

2.5 Possible mechanisms:
A closer look at mechanistic proposals is useful for a better understanding of
enantiospecific cross-coupling via Stille reactions. Cordovilla published a thorough review of
literature regarding the Stille mechanism up to 2015.50 He proposes the more detailed mechanism
shown in Figure 2.10. This mechanism rationalizes changes in selectivity attributed to ligand
and additive effects by obeying the rules of coordination chemistry.

After an initial

isomerization event, three potential routes of reactivity exist for the oxidative addition complex.
First, the organostannane can displace a ligand to form a cyclic transition state (Figure
2.10-a). This is supported by DFT calculations by the author that suggest a tetra-coordinate
palladium is more energetically favored than a concerted, penta-coordinate transition state.
Experimentally, it has been found that strongly electronegative halide substituents and weakly
binding ligands promote this pathway. Second, the organostannane can displace a halide or
leaving group substituent on palladium, which would directly lead to an open transition state
(Figure 2.10-b). Third, a neutral (solvent) substituent can replace the halide/leaving group prior
to transmetallation, resulting in a cationic palladium species. This complex is also believed to
participate in an open transition state (Figure 2.10-c). Open transition state mechanisms are
associated with weakly coordinating anionic substituents (e.g., triflates), or strongly coordinating
solvents.
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Proposed Stille catalytic cycle
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Figure 2.10: Detailed Stille catalytic cycle. The prototypical oxidative addition complex (1) has
three potential pathways of reactivity; organometallic displacement of a ligand (a), displacement
of an anionic substituent (b), or ligand substitution (c). These pathways affect the transition state
of transmetallation.

The stereospecificity of products from the earliest examples of C(sp3)-C(sp2) Stille
reactions with palladium as the sole catalyst showed that both mechanisms are reasonable. A
stereoretentive transformation is associated with a closed or cyclic transition state, while
stereoinversion is associated with an open transition state. However, it is important to
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acknowledge that even the more detailed mechanism is still probably an oversimplification of the
complete mechanism.
For enantiospecific Stille reactions that contain a copper additive, stereoretentive
products are formed exclusively.50 Copper has a unique effect on the Stille reaction, and the
relationship is not completely understood. Cordovilla proposes two different roles. First, copper
is a known ligand scavenger. In solution, it is possible that copper can accept a ligand during
transition states where exogenous ligand can be detrimental.

In a closed mechanism, for

example, excess ligand can compete for palladium coordination sites required for
transmetallation. As a ligand scavenger, copper does not participate in catalysis. Copper has
also been shown to participate as a co-catalyst.

The organostannane is proposed to

transmetallate to copper, which in turn transmetallates to palladium.51 In all stereospecific
transformations reviewed by Mee, copper is used in a higher mole % than palladium, so it is
entirely possible that copper operates both roles.
Interestingly, an investigation into the proposed cyclic transition state revealed the
reversible nature of the Stille transmetallation event.52 In 2008, Espinet reported the retro-Stille
reaction of a stannylhalide with the prototypical transmetallation complex of palladium (Figure
2.11). They biased the palladium complex with carbon groups incapable of reductive
elimination, and generated organostannane via reverse-transmetallation. This result is notable
because it confirms the proposed reversibility of transmetallation in the Stille reaction.
Additionally, it alludes to the dynamic nature of this mechanism. If reductive elimination is a
sink that pushes the equilibrium in a productive direction, can other reaction conditions be used
to promote or retard the various other facets of this proposed catalytic mechanism?
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Retro-Stille transmetalation

Rf Rf
PdLn
Rf= 3,5-C6Cl2F3
L= AsPh3

Rf
Rf Pd L
L
I Sn(Bu)3

Rf
Rf Pd
L

Sn(Bu)3
I

L
Rf Pd I
L
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Figure 2.11: Retro-Stille reaction. Reverse transmetallation can occur in a system when
reductive elimination cannot. For reactions where reductive elimination is an option, irreversible
reductive elimination drives the equilibrium.

2.6 Stereoretentive modified-Stille cross-coupling of 2°alkyl tricarbastannatranes:
Tin handle:
The first example of an enantiospecific cross-coupling of a completely unactivated
2°organostannane was presented in Nature Chemistry by the Biscoe group in 2013.53 Their
process was developed to combine isolable, enantioenriched tricarbastannatrane (stannatrane)
nucleophiles, electronically diverse organic electrophiles, and mild, general reaction conditions
(Figure 2.12). This methodology was possible by leveraging two previously discussed concepts;
the configurational stability of organostannanes, and the subversion of β-hydride elimination.
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Stereospecific Stille reaction
R1
N
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CuCl, KF
Ar

(X = Br, I, OTf)
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CH3CN, 60 ºC

R1
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Figure 2.12: Stereospecific modified-Stille reaction. Reported by Biscoe, this is the first
example of a completely unactivated stereospecific transmetallation from tin.

The Biscoe group was able to avoid the traditional challenges associated with
organostannane transmetallation by utilizing a stannatrane backbone in their nucleophiles
(Figure 2.13). This scaffold was discovered by Jurkschat in 1985 54, and was applied by Vedejs
in 1992 for primary C(sp3) transmetallation.55 It is proposed that the lone pair on nitrogen
donates into the tin valence system, and selectively activates the bonded carbon towards
transmetallation. This form of activation is independent of the electronic and structural
properties of the desired group itself. Additionally, a stannatrane scaffold precludes the need for
dummy ligands, which increases the efficiency of the method. This solved the challenge
associated with weak nucleophilicity of unactivated secondary alkylstannanes, without
compromising the advantage of configurational stability.
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Tricarbastannatrane handle
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Figure 2.13: Tricarbastannatrane handle. The tin-chloride can be purchased commercially or
prepared via tris-hydrozirconation of triallylamine, followed by treatment with dilute
tintetrachloride (a). Racemic 2° alkyl tricarbastannatranes can be prepared by reaction with an
alkyl Grignard or lithium reagent (b).

Catalyst system:
Biscoe found that enantioenriched stannatranes were capable of transmetallation, and
were able to protect the integrity of the chiral center with a finely tuned catalyst system.
Phosphine ligands have been used extensively in metal catalyzed coupling reactions, and they
have become incredibly specialized over the last decade. The class of interest is the Buchwald
ligands, which contain a biarylphosphine core.56 These multifunctional ligands have been tuned
to promote the various stages in the catalytic cycle. The ligand that promoted the reactivity
reported by Biscoe is known as Jackiephos, shown in Figure 2.14-a. The phosphine in this
ligand is considered relatively electron poor due to the fluorinated aryl groups present. Electronpoor phosphine ligands are typically associated with weak oxidative addition, yet Jackiephos still
promotes effective insertion into organic electrophiles. In a mono-ligated Pd(II) complex, the
electron rich lower ring can rotate inward to stabilize the metal charge. This allows Jackiephos
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to act as a cis-frozen pseudo-bidentate ligand, occupying both one and two coordination sites on
palladium (Figure 2.14-b).

JackiePhos
OMe
(a)

(b)

OMe Ar

P(Ar)2

MeO
iPr

Ar
P

iPr

Pd(II)
iPr

iPr

CF3
iPr

iPr

MeO
iPr

Ar =
CF3

bidentate-like
coordination

MeO

iPr

Ar Ar
P
OMe

iPr

Pd(II)

open coordination
site

Figure 2.14: JackiePhos. The structure of the multifunctional Buchwald ligand, JackiePhos is
shown (a). Pseudo-bidentate coordination to palladium is made possible by rotation of P-C
bond, which allows for unique ligand behavior (b).

This characteristic is unique to the Buchwald ligands and has several effects on the
catalytic cycle. With the lower ring engaged, an open coordination site is protected from a
ligand substitution event typically associated with an open transition state. This allows for a
closed transmetallation event, promoting a retentive mechanism.
Cordovilla showed that coordinative isomerization of palladium can be detrimental.50 He
cited experimental evidence to discuss how rapid cis-trans isomerization of the substituents on
palladium give rise to non-productive complexes. He argues that trans isomers formed during
cross-coupling act as a palladium trap, as reductive elimination can only occur in the cisconfiguration. This behavior is avoided in a palladium/Jackiephos catalyst for two reasons.
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Jackiephos is thought to be too bulky to bis-ligate palladium in the active catalyst, and lower ring
stabilization leads to the cis configuration exclusively.
Lastly, the Biscoe system utilizes copper(I) chloride and potassium fluoride additives.
They cite the rationale first proposed by Simon Mee in 2004 that discusses the synergistic effect
copper salts and fluoride ions have on the Stille reaction.51 Mee acknowledged the role of copper
as a ligand scavenger in ethereal solvents, but suggests that polar solvents promote its utility as a
co-catalyst. Biscoe proposes a reversible transmetallation from tin to copper, which generates a
more reactive organocuprate. The corresponding tin-chloride is then trapped as the less soluble
tin-fluoride, which pushes the equilibrium in a productive direction (Figure 2.15).

Copper and Fluoride synergy
N

R1

Sn

R2

CuCl

N

transmetalation 1

R1
Sn Cl

Cu
R2

Ar
X Pd L
transmetalation 2

R1
L Pd
Ar

R2

KF

insoluble

N

Sn F

Figure 2.15: Copper and Fluoride synergy. Copper salts and fluoride ions have been shown to
have a synergistic effect on the Stille reaction. The rate acceleration is attributed to co-catalysis
with copper, and a tin-trapping event that biases reversible transmetallation towards the
organocuprate.
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2.7 Conclusion:
The end goal for cross-coupling reaction methodology is mild reaction conditions that
reliably join any two molecular fragments in a rational manner. To that end, unsaturated systems
have been thoroughly investigated, which led to an unprecedented expansion of utility. So much
so, in fact, that some argue our chemical discovery institutions are being biased by the simplicity,
reliability, and robustness of these techniques. Critics suggest diversity-oriented synthesis as a
way to circumvent this potential bias.
If the over-use of C(sp2) cross-coupling is indeed biasing our structural motifs, then why
not adapt these same methods to accept more complexity? Over the last decade, several prolific
research groups are trying to achieve just that. Adapting a cross-coupling reaction to accept
complex organometallic nucleophiles is one important step in that direction.
When coupling a C(sp2) electrophile with a C(sp3) nucleophile, the most common way to
avoid unproductive side reactions is by utilizing a system that promotes both fast
transmetallation and reductive elimination. More often than not, the coupling groups themselves
are modified to accelerate both fundamental transformations, which inherently limits utility.
However, modern developments of the Stille reaction have been shown to be incredibly general
in scope. The applications of these developments are still under investigation. This dissertation
focuses on attempts to simplify the underlying methods involved, in order to accelerate the utility
of what promises to be an invaluable tool for organic synthesis.
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CHAPTER THREE
Research Problem:
3.1 Introduction:
The previous chapter introduced the first modified-Stille reaction capable of the
enantiospecific cross-coupling of completely un-activated enantioenriched 2° alkylstannanes.
This was perhaps the most significant development for both the Stille reaction and stereospecific
translation of chirality in the last decade. This work introduced an alternative, arguably superior,
method to the Suzuki reaction for the formation of enantioenriched C(sp)2-C(sp)3 bonds.
However, close inspection of the substrate scope will show that a suite of racemic alkyl
stannatranes can participate in the reaction, but only a few examples of enantioenriched
substrates were used to confirm the mechanistic proposal.1
The rationale for this limitation is simple. Interest in the preparation of enantioenriched
organostannanes was limited because the species had relatively no synthetic value in crosscoupling. Prior to this modified-Stille technique, trimethyl or tri-n-butyl based stannanes were
used to transfer a more labile substituent, and attempts to cross-couple a secondary system was
fraught with challenges (refer to Chapter two, “Cross-coupling a C(sp)3 nucleophile” and
“Alkyltin nucleophiles for enantiospecific cross-coupling”). With a limited set of established
preparation methods, the Biscoe group was able to confirm stereospecificity using two
enantioenriched stannatranes, and three enantioenriched cross-coupling products (Figure 3.1).
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Enantioenriched stannatranes
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Figure 3.1: Enantioenriched stannatranes.
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In 2013, Biscoe reported the use of these

enantioenriched organostannanes in enantiospecific cross-coupling.

3.2 Substrate limitations:
From a diversity-oriented synthesis perspective, critics of the generality of this method
could point to the limited enantioenriched substrate scope. This is an inappropriate judgment,
however, because the true limitation lies with the preparation of starting materials. We believe
the substrate compatibility of this cross-coupling method to be very general, and that a wider
array of enantioenriched tin-based nucleophiles are needed to prove it. The development of a
proper synthetic method to prepare enantioenriched 2° alkylstannatranes is the main focus of this
thesis work.
The typical preparation of a racemic alkylstannatrane is the reaction of an alkyl
lithium/Grignard reagent with 5-chloro-1-aza-5-stanna-bicyclo[3.3.3]undecane (Chapter two,
Figure 12). This method does not typically require purification. It was used to prepare eight of
the nine tin nucleophiles reported by Biscoe in 2013.1 However, there are several limitations to

40

this approach. Alkyl lithium reagents are not conducive to diverse functionality, and under
normal conditions do not produce optically active products. One solution reported was the
implementation of preparatory scale chiral chromatography (Chapter one, “separation”). Biscoe
reported that compound 1 was prepared racemic in 79% yield, and resolution resulted in an
enantioenrichment of 94% ee with a maximum yield of 41%. Racemic compound 2 was prepared
with a yield of 80%, and resolved to 99% ee with a maximum yield of 40%.1
A second solution reported the use of a chiral induction approach (Chapter one,
“induction”). Compound 2 was also prepared in 93%ee directly, with the use of inherently chiral
(-)-sparteine. Beak showed that (-)-sparteine directs lithiation at the pro-S α-N position of
pyrrolidine (Figure 3.2).2

Preparation of enantioenriched stannatranes

MgCl Stannatrane chloride

Sn

N

prep-HPLC

Sn

Ph
Ph

N
Boc

2. Stannatrane chloride

Boc
N

Sn

N

Boc
N

prep-HPLC

80% yield
racemic

1. s-BuLi, (-)-sparteine

N
Boc

Boc
N

Sn

2. Stannatrane chloride

93% ee
63% yield

1

Ph
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41% max yield

79% yield
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1. s-BuLi, TMEDA

N

Sn

N

2

99%ee (S)
40% max yield
H

N

2

N
N
H
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Figure 3.2: Methods for functional stannatrane preparation. These two methods represent
the limited procedures available for preparation of enantioenriched stannatranes.
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Formation of Sn-C bond
(a) SnX

RM

SnR

MX

H2C CH2
(b) SnH

or

Sn-C

CH

SnR

MX

HC CH
(c) SnM

RX

Figure 3.3: Formation of Sn-C bond. The three typical methods to form a tin-carbon bond; a
carbon nucleophile with tin-halide (a), hydro-stannylation of an alkene or alkyne (b), or a tin
nucleophile with a carbon electrophile.

3.3 Formal research project:
The modified-Stille reaction represents a method to achieve general, rational, complexity
in target molecules, but the limitations described were a major bottleneck for broad utility within
the synthetic community. Therefore, our formal research goal was to develop a synthetic method
to prepare optically active 2° alkylcarbastanatranes to simplify the modified-Stille reaction.

3.4 Literature review:
Because our target scaffold was relatively unexplored, we began our search in the text. It
was found that there are really only three reliable techniques to generate a tin-carbon bond
(Figure 3.3).3 The carbon-nucleophile approach had already been investigated thoroughly by our
group. This approach describes the Beak lithiation and the formation of racemates requiring
separation. Although there are examples of stereospecific inversion by a 2° carbon nucleophile,4
the processes were not the simple, general preparation we were looking for.

The
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hydrostannylation approach seemed promising at first.

Initially we envisioned a

hydrostannylation/hydrogenation sequence from an alkyne. The literature is flush with methods
of enantiospecific hydrogenation, and both procedures are moderately functional group tolerant.
However, the approach relies partially on an isolable stannylhydride, which we have been unable
to isolate for stannatrane. It is believed that nitrogen-activation in the backbone results in a
hydride that is too unstable to be handled, so we abandoned the approach for now.
Tin-metallation was previously unexplored in our group.

Davies references the

successful use of tin-lithium, tin-sodium, and tin-potassium in his text.3 Use of lithium was
chosen due to its broader application in the literature.5 The primary method to prepare
stannyllithium is deprotonation of tin-hydride. This method is reliable for various trialkyl-tin
species, but was incompatible with stannatrane. The cleavage of a tin-tin dimer has also been
reported, but for similar stability reasons could not be explored further. The approach we were
most interested in was the direct single electron transfer method using tin-chloride and lithium
metal (Figure 3.4).

Methods of tin lithiation
(a) R3SnH

LiNiPr2

R3SnLi

HNiPr2

(b) R3SnSnR3 R1Li

R3SnLi R3SnR1

(c) R3SnX

R3SnLi

2Li

LiX

Figure 3.4: Tin lithiation. The three common ways to lithiate tin is by deprotonation of tinhydride (a), dimer cleavage (b), or direct reduction with elemental lithium (c).
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We came to this conclusion after a thorough review of the literature, when we came
across two extremely promising reports that utilize this approach. Traylor in 1981 showed that
optically active alkylstannanes would result from a two-step synthesis from butanol derivatives
(Figure 3.5).6 A chiral alcohol was activated to tosylate before nucleophilic inversion of the
leaving group with a trimethyl tin anion. Although the enantiomer analysis is just assumed, he
reported almost complete inversion of stereochemistry in the tetraalkyl tin product. He prepared
the trimethyltin anion by the addition of trimethyltin chloride to a cooled THF mixture of lithium
wire.
Traylor preparation of alkylstannane
OTs

SnMe3

THF, rt

Li SnMe3

30 min

D

D

Figure 3.5: Traylor preparation of alkylstannane.
tetraalkyltin

using

inversion

of

an

alkyl

20% yield
98% es*

Traylor prepared an optically active

electrophile

with

trimethylstannyllithium.

Enantiospecificity was approximated as 98%es from the reported alcohol and invoking a formal
SN2 mechanism.
Naphthalide catalyzed reduction
Li(0) excess

5%

Li+
R3Sn-Cl

Li-Cl

R3Sn-Li

Figure 3.6: Naphthalide catalyzed reduction of stannyl halide. Using an excess of lithium
metal in THF, a catalytic amount of naphthalene can reduce tin-halide to an anion.
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Although effective for his investigation, this route to tin-lithium reagents was plagued by
very low reaction yield, unstable reagent solutions, and the formation of several toxic
byproducts. Another work, by the Uchiyama group in 2015, reported a superior preparation of
tin-lithium reagents. This group prepared stable solutions of trimethyl, triphenyl, and tributyl
stannyl lithium, using an SET mechanism from a THF solution of naphthalide radical anion
(Figure 3.6). They were able to show that catalytic naphthalene, in a THF mixture of lithium
metal, was able to reduce both stannyl chloride and the di-tin analogues to a highly reactive tin
anion. They showed this reagent resulted in excellent NMR yields when trapped with an alkyl
electrophile.7 With these works in mind, we set out to adapt a naphthalide-catalysis procedure to
generate a stannatrane anion, which we envisioned would reliably invert optically active carbon
electrophiles.

3.5 Hypothesis:
An Uchiyama protocol can reliably convert optically active carbon electrophiles into
enantioenriched 2° alkyl stannatranes to simplify tin-based stereospecific transformations.
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CHAPTER FOUR
Development of a tricarbastannatrane nucleophile:
4.1 Approach:
With our knowledge from the literature in hand, we designed an investigation that would
determine the validity of our hypothesis.

We noted the electrophiles compatible with the

Uchiyama protocol, summarized in Figure 4.1. He reported essentially quantitative yields using
iodomethane, benzyl bromide, allyl chloride, and trimethylsilyl chloride.1 We noticed that there
were no examples of secondary alkyl electrophiles, and the leaving groups were exclusively
halides.
Although alkyl halides are useful substrates in synthesis, we quickly focused our
attention on alkyl sulfonate electrophiles. This decision was made for several reasons. Primarily,
carbon-halogen bonds are known to lack stability in the presence of radicals, which is not the
case for sulfonates. If we are to adapt this protocol for 2° electrophiles, we need to ensure little
to no racemization will occur. Secondly, from a utility standpoint, enantioenriched alkyl
sulfonates are trivial to prepare from commercially available alcohols. The third consideration
we needed to make was the structural and electronic differences between the reported tin
chlorides and carbastannatranes chloride. Uchiyama reported similar results with his standard
conditions for trimethyl, tri-n-butyl, and triphenyl tin chloride. Comparison of the 1H NMR
spectra of methyl-tri-n-butyltin and methylstannatrane shows a significant up-field shift for the
CH3 signal of methylstannatrane. This is evidence that nitrogen activation in the stannatrane
backbone increases the electron density of tin, potentially making it harder to reduce.
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Scope of electrophiles reported by Uchiyama
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(nBu)3Sn

94%

CH3
(nBu)3Sn Si CH3
CH3

91%

Figure 4.1: Scope of electrophiles compatible with tin-lithium: Uchiyama reported high
yields for primary alkyl and silicon halides.1

Initial development
CH3-I

(n-Bu)3Sn-Cl

10% Naphthalene
5 eq Li(0)
THF, rt, < 3 h

H3C Sn(n-Bu)3

H3C OMs

H3C Sn(n-Bu)3

(Bu)3Sn-Li
OMs
OMs

Sn(n-Bu)3
Sn(n-Bu)3

Figure 4.2: Initial development. Uchiyama protocol was reproduced and applied to racemic
sec-butyl mesylate. All products were confirmed on small scale, with NMR spectra conforming
to expectations.
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4.2 Initial development and challenges:
A preliminary set of experiments was used to determine whether or not this methodology
would result in a workable synthetic approach. The Uchiyama procedure was implemented with
tri-n-butyltin chloride and trapped with a variety of on-hand electrophiles (Figure 4.2). Success
with iodomethane gave us confidence to begin screening sulfonates. We were pleased to observe
little difference in reactivity based on the leaving group. Once the procedure was validated for 2°
alkyl sulfonates, we began to explore the generation of a tricarbastannatrane nucleophile. Our
initial results were discouraging, as we observed no reaction between sec-butyl mesylate and
stannatrane lithium prepared by Uchiyama’s conditions (Figure 4.3-a). We decided to switch our
substrate to iodomethane and more thoroughly investigate the reaction conditions. We found that
significantly increasing the amount of naphthalene and lithium could result in the target product.
The positive result was quite clear via proton NMR, due to the characteristic proton shift of the
methyl group at -0.3ppm in CDCl3. These results encouraged us to screen against more useful
electrophiles (Figure 4.3-b).
While still in small scale, we began to probe the stereochemistry of alkylstannatrane
formation with substrate 1 shown in Figure 4.4. This compound had been fully characterized,
and facile enantiomer separation with a strong UV-vis signal made it an ideal candidate for
optimization. Analysis of our first crude reaction resulted in 60% es for the two-step reaction.
This was extremely encouraging, and we continued with this substrate for our optimization
experiments.
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CH3-I
rt, 1 h

N

Sn CH
3

R-OMs

N

Sn R

N

Sn

THF, rt, < 3 h

(b)

N

Sn Cl

50% Naphthalene
Excess Li(0)

N

Sn Li

rt- 60 °C, 1 h

THF, rt, 1.5 h

s-Bu-OMs
R= CH3, CH2CH3

60 °C, 1 h

Figure 4.3: Stannatrane lithium development. Harsher reaction conditions were required to
promote the reduction of stannatrane chloride
Stereochemical probe
HO

Ph 2.0 eq. TEA
1.1 eq. Ms-Cl

DCM, 0 ºC - rt
(R)-(−)
4-phenyl-2-butanol
99%ee (HPLC)

Ph

MsO

0.8 eq. Sn-Li

N

Sn

1

THF, 60 ºC, 1 h
(R)
racemate ND

(S)

Ph

(S)
60% es

(R)

(a)

(b)

Figure 4.4: Stereochemical probe. The preparation and stereochemical analysis of crude alkyl
stannatrane 1. Separation of the racemate (a), compared to inversion (b).
50

The crude reaction contained several unknown impurities alongside excess alkyl mesylate
and naphthalene, so we explored purification techniques. Racemic stannatrane preparations are
normally clean enough to use without purification. Alkyl stannatranes are typically viscous oils,
so we knew crystallization was not a valid approach. We attempted typical column
chromatography techniques, but observed significant decomposition. We attributed this to the
known acidity of silica gel. The backbone activation that allows alkylstannatranes to participate
in transmetallation also promotes side reactions under oxidative conditions.

This will be

discussed in more detail in Chapter Six. Previous reports have highlighted the acidity of silica
gel, so we tried several techniques to modify acidity, including trace TEA in the mobile phase, a
silica/K2CO3 gel mixture, and various additions of alumina gel, but we could not suppress
decomposition and remove impurities within the same system.

Reverse-phase C18

chromatography proved to be the appropriate method of purification.

4.3 Optimizations:
Reproducibility:
In early development, we realized the conditions in Figure 3-b were clearly not optimal.
We observed very low calibrated yields, and became concerned when several trials inexplicably
failed completely. In order to gain a better understanding of the reaction, we initially optimized
for reproducibility.
A THF solution of tin-lithium presents as dark green/black and opaque, but the presence
of this color was found not to be deterministic. Trapping with an electrophile at the instance of
color yields no product. We undertook several strict rate experiments to determine the optimal
reaction condition (Figure 4.5). The generation of color seemed to indicate an initiation reaction
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(T1), but additional time was required to generate useful quantities of anion (T1 + time) (trial 1
and trial 3). This can be rationalized by the initial generation of a stannatrane dimer, followed by
a slower, second reduction to an anion. Additionally, we found that once generated, the reaction
with an electrophile was fast (trial 3 and trial 5), but still not reproducible (trial 1, 3, and 6).
We then started to probe the role of each reagent in the initial mixture. Starting with
lithium, we observed peak reactivity somewhere around 2 hours. We subjected a pre-made
solution of Sn-Li to additional contact with lithium, and noted a decrease in yield. We also noted
a rapid rate increase in color generation with the addition of higher concentrations of
naphthalene. Interested by this, we set out to understand the real concentration of naphthalide is
in solution. If naphthalide behaves as a stable radical, directly reducing the tin-chloride, we
would expect to see formation of stoichiometric tin-lithium when more than 2 equivalents of
naphthalide are prepared.
Naphthalide was pre-formed in THF using an excess of lithium under 1x and 2x
concentrations, and allowed to stir overnight. To the resulting black solutions was added enough
tin-chloride to result in 3 equiv. and 6 equiv. of naphthalide. The reactions were allowed to stir
for 4 h at rt, and were quenched with iodomethane. The reactions were found to contain no
product. This was evidence that the real concentration of naphthalide is very low, and there
might be an equilibrium reaction between the lithium naphthalide and corresponding lithium
metal plus naphthalene (Figure 4.6). If this is true when using a large excess of lithium metal,
the resulting equilibrium could lead to incredibly high surface area lithium metal suspended in
solution, along side the tin-lithium generated.
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Time requirements for Sn-Li generation
(a)

50% Naphthalene
Sn Cl 15 eq. Li(0)
THF, conditions
1.0 eq

N

N

Sn Li

1.5 eq. R-OMs

N

Sn

Ph

conditions

(b)
T1 + time

rt, time

R-OMs
temp, time

T0

T1

NSn-Li

(c)

Trial

T2(min)

T2+ time

E+ + time

temp (°C)

NMR Conv %

1

18

1hr

1h

rt

50

2

18

2hr

1h

rt

60

3

18

3hr

3h

rt

80

4

18

3hr

3h

-4

75

5

18

3hr

20 min

rt

80

6

< 30

50min

2h

rt

80

7

< 30

50min

4h

rt

80

8

< 30

50min

0.5 h

50

80

9

< 30

50min

4h

50

80

Figure 4.5: Time optimization. A visualization of the reaction scheme is reported (a). T0 is
defined as the time of solvent injection. T1 is defined as the time that a dark colored opaque
solution is observed (b). Conditions in blue refer to the generation of Sn-Li, while conditions in
green refer to the inversion reaction with Sn-Li (c).
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Potential equilibrium reaction
Li

Li(0)

Figure 4.6: Equilibrium reaction.

The possible equilibrium between naphthalide and

lithium/naphthalene. In an environment with excess lithium, could lead to high surface area
lithium metal in solution.

Additionally, we found our magnetic PTFE stirbars were being destroyed by the reaction
conditions. In order to remove unknown variables, we tried sonication as a method of mixing.
Sonication at 45 °C resulted in faster initiation times, and removed the uncertainty of side
reactions with PTFE. Signs of reproducibility began to emerge, so we reduced the amount of
naphthalene/lithium to 10% and 2.2 eq. respectively. We found the new preparation to be
superior, and were pleased to observe reliability in our method among multiple trials.

4.4 Stereospecificity:
The next optimization we targeted was the enantiospecificity (% es) of the inversion. %
es is a more valuable tool for quantification of stereocontrol, because it isolates racemization to a
specific synthetic step. % es is defined as the enantioenrichment ratio of products to reactants (%
ee products/ % ee reactants).

A typical confirmation of stereospecificity involves several

instrumental steps that rely on analytical chiral resolution. Chiral resolution of the racemic
starting material and corresponding racemic products must be acceptable prior to a
stereochemical analysis. This way, we can define a method that will quantify the enantiomer
ratio of a stereospecific reaction. For the analysis reported in Figure 4, we prepared the racemic
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product with known methods and resolved the enantiomers with a Chiralcel OJ-RH chiral
column.
The reproducibility optimizations had little to no effect on enantiospecificity, which
varied around 55-80%es. We then began to run the inversion reaction in non-polar solutions of
mesylate, and quickly found encouraging results. By adding the THF solution of stannatrane
lithium to an n-hexane or ethyl ether solution of mesylate, we could completely suppress
racemization and confirm 100%es from the starting chiral alcohol (Figure7). It’s possible that
less polar solvents disrupt unproductive Sn-Li aggregation states.
Solvent Screen
N

Sn Cl

10% Naphthalene
2.2 eq. Li(0)

N

THF, 45 °C, 3h

Sn Li

1.0 eq. R-OMs

N

Sn

Ph

Solvent, rt, 1 h

1.5 eq

Solvent

mL

Cal NMR

ee%

1

THF

0.5 THF

74

74

2

THF

1.25 THF

54

76

3

0.5 n-hex

0.5 n-hex

68

>99

4

Et2O

0.5 Et2O

63

>99

Figure 4.7: Solvent screen. The results from a solvent effect investigation. It was found that
less polar solvents prevent racemization of the reaction.
References:
1.
Wang, D. Y.; Wang, C.; Uchiyama, M. J. Am. Chem. Soc. 2015, 137 (33), 10488.
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CHAPTER FIVE
Application:
This chapter will focus on the first goal of our hypothesis, the preparation of
enantioenriched 2° alkylstannatranes. Prior to this investigation, alkylstannatrane synthesis could
be considered prohibitively expensive. Prep-scale resolution of racemates added significant wait
times to any planned investigation, and generally led to optically active molecules without
defined stereochemistry. These limitations resulted in starting material that was precious and
difficult to obtain. We developed a method to prepare them reliably in-house, with defined
stereochemistry, and were able to obtain useful quantities of several known compounds.
Additionally, we used this method to easily generate novel molecules difficult or impossible to
make via known methods. This allowed us to investigate the second goal of our hypothesis, the
simplification of stereospecific transformations of novel tin nucleophiles. These transformations
will be discussed in the next chapter. What follows is the rationale and results of our target
scaffolds.

5.1 2-Butylcarbastannatranes:
Control of reproducibility and enantiospecificity encouraged us to begin implementing
the Sn-Li procedure at scale. Having confirmed the formation of compound 1 in 50% isolated
yield in 99%es on small scale, we shifted our attention to an enantioenriched sec-butyl system.
Sec-butyl carbastannatrane is a deceptively difficult target for cross-coupling. Unactivated
secondary systems are difficult to transmetallate, and sec-butyl is arguably the least activated 2°
chiral substituent possible. The electronic and steric similarity of the two groups on the chiral
carbon make enantiodifferentiation difficult, and enantiomer resolution at scale is highly
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unlikely. To date, there is no alternative method to prepare this type of enantiopure product. We
observed complete inversion and acceptable yield for compound 2 and 3 (Figure 5.1).

Alkyl stannatrane scale up
(R)-4-phenylbutanyl)
mesylate
n-hexane, rt, 1 h

N

Sn Cl

10% Naphthalene
2.2 eq. Li(0)

N

Sn Li

THF, 45 °C, 3h
1.2 eq.
2.4 mmol

(R)-sec-butyl mesylate

N

Sn

Ph 1

41% yield
98% ee
99% es

N

Sn

2

52% yield
98% ee*
99% es*

N

Sn

3

47% yield
91% ee*
100% es*

n-hexane, rt, 1 h

(S)-sec-butyl mesylate
n-hexane, rt, 1 h

Figure 5.1: Primary scale up of enantioenriched alkylstannatrane. Our initial scale up
results for the 2 mmol reaction of optically active alkyl mesylates. *Enantiospecificity of secbutyl stannatranes approximated by derivatization via cross-coupling and chiral-GC of the
starting alcohol.

5.2 3-Octylcarbastannatrane
A potential criticism of the modified-Stille cross-coupling system is that many of the
acyclic 2° tin compounds used contain an α-methyl group. Although doubtful, it is possible
more internal positions on an unactivated nucleophile could hinder the quick transmetallation our
arylation protocol relies on. It is also possible that the transmetallation complex, now bulkier
due to the more internal position, could begin to show signs of isomerization. We decided to
probe this using an octane nucleophile. If there were dependence, the cross-coupling results of
the 1, 2, 3, and 4 position on octane would reveal it. The confirmation of n-octane transfer was
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unnecessary, because Vedejs had successfully coupled an n-butyl group with a variety of aryl
bromides using the stannatrane scaffold in 1992.1
We already had evidence that the 2 position was stereospecific, so we targeted the three
position of octane for enantiomer analysis. The Biscoe group had also confirmed excellent yield
for the racemic cross-coupling of the 3 position, but due to difficulties in chiral resolution, was
unable to confirm enantiospecificity. We implemented the tin-lithium procedure with racemic 3octyl mesylate to prepare compound 4. The inversion went smoothly and we observed 50%
yield (Figure 5.2). The first step in the stereospecificity proof, the necessary resolution of the
racemate, has failed. Indirect analysis by resolution of cross-coupling derivatives has also failed.
Enantiomer analysis of this compound is ongoing. We believe, similar to sec-butyl groups, that
similarity of substituents on the chiral carbon are leading to difficulties in analytical
enantiodifferentiation.

3-ocyl stannatrane
N

OMs
Et

Pent

1.5 eq Sn-Li

Sn

4, 50% yield

THF, rt, 2 h
Et

Pent

Figure 5.2: 3-octyl stannatrane. The racemic mesylate led to the target product in acceptable
yield. Attempts to resolve the alcohol, mesylate, stannatrane, and four of its cross-coupling
derivatives have failed.
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5.3 Silyl-Protected alcohol 5:
Another nucleophilic substrate of interest is the primary alcohol derivative of sec-butylstannatrane, compound (6) shown in Figure 5.3. The cross-coupling of this substrate would
emphasize the functional group compatibility of the modified-Stille reaction. Starting from
commercially available 1,3-butanediol, we employed an established two-step procedure to
acquire the TBDMS protected, enantioenriched 2° alkyl mesylate. The inversion with Sn-Li also
proceeded smoothly. Compound 5 was then subjected to a known deprotection protocol. We
observed an 85% yield for the deprotection step, and a direct enantiomer analysis revealed an
enantiospecificity of 99%.

Enantioenriched alcohol synthesis

(R)

1.2 eq TBS-Cl
10% DMAP
2eq TEA

OH
OH

OH
O

DCM
rt, 12h

80%

n-hexane, rt, 2 h

OMs
O

Ether, rt

Si

90%
N

N

1.5 eq. Sn-Li

Si

1.5 eq Ms-Cl
2eq TEA

TBAF,
0°C, 20min

Sn
O
5, 45%

Si

THF
rt, 1 h

Sn
(S)
OH
6, 85% yield
99% es

Figure 5.3: Synthesis of enantioenriched alcohol. The target alcohol was prepared in 4 steps
from enantioenriched (R)-(-)-1,3-butanediol.
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5.4 Alkene:
Success with the new classes of substrate encouraged us to investigate the tolerance of tin
lithium inversion to areas of unsaturation. From a total synthesis perspective, it is valuable if
cross-coupling techniques can introduce handles for further chemical manipulation. With this in
mind, we targeted a terminal and a substituted alkene, and obtained the commercially available
4-penten-2-ol, and 6-methyl-5-hepten-2-ol. We observed compounds 7 and 8 in yields of 25%
and 55% respectively (Figure 5.4). We attribute the decrease in yield for 7 to the potential for
deprotonation/elimination of the alkylmesylate. We suspect there to be competing elimination in
all of our tin-lithium reactions, which could be attributed to the basicity of the tin anion. No
efforts to probe this specific phenomenon have begun yet. Attempts to resolve compound 7 and 8
directly have failed. Separation of a derivative of compound 8 has been achieved, allowing for
an assignment of 99% es of the alkylstannatrane.

Inversion of alkene-containing electrophiles
N

OMs

1.5 eq Sn-Li

Sn

THF, rt, 2 h

7, 25% yield

N

OMs

1.5 eq Sn-Li
n-hexane, rt, 2 h

Sn

8, 55% yield
99% es*

Figure 5.4: Inversion of alkene-containing electrophiles. We observed 25 and 55% yield for
the inversion of a terminal and internal alkenyl mesylate. *Enantiospecificity of internal alkene
was approximated by derivatization via cross-coupling and chiral-GC of the starting alcohol.
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5.5 Ester:
An ester-containing nucleophile is another valuable substrate from a total synthesis
perspective.

Like the alkenes, this would introduce a useful chemical handle for further

derivatization.

Our previous method for obtaining a stannatrane ester relied on multiple

synthetic steps and chiral prep-HPLC separation of the racemate (Figure 5.5). Starting from the
mesylate of the commercially available ethyl 3-hydroxybutyrate, we prepared the zinc iodide,
and quenched with stannatrane chloride. The material was then outsourced for enantiomeric
separation. Although the method was successful, the four steps plus enantiomeric separation was
not conducive to a process with common synthetic utility.
Synthesis of ester-containing nucleophile
OH

EtO

OMs

EtO
O

O

O

(a)
ZnI

EtO

OMs

EtO
O 9

Sn

EtO

O

(b)

I

EtO

N

10

O

Sn-Zn(Et)2Li
n-hexane

Sn

EtO
O

N

10,
60% yield
50% es

Figure 5.5: Synthesis of ester-containing nucleophile. The prior method to obtain the
compound 10. The commercially available alcohol was activated to a sulfonate with known
methods.

The resulting mesylate was then substituted with sodium iodide to form the

alkyliodide. Insertion with zinc metal led to the alkylzinc iodide, which was then quenched with
stannatrane chloride (a). Racemization of final product is found with the direct inversion of
compound 9 with tin-zincate (b).
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We set out to implement the tin-lithium procedure in one step from compound 9. We
quickly found that decomposition of the mesylate is the prominent transformation, and observed
calibrated yields of 0-5% of alkyl tin using our standard conditions. Discouraged by this, we
went back to the literature and found precedent discussing several methods to attenuate the
reactivity of tin-lithium. Some examples of interest include multidentate-ligation with alkyl
amine, tin-zincate, tin-cuprate, and tin-magnesium compounds.2-8

These methods will be

discussed in a later section in more detail.
Substitution of the compound 9 using the standard tin-lithium conditions is prohibitively
low yielding, but the reaction with tin-diethylzincate resulted in compound 10 with an isolated
yield of 60%. Disappointingly, enantiomer analysis revealed complete racemization. When
utilizing tin-zincate with electrophiles that do not contain a carbonyl, we discovered
racemization did not occur.
Tin-zincate substitution reaction

OMs

EtO

Sn-Li

OMs

Sn-Zn(Et)2-Li

Sn

EtO

O

5% calibrated yield

N

60% isolated yield

O

OMs

EtO

N

O

O
EtO

Sn

EtO

Sn-Zn(Et)2-Li

Sn

EtO

O

N

50% es

O

Figure 5.6: Tin-zincate substitution reaction. Vastly different reactivity is observed for
substitution of an ester-containing electrophile.

Superior yield is observed in the racemic

substitution using a novel stannatrane-zincate, but the process does not lead to enantiopure target
molecules.
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Attempts to control enantiopurity have failed. Optimization of solvent, temperature, and
reaction time have led to products with a maximum of 50%ee (Figure 5.6).

Although

elimination is still possible, we believe the tin-lithium reacts directly with the carbonyl, resulting
in very low yields. Reaction with tin-zincate results in a higher overall yield, but the mechanism
is not stereospecific. Racemization with tin-zincate might be attributed to a pre-coordination
event between the carbonyl and zinc. Although compound 10 was not prepared with a high %
ee, this method is still an improvement. Our previous method was reduced to two steps, and the
target enantiomer can be generated in a higher overall ratio.

5.6 Derivatization of alkylstannatranes:
Success with alkene- and alcohol-containing substrates allowed for chemical
manipulation post stannatrane installation. Previous experiments in the lab have shown the Sn-C
bond to be stable to reductive conditions. An example of this is the formal reduction of the esterstannatrane with lithium aluminum hydride, which will be discussed in a later section.
With compound 5, we wanted to know if protecting group manipulation was possible.
We already knew silicon based protecting groups were undisturbed by inversion and crosscoupling conditions. We also knew the stannatrane backbone was not disturbed by the silyldeprotection protocol. With this in mind, we attempted a one pot protecting group substitution
with benzoyl chloride (Figure 5.7). We achieved an isolated yield of 88% of compound 11, and
confirmed stereospecificity of 99% es after hydrolysis of the protecting group. This important
substrate not only highlights the stability of alkylstannatrane to reductive conditions, it
exemplifies the ability to incorporate orthogonal protecting group strategies should the need
arise.
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Protecting group manipulation
N

N

1) 1.2 eq. TBAF
THF, 0 - 25 ºC 3 h

Sn
O

Si

Sn

O

2) 4 eq. TEA, Bz-Cl
THF, rt, 12 h

O

Ph

11
88% yield
99% es

Figure 5.7: Protecting group manipulation. We highlight stannatrane backbone reaction
stability by preparing an orthogonal protecting group in one pot from the TBDMS protected
alcohol. We isolated this compound in 88% yield with a confirmed enantiospecificity of 99%.

In addition to protecting group manipulation, we targeted compound 7 for addition
reactions. We found that diborylation was possible in the presence of potassium carbonate and
water in t-butanol solvent. This reaction afforded compound 12 in 71% yield with a dr of 1:1.2
(Figure 5.8). Reactions utilizing these novel nucleophiles will be discussed in Chapter 6.

Diborylation of alkene
N
Sn

3 eq. (BPin)2
4 eq. K2CO3
H2O, t-BuOH,
60 ºC, 12 h

N
Sn

BPin
BPin

12
71% Yield
1:1.2 dr

Figure 5.8: Diborylation of alkene. A racemic, alkene-containing stannatrane was successfully
diborylated under reductive conditions. Compound 12 contains 3 metallic handles for further
chemical manipulation.
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5.7 Alternative sources of tin anion:
As previously mentioned, our successful preparation of the tin anion opened the door to
other metal-based tin nucleophiles. It has been previously reported that anionic tin is capable of
transmetallation from lithium to various other metals. The more established transformations are
that between tin and zinc. First described in 1966 by Noltes, and further developed by Nozaki in
1984, various bonds between tin and zinc have been used for addition reactions to alkynes.4, 5
The concept of attenuating the reactivity of the tin nucleophile via transmetallation was
extremely attractive to us.
We also found precedent for the less well-known reactivity of tin-cuprate and tinmagnesium compounds. The first example of a synthetically useful tin-copper based reagent was
by Piers, in 1978.7 He was able to transmetallate from lithium to copper, and use the resulting
reagent for conjugate addition reactions. By direct comparison, he was able to show the
divergent substrate reactivity between tin-cuprate and tin-lithium (Figure 5.9). He observed
incomplete conversion and/or di-addition when using tin-lithium and substrates represented in
Figure 9-a. Addition of 1 equiv. of copper phenylthiolate to a cold solution of tin-lithium
resulted in excellent yields for the same substrates. Conversely, he reported a superior yield with
tin-lithium when using reagents represented in Figure 9-c. He also reported several examples of
comparable reactivity (Figure 9-b).
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Stannyl lithium vs. cuprate

yield %
1.0 eq
O

O

X = Li

X = Cu

*

86

93

76

74

*

1.1 eq. Sn-X

(a)

SnMe3

I

O

O
1.1 eq. Sn-X

(b)

SnMe3
O

O
(c) EtO

1.1 eq. Sn-X

EtO
SnMe3

Figure 5.9: Stannyl lithium vs. cuprate reactivity. The addition of PhSCu to a solution of
stannyl lithium results in divergent reactivity of conjugate addition reactions.7 *Yield of target
not reported, investigation references either predominant di-addition or recovery of starting
materials.

Tamborski and Soloski reported a magnesium-based source of tin in 1961.

They

described the structure of this compound as [(Ph)3Sn]2Mg, but did not report much in the way of
synthetic utility.8 More importantly, their work led to the development of (Ph)3SnMgBr by
Creemers in 1969.3 This was further developed in Valade in 1971 for additions to unsaturated
ketones.6 We predicted similar functional group compatibility problems using stannatrane as a
Grignard reagent. Looking further, we came across a methyl-magnesium tin derivative. First
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discovered by Nozaki in 1984, this reagent was used in stannyl-metallation reactions with
terminal acetylenes.5
Perhaps the better-known possible modifications to lithium reagents come in the form of
alkyl amine ligation. Although the data can sometimes be contradictory, Collum highlighted
several advantages to using alkyl amine ligands for reactions using carbon-based lithium
reagents (Figure 10). Published in 1992, he discussed the impact of TMEDA as a modifier for
organolithium reactivity.2 His review questioned the commonly accepted mechanistic rationale;
that evidence of strong solvation, low aggregation, and high reactivity are individually accepted
as evidence of the other two. Regardless of mechanism, the results using amine ligation for
stabilization and robustness via lithium coordination seemed a valuable system to try.

If

stannatrane lithium exists in an aggregate state like the carbon example in Figure 5.10, perhaps
use of a coordinating ligand would be beneficial. We predicted our moderate yields would
improve, and that racemization pathways might be reduced or suppressed by the addition of
alkylamine coordinating groups on lithium.

TMEDA and lithium aggregates
Li
C R

R C
Li

TMEDA

N
2 R C Li
N

Figure 5.10: TMEDA and lithium aggregates. The addition of amine ligands has a beneficial
effect on carbolithium nucleophiles. It is proposed that naturally occurring conglomerate states
(left) are disrupted (right).
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With all these possible modifications in mind, we targeted zinc, magnesium and nitrogen
as the most likely methods of attenuation (Figure 5.11). Using compound 19 as a model
substrate, we were able to compare the reactivity and stereospecificity of the six unique tin
anions.
We found little difference in yield or % es when using compound 13 or 14. We found a
significant decrease in yield when using compound 15. All other sources resulted in a slight to
significant reduction in NMR yield. We found enantiospecificity remained intact for all sources
except for the tridentate PMDTA (Figure 5.12). Moving forward with the more functionalized
compound 9, we found that compound 14 gave a vastly improved yield, but resulted in a
disappointing amount of racemization in the final product (Figure 5.13).

Additional

nucleophilic sources of tin are still being investigated in these reactions.
Transmetalation from lithium
1.1 eq. Zn-(Et)2

N

Sn

N

Sn Zn Sn

0 °C, 1 h

N

Sn Li

13
1.0 eq.
0.3M in THF

0.49 eq. Zn-Br2
0 °C, 1 h

Zn(Et2)Li

14

N

3.0 eq. TMEDA
0 °C, 1 h
3.0 eq. PMDTA
0 °C, 1 h

15

N

Sn

Li-TMEDA

16

N

Sn

Li-PMDTA

17

N

Sn MgCH3

PMDTA
N

N

N

0.9 eq. CH3MgI
0 °C, 1 h

18

Figure 5.11: Transmetallation from lithium. A solution of tin-lithium was subjected to
attenuating metals or nitrogen ligands to investigate reactivity with model carbon electrophiles.
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Inversion with alternate tin sources
Ph

OMs 1.2 eq. Sn-X

19

N
Sn

Ph

n-hexane, rt

Sn source

NMR yield %

ee %

13

80

98

14

NA

97

15

< 20

NA

16

65

97

17

50

90

18

40

97

Figure 5.12: Inversion with alternate sources of tin. The six tin anions were used with the
model substrate to probe yield and enantiopurity of the target stannatrane.

Inversion with functional electrophile
EtO

N

OMs 1.2 eq. Sn-X

O

Sn

EtO

solvent, rt

O

9

Sn Source

yield %

solvent

ee%

13

<5

THF

NA

14

60

THF

NA

14

NA

n-hexane

50

14

NA

ether

0

14

NA

THF

0

Figure 5.13: Inversion with functional electrophile. The reactivity of nucleophiles with an
ester-containing mesylate is observed.
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5.8 Inversion limitations:
Ideally, our lab would utilize this process for a wide range of enantioenriched
electrophiles for which inversion is a valid mechanism. To a degree, we have accomplished that
goal. Our system can tolerate various positions of branched alkanes, substituted or terminal
alkenes, and silyl protected alcohols. It is also useful in reducing the total number of synthetic
steps to form some of our more interesting cross-coupling nucleophiles, while simultaneously
reducing our dependence on chiral prep-HPLC.

Incompatible scaffolds
(a) OMs
O

OMs

O
OMs

OMs

(b)

RN

OMs

OMs

OEt
O
no reaction

OTs
CF3

(c)

RN

tBu
OMs

OMs
R

unstable compounds

O

complete decomposition

Figure 5.14: Incompatible scaffolds. The incompatible carbon electrophiles fall into three
groups; electrophiles that result in unstable alkylstannatranes (a), do not participate in the
reaction (b), or those that decompose completely (c).

During our electrophile investigation, we discovered several classes of compounds with
which our current system is not compatible (Figure 5.14). Perhaps the most important limitation
we found is with electrophiles that contain a carbonyl. The literature reports tin-anion reactivity
at the carbonyl of aldehydes, and our own experience with compound 10 shows complications
when carbonyls are present.
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Another limitation we found was our work with cyclic and heterocyclic structures. We
observed compatibility with the alicyclic structures of cyclohexyl and cyclopentyl mesylate. We
found these compounds formed the expected products with calibrated HPLC yields in line with
our expectations. Further pursuing of the mesylates from 4-tert-butylcyclohexanol and ethyl 3hydroxycyclohexane-1-carboxylate, we observed no reaction (Figure 14 group-b).

This is

evidence that the tricarbastannatrane anion is too bulky to overcome 1,3-diaxial hydrogen
interactions.
Other structures of interest to us are common heterocycles (Figure 14 group-a). We’ve
previously highlighted the stability and utility of stannatrane nucleophiles containing αheteroatoms in cyclic structures, so we looked at scaffolds containing β-heteroatoms. Results
with group-a electrophiles were discouraging. We observed the 60-80% NMR yields in the crude
reactions, but isolation and handling led to complete decomposition.

5.9 Scope:
We have directly prepared several enantioenriched alkylstannatrane nucleophiles suitable
for stereospecific transformations (Figure 5.15). We have explored the 2 and 3 position of
completely un-activated carbon chains, substituted and terminal alkenes, and a silyl protected
alcohol (Figure 5.15-a). Additionally, this process resulted in access to the free alcohol, the
benzoyl protected alcohol, and the di-borylated alkene (Figure 5.15-b). In future investigations,
we will more thoroughly evaluate the inversion of electrophiles containing protected aldehydes,
ketones, amides, and begin to explore nucleophilic tin in addition reactions.
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Scope of 2º alkylstannatranes prepared by inversion

(a)

Sn
(±)
(R)
(S)

50%, (NA)
50%, (99%)
50%, (99%)

Sn
(±)

N

Sn
Ph
(±)
(R)
(S)

N

50%, (NA)

Sn

50%, (NA)
50%, (99%)
50%, (99%)

Sn
(±)
(S)

N

(c)
Sn

N

Sn

N

(±) 25%, (NA)

N

50%, (NA)
55% (99%)

N

Sn
TBDMSO
(±)
(S)

N

45%, (NA)
45%, (99%)

(b)
Sn
HO
(±)
(S)

N

Sn

N

BzO
85%, (NA)
85%, (99%)

(±)
(S)

Bpin

Sn

N

Sn

N

O

Bpin
85%, (NA)
85%, (99%)

EtO

(±)

70%, (NA)

(±) 60% (NA)

Figure 5.15: Scope of 2° alkyl stannatranes prepared by inversion. Access to these
compounds have been achieved by inversion (a, c), or a derivatization that depends on the
inversion reaction (b).
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CHAPTER SIX
Simplification of stereospecific transformations:
The Suzuki reaction has had an undeniable impact on the ability to forge a variety of
enantiospecific bonds. However, the various limitations discussed in Chapter two describe the
structural limitations of that approach. The modified-Stille reaction has been shown capable of
avoiding those mechanistic and substrate limitations. The preparation of organostannanes has not
been investigated nearly as thoroughly as that of organoboron, which has resulted in relatively
little utility in synthesis.

Additionally, the methods that were established relied on harsh

conditions and expensive separations. The first goal of the hypothesis was to develop an
alternative synthesis of alkylstannane targets of interest, and that goal was accomplished.
The second goal of the hypothesis, however, is to elucidate a possible effect on the
broader utility of tin-based stereospecific transformations. The stannatrane scaffold has been
found to uniquely activate a general scope of 2°alkyl coupling partners in stereospecific arylation
cross-coupling reactions 1. Additionally, our lab discovered they participate in acylation crosscoupling and electrophilic halogenation reactions with excellent stereospecificity.2,

3

This

chapter focuses on the impact of the tin-lithium development on the ability to easily implement
stereospecific transformations from tin.

6.1 Mechanistic determination via stereospecificity and absolute configuration:
The overarching theme of this dissertation is predictable, versatile, stereospecific
transformations. To assign mechanistic information to a specific reaction, stereospecificity of the
reaction must be determined. The analysis techniques typically performed are chiral HPLC, GC,
and to a lesser extent, optical rotation. In order to assign stereospecificity for organostannane
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reactions, a several-step synthetic process is typically employed. A racemic alkyltin is prepared,
and the enantiomers are resolved analytically. An enantioenriched sample is then prepared, and
the single enantiomer is confirmed with the same technique. The organostannanes are then
subjected to a reaction, and a resolution method for the products is developed. We then observe
the peak ratios for the enantioenriched products and starting material, and assign a % es value (%
ee product / % ee starting material). This value accurately describes the degree to which a
reaction has not racemized during the specified transformations. This is evidence of
stereospecificity, but not mechanism.

In order to rationally incorporate a chiral group in

synthesis, we need the ability to assign an invertive or retentive mechanism for the
transformation.
Absolute configuration analysis of the starting material and product can result in
mechanistic insight. However, this process is not trivial. Several of the common techniques
include X-ray crystallography, derivatization followed by NMR, circular dichroism (CD) or
empirical correlations from the literature.4-7 Each of these techniques is a broad, independent
scientific field, so will only be mentioned in the context of the applicability to our methods.
Prior to the development of tin-lithium, our lab found it difficult to confirm the absolute
configuration of alkylstannatranes. We could independently confirm proper resolution of the
racemate, but were unable to implement the above-mentioned techniques for a variety of reasons.
The majority of alkylstannatranes present as viscous oils, so that precluded XRD as an option.
We attempted several vibrational circular dichroism (VCD) analyses, but it proved to be less
accurate with complex tin compounds.

The tin-lithium reaction allows us to define the

stereochemistry of alkyltins by assigning inversion through SN2 from the starting alcohol. We
can then implement one of the above-mentioned techniques on the more well-behaved organic
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cross-coupling products.2,

3

We used this method to confirm the absolute configuration of

compound 1.

Proof of absolute configuration with tin-lithium procedure
N

Sn

LiAlH4

O

N

N

Sn

Sn

1) Sn-Li

OMs OTBDMS

2) TBAF
OEt

1

OH
(racemic)

OH

from Sn-Li
(racemic)

from prep-HPLC

Figure 6.1: Proof of absolute configuration. Starting from commercially available alcohols
with defined stereochemistry, we were able to define an important substrate empirically by
derivatization.
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We wanted to compare the single peak from a prep-HPLC resolution of with that of the
same compound from a tin-lithium reaction.

For ease of resolution, we chose to target

compound 2. As mentioned before, a large advantage to using stannatrane is that it seems
infinitely stable to reductive conditions. This permits functional group manipulation after the
tricarbastannatrane backbone is installed. We reduced both a racemic and prep-HPLC
enantiopure sample of compound 1 with lithium aluminum hydride (Figure 1-a), and resolved the
enantiomers with a Chiralpak-IA column. We then compared the trace to that from a reaction
that utilized tin-lithium (Figure 1-b). We determined the absolute configuration for peak 2 to be
(S) (Figure 6.1). This method has greatly reduced the difficulty in assigning stereochemistry to
our starting substrates, and is the basis for our mechanistic proposals.

6.2 Acylation:
The arylation reaction developed in 2013 showcased the reactivity and configurational
stability of unactivated alkylstannatranes.1 Our lab then began to exploit additional reaction
pathways. During the early development of the Stille reaction, acyl-chloride reagents were found
to be acceptable coupling partners.8, 9 These reactions were limited to the typical stannanes
previously discussed (Chapter two, “Alkyltin nucleophiles for enantiospecific cross-coupling”).
This adaptation was developed further for the stereospecific cross-coupling of alkyltin species,
but were strictly limited to transmetallation of activated coupling partners.10, 11
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Enantioenriched ketone synthesis
O

OM
(a)

XR2

R3

R2

M
R2

O

O

R1
(b)

R1

R3

R3

R3

X

Figure 6.2: Enantioenriched ketone synthesis.

R1
R2

To prepare enantioenriched kentones, an

alternative to the stereospecific enolate reaction (a) is the cross-coupling of an organometallic
nucleophile with an acyl-halide (b).

Our lab began to pursue an adaptation of the acylation reaction to capitalize on the
superiority of carbastannatrane as a metallic handle.

The total transformation of such an

approach results in the selective generation of α-substituted ketones, a product typically formed
by an asymmetric enolate reaction (Figure 6.2). Asymmetric enolate chemistry implements a
catalyst or chiral auxiliary to control deprotonation, facial attack, and chemoselectivity. Chiral
information is imprinted on the substrate via enantiodifferentiation between the two possible
transition states of enantiomer formation (Figure 6.2-a). The limitations of this method were
previously discussed (Chapter one, “induction”).

The ability to couple an acyl group

stereospecifically via cross-coupling would represent a general alternative method to synthesize
α-substituted ketones (Figure 6.2-b).
The first example of this type of bond formation was developed by Falck in 1994 (Figure
6.3).11 He successfully coupled a wide variety of acyl chloride electrophiles and α-heteroatom
containing organostannanes with a palladium/copper cocatalyst system.

He reported an

impressive substrate scope, and an enantioenriched example that resulted in products with 98%
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stereoretention. Inspired by these results, our lab developed the first example of a stereospecific
cross-coupling of an unactivated alkyl tin reagent with an acyl electrophile (Figure 6.4).3

Falck acylation of activated stannanes
R1 R2
(n-Bu)3Sn

(PPh3)2PdCl2

O

OBz

Ph

Cl

CuCN, toluene,
75 ºC, 12-64 h

R1 R2
Ph

OBz
O

Figure 6.3: Falck acylation of activated stannanes. Falck discovered the enantioselective
generation of ketones using activated stannanes and a palladium/copper cocatalyst.

Stereospecific acylation of unactivated alkylstannanes
O
Ar

X

+

X= Cl, SPh

N

R1

Sn
R2

Pd(PPh3)4 (2 mol %)
CuCl (2 equiv)
CH3CN, 60 ºC

12 h

O
Ar

R1

R2
70 - 90% yield
93 - 100% es

Figure 6.4: Stereospecific acylation of unactivated alkylstannanes. Biscoe reported the
acylation of enantioenriched alkylstannatranes using a palladium/copper catalyst system under
mild conditions.

We found that oxidative addition with palladium tetrakis proceeded smoothly between
the C-X bond of an acyl chloride and the more stable thioester. In the presence of copper
cyanide, we observed clean transmetallation of primary and enantioenriched secondary centers
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from stannatrane. Reductive elimination resulted in α-substituted ketones with little to no trace
of isomerization or racemization.3 Additionally, we were able to achieve two examples of the
first unactivated transfer of a tertiary center from tin using a palladium/Jackiephos catalyst.
In order to highlight the generality and rationality of this transformation, we implemented
the stannatrane-lithium procedure to generate several enantioenriched nucleophiles with defined
absolute configuration (Figure 6.5). These compounds, a long side the nucleophiles we prepared
with traditional methods, allowed for the elaborate substrate scope for stereospecific acylation
(Figure 6.6). We were able to show that both unactivated (Figure 6.6-a) and activated (Figure
6.6-b) enantioenriched alkylstannatranes result in retentive cross-coupling products.

Preparation of enantioenriched alkylstannatranes
(R)-4-phenylbutanyl)
mesylate
n-hexane, rt, 1 h

N

Sn Cl

10% Naphthalene
2.2 eq. Li(0)

N

Sn Li

THF, 45 °C, 3h
1.2 eq.
2.4 mmol

(R)-sec-butyl mesylate

N

Sn

Ph 2

41% yield
98% ee
99% es

N

Sn

3

52% yield
98% ee*
99% es*

N

Sn

4

47% yield
91% ee*
100% es*

n-hexane, rt, 1 h

(S)-sec-butyl mesylate
n-hexane, rt, 1 h

Figure 6.5: Preparation of enantioenriched alkylstannatranes. The use of stannatrane-lithium
to easily generate enantioenriched starting materials with defined stereochemistry. This allowed
for a broader substrate scope to be investigated.
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Scope of enantiospecific acylation
O

O

(a)

O
Ph

O
78%
100% es

87%
100% es

67%
97% es
O

O

Ph

Ph
N O
85%
93% es

(b)

71%
99% es

O

O

O

OEt

OEt

OEt

O

O

O

O
78%
99% es

93%
100% es

75%
99% es

O

O

Ph

Ph

78%
98% es

71%
100% es

Figure 6.6: Scope of enantiospecific acylation. With conditions from Figure 4, we generated a
scope of enantioenriched coupling products from starting materials generated by stannatranelithium (a), and traditional methods (b).

Perhaps the most explicit showcase of the generality and predictability in acylation
coupling was with the thioester of (S)-Naproxen (Figure 6.7). We decided to probe individually
with both (R) and (S) sec-butyl stannatrane (compounds 3, 4). The lack of functionality or
directing groups in the nucleophile fragment would stress the inherent translative behavior of this
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method. The Naproxen thioester contains a chiral center beta to the bond cleaved during
oxidative addition. In theory, the proximal chiral group could impact the desired selectivity of
acylation. We obtained each diastereomer of the Naproxen derivative selectively. As expected,
we found proximal chirality did not impact stereoselectivity.

Selective acylation of Naproxen derivatives

Sn

60% Yield
22:1 dr

N

MeO
SPh
or

MeO
Sn

N

O

a

O

MeO

O

65% Yield
49:1 dr

(a): Palladium/Jackiephos

Figure 6.7: Selective acylation for Naproxen derivatives. Using a palladium/Jackiephos
catalyst, we selectively generated each diastereomer of the Naproxen derivative by translation of
chiral information dictated solely by the alkylstannatrane.

6.3 Electrophilic halogenation:
As discussed previously, the structural and electronic forces that promote
transmetallation from stannatrane also make it reactive to oxidative conditions. This limits the
ability to perform distal oxidative chemical manipulations with the goal of keeping the
stannatrane backbone intact. However, the Sn-C bond is predictably reactive to electrophilic
halogen sources. In 2017, we discovered a rare example of a transition metal-free stereospecific
electrophilic fluorination of a configurationally stable organometallic nucleophile.2 This process
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was found to be amenable to the incorporation of chlorine, bromine, and iodine as well. The
ability to quickly and cheaply generate enantiodefined 2° alkylstannatranes was essential for the
complete investigation.
Fluorination of 2° substrates has been of recent interest to the synthetic community.12-15
This is due to the historical difficulty in selectively incorporating fluorine into complex
molecules, and the growing importance of fluorine containing drug targets.16 One approach to
generate an enantioenriched C-F bond is the translative deoxyfluorination of an enantioenriched
alcohol.15, 17 It has been applied with great success in complex drug targets, but suffers from a
lack of selectivity in the presence of multiple potential reaction sites. A second approach
involves the reliance on a transition metal catalyst.13, 14 These transformations proceed through a
radical mechanism predominately, and stereospecificity in the final products are uncertain.
An alternative route to stereospecific fluorination is the combination of an organometallic
nucleophile and an electrophilic source of fluorine.

Aggarwal has pioneered the use of

enantioenriched phenyl-lithium activated organoboron nucleophiles in this type of reaction
(Figure 6.8).18 This method was successful for the formation of 1°, 2° and 3° fluorides, and was
proven invertive for several 2° centers. The scope included azides, protected alcohols, alkenes,
and tert-butyl esters, and an example of a cholesterol derivative fluorinated in high
diastereomeric ratio (d.r.).18 The major limitation of this method is the reliance on a preactivation event with phenyl-lithium, a process that severely limits functional group
compatibility.
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Stereospecific electrophilic fluorination of activated organoboron nucleophiles

BPin

O
Ph B O

Ph-Li

PMP

Selectfluor II,
Styrene
3 Å MS, CH3CN,
-10 ºC, 2 h

PMP

F
PMP
83% yield
100% es

PMP= para-methoxy phenyl

CH3
N
N
2BF4
F
Selectfluor II

Figure 6.8: Stereospecific electrophilic fluorination of activated organoboron nucleophiles.
Aggarwal successfully implemented selectfluor II and styrene to fluoronate an enantioenriched
organoboron nucleophile. The reaction relies on pre-activation to the boron “ate” complex by
the addition of phenyl-lithium.

On the same subject, Ritter utilized a similar fluorinating agent for the electrophilic
halogenation of aryl-tri-n-butylstannanes.19 This process relied on a silver additive to
successfully fluorinate C(sp2) carbon bonds from tin (Figure 6.9). This supporting evidence
encouraged us to pursue a similar approach with the now readily available enantioenriched
alkylstannatranes.

Electrophilic fluorination of arylstannanes
Sn(n-Bu)3
Ph

acetone, 23 ºC
20 min

Cl

Ag*

2 eq. AgOTf
Ph

F

N
N
F

2PF6

Ph
83% yield

Figure 6.9: Electrophilic fluorination of arylstannanes. Ritter showed that arylstannanes
were capable of fluorination reactions using a selectfluor derivative in the presence of superstoichiometric silver triflate. *Ritter proposed a complex process involving silver catalysis of
organosilver aggregates.19
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With the work of Ritter and Aggarwal in mind, we began to probe various stannatrane
nucleophiles for reactivity.2 Our preliminary results showed that primary stannatranes under
Ritter’s conditions afforded product in 28% yield (Figure 6.10-a). Removal of silver triflate in a
control experiment surprisingly afforded the better yield of 64% (Figure 6.10-b). The more
optimal conditions were applied to the racemic model substrate 2 for further optimization and
control reactions (Figure 6.10-c).

Electrophilic fluorination of alkylstannatrane
(a)

(b)

N

N

Sn n-C10H22

Sn n-C10H22

2 eq. AgOTf
1.5 eq. selectfluor
CH3CN, rt

1.5 eq. selectfluor

F n-C10H22 28% yield

F n-C10H22 64% yield

CH3CN, rt

N

(c)

F

1.5 eq. selectfluor

Sn
2

CH3CN, rt

62% yield

Ph

Ph

Figure 6.10: Electrophilic fluorination of alkylstannatrane. Evidence of desired reactivity
(a,b) led us to optimize the more synthetically valuable secondary systems (c).

Our optimized conditions proved capable of fluorinating unactivated primary, secondary,
benzylic,

and

heteroatom-containing

stannatrane-based

nucleophiles

(Figure

6.11).2

Additionally, the replacement of selectfluor with electrophilic sources of chlorine, bromine, and
iodine provided the alkylhalides in good yield (Figure 6.12).
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Electrophilic fluorination of 1º and 2º alkylstannatranes
N

1.5 eq. selectfluor

Sn

CH3CN, rt, 5 - 60 min

R

Ph
F

R

Ph

F
CH3

H 3C

65%

F

7

EtO

56%

66%

CH3
55%

CH3

HO

F

O

F

F

t-Bu

BPin
58%

F

O
H 3C

F

BPin

H 3C

53%

60%

F

F

O

CH3

8

R= H, CH3

F

O

CH3
50%

64%

CH3
70%

Figure 6.11: Electrophilic fluorination of 1° and 2° alkylstannatranes. Several examples are
reported of electrophilic fluorination, a reaction reliant entirely on activation through the
stannatrane backbone.
Electrophilic halogenation of 1º and 2º alkylstannatranes
N

1.5 eq. X+

Sn
Ph

CH3CN, rt, 5 - 60 min

trichloroiso
cyanuric acid

selectfluor
F

Ph

R

Ph

52%

X R= H, CH3

Cl

Ph

65%

Br

I
68%

Br
Ph

62%

Ph

82%

Cl
Ph

Ph

iodine

N-bromosuccinimide

65%
F

R

Ph

I
Ph

60%

63%

Figure 6.12: Electrophilic halogenation of 1° and 2° alkylstannatranes. 1° and 2°
alkylstannatranes smoothly underwent halogen substitution in the presence of electrophilic
sources of halogen.2
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Attempts to probe stereospecificity of this reaction initially resulted in a non-negligible
amount of racemization in the final products. Aggarwal has shown that the addition of a radical
trap can suppress racemization in the fluorination of activated organoboron nucleophiles.18 We
employed styrene, and observed a concomitant increase in stereospecificity (Figure 6.13).
Relying on stereochemical definition made possible with stannatrane-lithium, we were able to
assign an invertive pathway through an SE2 mechanism (Chapter 2 “Enantiospecific crosscoupling of configurationally stable nucleophiles”).

Stereospecific electrophilic halogenation of alkylstannanes
N

CH3CN, -5 °C, 2 h

R
F
Ph

56%, 86% es*

81%, 96% es

HO

TBDMSO

es*

59%, 90% es*

I

Ph

Ph

71%, 98% es

52%, 94% es

F

F

R

Br

Cl

Ph

43%, 83%

X

styrene, 1.5 eq. X+

Sn

F

O

F

BzO

EtO

65%, 89% es*

49%, 88% es*

Figure 6.13: Stereospecific electrophilic halogenation of alkylstannanes. The addition of
styrene helped reduce racemization in the stereospecific electrophilic halogenation of
alkylstannatrane nucleophiles. * addition of 0.5 equiv. of pyridine led to optimized
enantiospecificity.
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6.4 Arylation:
As the development of stannatrane-lithium proceeded, we began to realize the arylation
chemistry from 2013 deserved a deeper look. A more thorough investigation into the electronic
effects of the electrophile on stereofidelity, compatible coupling partners, and insights into the
overall synthetic utility of a stannatrane backbone is currently underway. What follows is a
summary of this project to date.

Electronic effects on arylation stereofidelity:
Although previous work by our group suggested the generality of electrophile scope, the
scarcity of our tin nucleophiles precluded a more systematic investigation. We decided to probe
how the electronics of the aryl-bromide electrophiles effect the stereochemistry of cross coupling
products. We chose (S)-(+)-sec-butyl tricarbastannatrane as the probe because it was the most
simple, least activated substrate (Figure 6.14).
Arylation of s-Bu-stannatrane
Br

R

L-Pd(0)

R

Pd(II)LAr
LPd(II)(X)Ar

N

Transmetallation

Sn

N

Sn
X

Figure 6.14: Arylation of s-Bu-stannatrane. We decided to probe the electronic effects of the
electrophile on stereofidelity of the total transformation.
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In order to assign absolute configuration of the starting material, we chose to derivatize
via cross coupling with a deactivated (electron rich) aryl bromide. We observed an average of
98% ee for sec-butyl anisole after 3 runs. This confirms that the minimum % ee of the starting
material is 98%. The (R)-(−)-sec-butyl mesylate was assigned as the alcohol at 99% ee by
chiral-GC, which results in an overall enantiospecificity (es) of alkyltin formation of 99%.
We then expanded the set of aryl bromides to include the highly activated 4bromonitrobenzene and two electronically neutral substrates. It was found that in a total of 9
trials, we achieved greater than 80% calibrated GC yield, with an average es of 98%. The results
are reported in Figure 6.15. This aligned well with our expectations, and further supports the
generality of this method.

Electronic effect on stereofidelity

R
N

Sn
Br
(S) 1.2 eq

1.0 eq.

5% Pddba2
10% Jackiephos

R

2eq CuCl, KF
0.2mL CH3CN
60ºC, >6hr

(S)
83% average yield
98% average es
9 Trials

O

2 trials
83% yield
98% es

NO2

2 trials
89% yield
96% es

2 Trials
82% yield
99% es

3 Trials
82% yield
98% es

Figure 6.15: Electronic effect on stereofidelity. Aryl-bromides with different electronic effects
had no effect on the reagent-controlled incorporation of chirality.
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From a utility perspective, these results indicate that translation of chiral information
from a commercially available alcohol is incorporated directly into the final product of a crosscoupling reaction with total stereofidelity over three steps.

Due to the abundance of

commercially available chiral alcohols, this work has the potential to broadly impact organic
synthesis.

6.5 Summary of compatible coupling partners:
As discussed previously, stannatrane-lithium has allowed us to cheaply and efficiently
prepare 2° enantioenriched alkylstannatranes with a defined absolute configuration (Figure
6.16). The results from these nucleophiles participation in arylation cross-coupling reactions are
still ongoing. We believe previous evidence of clean inversion of alkyl electrophiles precludes
the possibility of racemization in formed alkylstannatranes. We define the stereochemistry as the
inverse of the chiral alcohols. The major bottleneck to this investigation is the analytical
resolution of the cross-coupling products.

We are constantly improving our chiral-HPLC

methods for separation, and expect the complete investigation to be published this year.
Compounds 5-8 have been chosen for the initial arylation work (Figure 6.17). These
compounds have been chosen as the linchpin of this investigation due to their significant
structural or functional differences to previously published tin nucleophiles. Our results have
been encouraging. Racemic compound 5 has been shown to cross-couple with a diverse set of
aryl-bromides on small scale with isolated yields of 50-80%.

All attempts to resolve the

nucleophile and cross-coupling products have failed.
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Scope of 2º alkylstannatranes prepared by inversion
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Figure 6.16: Scope of 2° alkylstannatranes prepared by inversion.

Selected alkylstannatranes for arylation investigation
Et
5

N

6

Sn

Pent

N

Sn

7 R= TBDMS

N

Sn

OR

8 R= H

Figure 6.17: Selected alkylstannatranes for arylation investigation. These compounds have
been chosen for immediate investigation for compatibility in arylation cross-coupling.
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Stereospecific arylation of 6
O
Sn

N
Br

1.2 eq
98%ee

1 eq =
.02mmol

N
H

O

Pd(dba)2 (5 mol %)
JackiePhos (10 mol %)
2eq CuCl, KF

O
N
H

CH3CN, 60 ºC, 4h

O

99% es

Figure 6.18: Stereospecific arylation of compound 6. Although direct resolution of compound
5 has failed, comparison of the % ee of the starting alcohol (99% ee) and final coupling product
(98% ee) allow us to assign 99% es for the total transformation of compound 6.

Compound 6 has resulted in cross-coupling products easily resolved with chiral-HPLC.
We successfully confirmed the starting alcohol at 99% ee, but have been unable to directly
measure the enantioenrichment of compound 6. Confirmation of a single enantiomer peak after
cross-coupling allows us to infer a total three-step enantiospecificity of 99%es. Compounds 7
and 8 have only just started to be investigated. Both compounds have been found to crosscouple in good yield on small scale. Compound 7 results in coupling products easily resolved,
and stereospecificity assignments are currently being done. The coupling of compound 8 is
encouraging, but small-scale isolation experiments have not been conducted yet.

92

References:
1.

Li, L.; Wang, C. Y.; Huang, R.; Biscoe, M. R. Nat. Chem. 2013, 5 (7), 607.

2.

Ma, X.; Diane, M.; Ralph, G.; Chen, C.; Biscoe, M. R. Angew. Chem. Int. Ed. 2017, 56

(41), 12663.
3.

Wang, C. Y.; Ralph, G.; Derosa, J.; Biscoe, M. R. Angew. Chem. Int. Ed. 2017, 56 (3),

856.
4.

Batista, J. M.; Cass, Q. B. Molecules 2018, 23 (2).

5.

Harada, N. Molecules 2016, 21 (10).

6.

Mishra, S. K.; Suryaprakash, N. Tetrahedron: Asymmetry 2017, 28 (10), 1220.

7.

Taniguchi, T. Bull. Chem. Soc. Jpn. 2017, 90 (9), 1005.

8.

Kosugi, M.; Shimizu, Y.; Migita, T. Chem. Lett. 1977, 6 (12), 1423.

9.

LJ. W. Labadie, J. K. S., D. Tueting, J. Org. Chem. 1983, 48, 4634.

10.

Kells, K. W.; Chong, J. M. J. Am. Chem. Soc. 2004, 126 (48), 15666.

11.

Ye, J.; Bhatt, R. K.; Falck, J. R., J. Am. Chem. Soc. 1994, 116 (1), 1-5.

12.

Fujimoto, T.; Ritter, T. Org. Lett. 2015, 17 (3), 544-7.

13.

Jiang, X.; Gandelman, M. J. Am. Chem. Soc. 2015, 137 (7), 2542.

14.

Li, Z.; Wang, Z.; Zhu, L.; Tan, X.; Li, C., J. Am. Chem. Soc. 2014, 136 (46), 16439.

15.

Nielsen, M. K.; Ugaz, C. R.; Li, W.; Doyle, A. G. J. Am. Chem. Soc. 2015, 137 (30), 9571.

16.

Müller, K.; Faeh, C.; Diederich, F. Science. 2007, 317 (5846), 1881.

17.

Sladojevich, F.; Arlow, S. I.; Tang, P.; Ritter, T. J. Am. Chem. Soc. 2013, 135 (7), 2470.

18.

Sandford, C.; Rasappan, R.; Aggarwal, V. K. J. Am. Chem. Soc. 2015, 137 (32), 10100.

19.

Furuya, T.; Strom, A. E.; Ritter, T. J. Am. Chem. Soc. 2009, 131 (5), 1662.

93

CHAPTER SEVEN
Conclusion:
“An Uchiyama protocol can reliably convert optically active carbon electrophiles into
enantioenriched 2° alkyl stannatranes to simplify tin-based stereospecific transformations.”
The above statement has governed the entirety of this dissertation; from rationale, to
development, application, and results. In short, it is hoped that this work is convincing evidence
of success in this area.

Complete control of the chemical space is the ongoing challenge of research chemists. In
historical attempts to meet that goal, we have discovered chemical solutions to many problems
associated with an industrialized world. Agriculture, energy, and medicine, possibly the three
most important pillars of society, are undeniably tied to the successes and failures of chemistry.
Therefore, the future of these industries is equally tied to our work.
In an effort to manipulate chemical space with better control, Ei-ichi Negishi, Kenkichi
Sonogashira, Richard Heck, Makoto Kumada, Akira Suzuki and John Stille developed incredibly
robust and reliable methods to join unsaturated chemical fragments through the manipulation and
attenuation of palladium catalysis. Their work in organometallic chemistry has revolutionized
the way carbon bonds are formed in synthesis. This work has been so impactful to modern
synthesis; it is rare to come across a complex multi-step synthesis without at least one reference
to a cross-coupling reaction.
In the last decade, several authors have published evidence of structural bias that occurs
by dependence on palladium based cross-coupling reactions. Their overarching criticism relies
on one main avenue of thought; that modern organopalladium chemistry is not conducive to the
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saturated complexity associated with target molecules of the future. Although there are many
potential approaches to combat this structural bias, several prolific research groups have taken
the stance that adapting transition-metal catalyst systems to accept saturated coupling fragments
is the most logical solution.
Selective incorporation of saturated fragments via transition metal catalysis comes with a
variety of challenges. Configurational stability, nucleophilicity, and β-hydride elimination are
perhaps the greatest hurdles to overcome. The Suzuki and Stille cross-coupling reactions seem
uniquely adept at avoiding these pitfalls. The most state-of-the-art applications of both reactions
seem quite capable of the desired reactivity.
The major drawbacks in Suzuki chemistry are the limitations in generality and
predictability associated with stereospecific transformations. Often times the intended coupling
partner is limited by structural and electronic requirements that promote selective
transmetallation. The mechanism of transmetallation is sensitive to these subtle changes as well,
which can result in a complete and unexpected reversal of chiral translation among similar
scaffolds. While the Stille reaction has been found to be much more general and predictable in
scope, it has suffered from a historical lack of interest in stereospecific transformations for
several reasons.
Until recently, the Stille reaction was limited to the same structural and electronic
limitations as the Suzuki reaction.

C(sp3) centers participated in transmetallation only if

activation requirements within the coupling partner of interest were met. The modified-Stille
reaction published in 2013 by the Biscoe group applied the reaction in a more general scope by
modifying the tin-handle and implementing an optimized catalyst system. This development
unlocked saturated, completely unactivated coupling partners as compatible reagents for the
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stereospecific arylation, acylation, and fluorination of C(sp3) centers. However, this reactivity
was so novel that preparation of compatible tin compounds was extremely limited. As is stood,
this major bottleneck severely reduced the utility of the modified-Stille reaction by the broader
synthetic community.
Our previous synthesis of alkylstannatranes implemented carbon based anions with a
limited ability to produce enantioenriched final products. We then relied on the prep-scale
HPLC resolution of racemates to obtain small amounts of compatible starting material for
stereospecific cross-coupling.

This process was time-consuming, inefficient, and quite

expensive.
We found that a modified-Uchiyama reduction of carbastannatrane chloride generates an
appropriate anion for the clean inversion of carbon electrophiles.

This method was used to

prepare a suite of stereodefined enantioenriched alkylstannatrane nucleophiles cheaply and
efficiently, which greatly impacted our ability to investigate the unique reactivity of these
reagents.

This development is major progress toward the general utility of tin-based

stereospecific transformations to create complex molecules with stereodefined chirality.
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General Reagent Information
BDH brand ethyl ether was purchased from VWR. EMD brand Omnisolv THF (unstabilized)
was also purchased from VWR. These solvents were transferred to separate 20 L solventdelivery kegs and vigorously purged with argon for 2 h. The solvents were further purified by
passing them under argon pressure through two packed columns of neutral alumina. s-BuLi (1.4
M in cyclohexane) and isopropylmagnesium chloride (2.0 M in ether) were purchased from
SigmaAldrich.
5-Chloro-1-aza-5-stannabicyclo[3.3.3]undecane
was
purchased
from
SigmaAldrich or prepared via the method of Vedejs.1 Pd(PPh3)4 was purchased from Strem.
Anhydrous acetonitrile (Sigma-Aldrich) was purged with argon prior to use. Grignard reagents
were prepared from their corresponding alkyl chlorides or bromides using a literature procedure.2
Thioesters were prepared from their corresponding carboxylic acids or acyl chlorides using a
literature procedure.3 Molarities of Grignard reagents were determined using iodine titration.4
Reagents and solvents were used as received unless otherwise noted. Flash chromatography was
performed using Silicycle silica gel (ultra pure grade). Reverse-phase chromatography was
performed using C18 silica gel from Silicycle (17% carbon, 40-63 mm) or from Acros (23%
carbon, 40-63 mm).
General Analytical Information
All compounds were characterized by 1H NMR and 13C NMR spectroscopy. Copies of the 1H
and 13C spectra for all new compounds can be found at the end of the Supporting Information.
All previously unreported compounds were additionally characterized by high resolution MS.
Nuclear Magnetic Resonance spectra were recorded on a Bruker 300 or Varian 500 MHz
instrument. All 1H NMR experiments are reported in δ units, parts per million (ppm), and were
measured relative to the signals for residual chloroform (7.26 ppm). All 13C NMR spectra are
reported in ppm relative to deuterochloroform (77.23 ppm), and were obtained with 1H
decoupling. High resolution MS analyses were performed on an Agilent 6520 Q-TOF
instrument. All GC analyses were performed on a Shimadzu GC-2010 gas chromatograph with
an FID detector using a 25 m x 0.20 mm capillary column with cross-linked methyl siloxane as
the stationary phase, or using a 30 m x 0.32 mm chiral column (Rt®-βDEXsm from Restek). All
GC yields were calibrated using dodecane or tetradecane as an internal standard. Chiral HPLC
analyses were performed on a Shimadzu Prominence HPLC system with binary mobile phase
pumps and UV-vis detector (LC-20AB, SPD-20A) using an OJ-RH (4.6 mm x 150 mm; particle
size: 5 µm) chiral column (Daicel Chemical Ind., Ltd), an IA-3 (4.6 mm x 150 mm; particle size:
3 µm) chiral column (Daicel Chemical Ind., Ltd), or an IA (4.6 mm x 150 mm; particle size: 5
µm) chiral column (Daicel Chemical Ind., Ltd). VCD analysis was performed by BioTools, Inc
(Jupiter, Fl). Preparative HPLC separations were performed by Chiral Technologies, Inc. Thin
layer chromatography was performed using EMD millipore normal phase silica-coated glass
plates (F254, #105715), or using EMD millipore reverse phase silica-coated glass plates (F254S, #105560).
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Procedural Information
General procedure A for the preparation of racemic secondary alkylcarbastannatranes.
All reactions were performed in oven-dried glassware under an atmosphere of Ar. secAlkyllithium, sec-alkylmagnesium or sec-alkylzinc reagents (1.5–3.0 equiv) were added to the
suspension of 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane1 (1 equiv) in anhydrous solvent at
-78 °C. The resulting mixture was stirred at -78 °C for 3 h, allowed to warm to room
temperature, and stirred overnight. The reaction mixture was poured into a separatory funnel
containing a mixture of water and ether. The organic layer was separated, washed with brine,
dried over Na2SO4, and filtered. Solvent was removed under reduced pressure and dried in vacuo
to provide the crude product. The crude secondary alkyl tin reagents were used without
purification, or following purification via Kugelrohr distillation or C18 chromatography.
Homocoupling from Grignard formation constituted the major residual byproduct in the crude
product.
General procedure B for cross-coupling reactions.
Pd(PPh3)4 (2 mol %) and CuCl (2 equiv) were weighed out on the benchtop in an oven-dried test
tube with stir bar. With stirring begun, the septum screw top tube was evacuated (80 mTorr) and
backﬁlled three times with argon using a needle attached to a vacuum manifold. The tin reagent
(1.1 equiv) and acyl chloride (1 equiv) were then added to the test tube via microsyringe,
followed by degassed CH3CN (1 mL for 0.3 mmol scale). If the acyl chloride was a solid, it was
weighed out on the benchtop alongside the other solids. The tube was sealed using electrical
tape, and heated to 60 °C for 12 h. The reaction mixture was cooled to rt, diluted with ether, and
washed with brine. The organic layer was dried over Na2SO4, filtered, and concentrated to
provide the crude product. The crude product was purified by column chromatography.
General procedure C for cross-coupling reactions with heterocyclic acyl chlorides.
Pd(PPh3)4 (2 mol %) and CuCl (2 equiv) were weighed out on the benchtop in an oven-dried
Schlenk tube with stir bar. With stirring begun, the Schlenk tube was evacuated (80 mTorr) and
backﬁlled three times with argon using a needle attached to a vacuum manifold. The tin reagent
(1.1 equiv) and acyl chloride (1 equiv) was then added to the Schlenk tube via microsyringe,
followed by degassed CH3CN (1 mL for 0.3 mmol scale). If the acyl chloride was a solid, it was
weighed out on the benchtop alongside the other solids. The Schlenk tube was sealed with a
Teflon stopper, and heated to 60 °C for 12 h. The reaction mixture was cooled to rt, diluted with
ether, and washed with brine. The organic layer was dried over Na2SO4, filtered, and
concentrated to provide the crude product. The crude product was purified by column
chromatography.
General procedure D for cross-coupling reactions with t-butyl carbastannatrane.
Pd(dba)2 (5 mol %), Jackiephos (10 mol %), CuCl (2 equiv), and t-butyl carbastannatrane (1.1
equiv) were weighed out on the benchtop into an oven-dried Schlenk tube with stir bar. With
stirring begun, the Schlenk tube was evacuated (80 mTorr) and backﬁlled three times with argon
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using a needle attached to a vacuum manifold. The acyl chloride (1 equiv) was then added to the
Schlenk tube via microsyringe, followed by degassed CH3CN (1 mL for 0.3 mmol scale). If the
acyl chloride was a solid, it was weighed out on the benchtop alongside the other solids. The
Schlenk tube was sealed with a Teflon stopper, and heated to 60 °C for 12 h. The reaction
mixture was cooled to rt, diluted with ether, and washed with brine. The organic layer was dried
over Na2SO4, filtered, and concentrated to provide the crude product. The crude product was
purified by column chromatography.
General procedure E for cross-coupling reactions with thioesters.
Pd(PPh3)4 (2-5 mol %), CuCl (2 equiv), and thioester (1 equiv) were weighed out on the
benchtop into an oven-dried Schlenk tube with stir bar. With stirring begun, the Schlenk tube
was evacuated (80 mTorr) and backﬁlled three times with argon using a needle attached to a
vacuum manifold. The tin reagent (1.1 equiv) was then added to the Schlenk tube via
microsyringe, followed by degassed CH3CN (1 mL for 0.2 or 0.3 mmol scale). The Schlenk tube
was sealed with a Teflon stopper, and heated to 60 °C for 12 h. The reaction mixture was cooled
to rt, diluted with ethyl acetate, and washed with brine. The organic layer was dried over
Na2SO4, filtered, and concentrated to provide the crude product. The crude product was purified
by column chromatography.
General procedure F for the preparation of optically active secondary alkylcarbastannatranes.5
To an oven dried round bottom flask with stirbar, 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (588 mg, 2 mmol) and naphthalene (128 mg, 1 mmol) were added. The
flask was evacuated (<100 mtorr) and backfilled with argon three times. With the flask under a
flow of argon, the septum was removed and lithium granules (free of oil) were added (250 mg,
35 mmol). This was followed by two additional evacuation/backfill cycles. Anhydrous THF (40
mL) was added to the flask via syringe, and the mixture was stirred at room temperature. The
solution turned dark green/black within 30 min. Upon color change, the solution was stirred at
room temperature for an additional hour. In a separate 100 mL flask under argon, with stirbar
and rubber septum, the optically active alkyl mesylate (1.2–1.5 equiv) was dissolved in
anhydrous THF (20 mL). The mesylate solution was heated to 60 °C. The stannatrane lithium
mixture was removed from the excess lithium via cannula or needle/syringe, and transferred
dropwise to the mesylate solution over 5 mins. The reaction stirred at 60 °C for an additional
hour. The reaction mixture was extracted with ethyl ether (60 mL), followed by brine (100 mL),
and dried over Na2SO4. The reaction solution was filtered and concentrated to provide the crude
product. The crude product was purified (40–50% isolated yield) by C18 silica (80/20
acetonitrile/water to 100% acetonitrile), fractions analyzed using HPLC (220/254 nm) or reversephase TLC.
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Additional optimization experiments:
O

CH 3
+ N

Sn

Pd(PPh 3)4 (2 mol %)
CuCl (2 equiv)

Ph
Cl
CH 3 CH3CN, 60 ºC, 6 h
1 equiv
1.1 equiv
(0.02 mmol)
entry
variations from above

O
CH 3

Ph

CH 3

GC yield (%)

1

CuCl w/ 1 equiv. Bu4NCl

<5

2

CuCN instead of CuCl

10

3

CuCN w/ 1 equiv. Bu4NCl

<5

4

CuBr instead of CuCl

49

5

CuBr w/ 1 equiv. Bu4NCl

<5

6
7
8

No Cu(I) / 1 equiv. Bu4NCl
1,4-dioxane instead of CH3CN
THF instead of CH3CN

<5
42
59

N-Heterocyclic carbastannatranes that failed in cross-coupling reactions:
Boc
N
N

Sn

N

BocN
Sn

N

Sn

N CH3
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Compound Characterization
H3C
N

Sn
CH3

5-(sec-Butyl)-1-aza-5-stannabicyclo[3.3.3]undecane.5 General procedure A was employed
using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (2.94 g, 10.0 mmol) in ether (40 mL) and
s-BuLi (1.4 M in cyclohexane, 15 mL, 21 mmol). A yellow oil (3.18 g, 99%) was isolated. 1H
NMR (500 MHz, CDCl3) δ: 2.35 (t, J = 6 Hz, 6H), 1.64 (app. quint, J = 6 Hz, 6H), 1.41-1.51 (m,
3H), 1.05 (d, J = 7.5 Hz, 3H), 0.86 (t, J = 7 Hz, 3H), 0.63 (t, J = 6.5 Hz, 6H) ppm. 13C NMR
(125 MHz, CDCl3) δ: 55.0, 29.4, 26.7, 23.7, 18.5, 14.8, 5.7 ppm.
(R)- and (S)-5-(sec-Butyl)-1-aza-5-stannabicyclo[3.3.3]undecane. The general procedure F
was employed using (S)-(sec-butyl) mesylate or (R)-(sec-butyl) mesylate (430 µL, 3 mmol). A
pale yellow oil (40–50%) was isolated. Enantiomeric excess of product ranged from 91–99% ee
(determined by derivatization with 4-bromoanisole or 4-bromobenzotrifluoride – see page 21 of
SI).6,7

CH3
N

Sn
CH3

5-(iso-Propyl)-1-aza-5-stannabicyclo[3.3.3]undecane.6 General procedure A was employed
using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.47 g, 5.0 mmol) in ether (20 mL) and
isopropylmagnesium chloride (2.0 M in ether, 7.5 mL, 15 mmol). A yellow oil (1.41 g, 95%)
was isolated. 1H NMR (500 MHz, CDCl3) δ: 2.38 (t, J = 6 Hz, 6H), 1.67 (app. quint, J = 6 Hz,
6H), 1.09 (d, J = 7.5 Hz, 6H), 0.70-0.76 (m, 1H), 0.65 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125
MHz, CDCl3) δ: 54.9, 23.6, 21.6, 17.7, 4.6 ppm.

N

Sn

O

5-(Tetrahydro-2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane.6 General procedure A
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.88 g, 3.0 mmol) in THF
(30 mL) and (tetrahydro-2H-pyran-4-yl)magnesium chloride (0.62 M in THF, 7 mL, 4.3 mmol).
A pale yellow solid (983 mg, 95%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 3.87 (m, 2H),
3.33 (dt, J = 11, 2 Hz, 2H), 2.36 (t, J = 6 Hz, 6H), 1.64 (app. quint, J = 6 Hz, 6H), 1.50-1.55 (m,
4H), 0.89-0.95 (m, 1H), 0.64 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 71.0, 54.8,
31.3, 26.0, 23.4, 4.6 ppm.
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CH3
N

Ph

Sn

5-(4-Phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane.6 General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.65 g, 5.6 mmol) in THF (50
mL) and (4-phenylbutan-2-yl)magnesium chloride (0.28 M in THF, 23 mL, 6.4 mmol). A pale
yellow oil (1.74 g, 79%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 7.25-7.28 (m, 2H), 7.167.19 (m, 3H), 2.50-2.65 (m, 2H), 2.36 (t, J = 6 Hz, 6H), 1.76-1.81 (m, 1H), 1.65 (app. quint, J =
6 Hz, 6H), 1.23-1.39 (m, 1H), 1.13 (d, J = 7.5 Hz, 3H), 0.79 (quart, J = 7.5 Hz, 1H), 0.67 (t, J =
6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 143.9, 128.6, 128.3, 125.5, 54.9, 39.0, 36.5,
24.2, 23.6, 18.6, 5.6 ppm.
(S)-5-(4-Phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (19). General procedure F
was employed using (R)-(4-phenylbutan-2-yl)mesylate (500 µL, 2.4 mmol). A pale yellow oil
(320 mg, 40%) was isolated. Enantiomeric excess of product ranged from 91–99% ee between
different runs. Enantiomers could also be separated on a preparative scale using a Chiralpak OJH column with a 95:5 methanol:water eluent.

CH3
N

Sn
CO2Et

Ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate (20).6 General procedure A
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.88 g, 3.0 mmol) in DMF
(8 mL) and (4-ethoxy-4-oxobutan-2-yl)zinc iodide (0.61 M in DMF, 10 mL, 6.1 mmol). An
orange oil (509 mg, 45%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 4.09 (quart, J = 7 Hz,
2H), 2.39-2.43 (m, 1H), 2.35 (t, J = 6 Hz, 6H), 2.23-2.27 (m, 1H), 1.64 (app. quint, J = 6 Hz,
6H), 1.24 (t, J = 7 Hz, 3H), 1.02-1.13 (m, 4H), 0.65 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125
MHz, CDCl3) δ: 175.5, 60.0, 54.9, 40.7, 23.5, 19.8, 18.4, 14.6, 5.2 ppm. Enantiomers were
separated on a preparative scale using a Chiralpak OJ-H column with a 100:0.1 hexane:IPA
eluent.

N

Sn

Ph

5-(3-Phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (294 mg, 1 mmol) in THF (5
mL) and 3-phenylpropylmagnesium chloride (0.31 M in THF, 10 mL, 3.1 mmol). A yellow oil
(189 mg, 50%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 7.27-7.14 (m, 5H), 2.53 (t, J = 7.5
Hz, 2H), 2.36 (t, J = 6.2 Hz, 6H), 1.69 (quint, J = 6 Hz, 2H), 1.62 (app. quint, J = 6 Hz, 6H), 0.64
(t, J = 6 Hz, 6H), 0.48 (t, J = 6.0 Hz, 2H) ppm. 13C NMR (125 MHz, CDCl3) δ: 143.6, 128.7,
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128.3, 125.5, 54.9, 41.5, 29.9, 23.6, 16.4, 6.8 ppm. HRMS (ES+): Calcd (116Sn) (M-Na)+
394.1246; Found (116Sn) 394.1251.
H 3C
N

Sn
Ph

5-(1-Phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane (21). General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (206 mg, 0.7 mmol) in THF (5
mL), and 1-phenylethyl magnesium chloride (0.21 M in THF, 10 mL, 2.1 mmol). A pale yellow
oil (100 mg, 38%) was isolated and stored under argon. 1H NMR (500 MHz, CDCl3) δ: 7.176.87 (m, 5H), 2.32 (t, J = 6 Hz, 6H), 2.03-1.70 (m, 3H), 1.61 (app. quint, J = 6 Hz, 6H), 0.92 (t, J
= 7.5 Hz, 3H), 0.61 (t, J = 6 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 149.8, 128.0, 125.8,
121.8, 54.8, 43.0, 25.0, 23.6, 15.5, 5.9 ppm. HRMS (ES+): Calcd (116Sn) (M-Na)+ 402.1220;
Found (116Sn) 402.1226. Enantiomers were separated on a preparative scale using a Chiralcel OJH column with a 95:5 methanol:water eluent.

N

Sn

CH 3
CH 3
CH 3

5-(tert-Butyl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure A was employed
using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (588 mg, 2.0 mmol) in THF (20 mL) and tbutyl lithium (1.4 M in ether, 4.3 mL, 6 mmol). A pale yellow solid (0.35 g, 56%) was isolated.
1
H NMR (500 MHz, CDCl3) δ: 2.35 (t, J = 6 Hz, 6H), 1.65 (app. quint, J = 6 Hz, 6H), 0.92 (s,
9H), 0.63 (t, J = 6 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 54.8, 30.3, 23.7, 4.2 ppm.

O
O

1-(Furan-2-yl)-4-phenylbutan-1-one (4). General procedure C was employed using 2-furoyl
chloride (39 mg, 0.3 mmol) and 5-(3-phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane (125
mg, 0.33 mmol). A yellow liquid (86 mg, 89%) was isolated by column chromatography (90:10
pentane/MTBE). 1H NMR (300 MHz, CDCl3): δ 7.57-7.56 (dd, J = 1.8, 3 Hz, 1H), 7.29-7.13 (m,
6H), 6.52-6.51 (dd, J = 1.8, 3 Hz, 1H), 2.84 (t, J = 7.5 Hz, 2H), 2.71 (t, J = 7.5 Hz, 2H), 2.06 (q,
J = 7.5 Hz, 2H) ppm. 13C NMR (125 MHz, CDCl3): δ 189.6, 153.0, 146.4, 141.8, 128.7, 128.6,
126.2, 117.1, 112.3, 37.9, 35.4, 25.9 ppm. HRMS (ES+): Calcd (M-Na)+ 237.0891; Found
237.0894.
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O

O

Phenyl(tetrahydro-2H-pyran-4-yl)methanone (5).11 General procedure B was employed using
benzoyl chloride (42 mg, 0.3 mmol) and 5-(tetrahydro-2H-pyran-4-yl)-1-aza-5stannabicyclo[3.3.3]undecane (113 mg, 0.33 mmol). A white solid (52 mg, 91%) was isolated
by column chromatography (94:6 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.96-7.93 (m,
2H), 4.09-4.03 (m, 2H), 3.61-3.45 (m, 3H), 1.96-1.76 (m, 4H) ppm. 13C NMR (75 MHz, CDCl3):
201.80, 135.80, 133.10, 128.80, 128.30, 67.30, 42.60, 29.10 ppm.
O
CH 3
S

CH 3

1-(Benzo[b]thiophen-2-yl)-2-methylpropan-1-one (6). General procedure C was employed
using benzo[b]thiophene-2-carbonyl chloride (55 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol). A yellow liquid (42 mg, 68%) was isolated
by column chromatography (95:5 hexanes/ether). 1H NMR (300 MHz, CDCl3): 7.97 (s, 1H),
7.91-7.86 (m, 2H), 7.49-7.38 (m, 2H), 3.60 – 3.46 (septet, J = 7 Hz, 1H), 1.31-1.29 (d, J = 6 Hz,
6H). 13C NMR (75 MHz, CDCl3) δ 199.2, 143.3, 142.7, 139.43, 128.8, 127.5, 126.1, 125.2,
123.2, 37.3, 19.7 ppm. HRMS (ES+): Calcd (M-Na)+ 227.0507; Found 227.0527.
O
CH 3
O

CH 3

1-(Benzofuran-2-yl)-2-methylpropan-1-one (7).9 General procedure C was employed using
benzofuran-2-carbonyl chloride (54 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol). A yellow liquid (38 mg, 68%) was isolated
by column chromatography (95:5 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.71 (d, J = 9
Hz, 1H), 7.59 (dd, J = 1, 9 Hz, 1H), 7.52 (d, J = 1 Hz, 1H), 7.47 (dt, J = 3, 5 Hz, 1H), 7.33 – 7.28
(m, 1H), 3.48 (heptet, J = 6.5 Hz, 1H), 1.28 (d, J = 6 Hz, 6H) ppm. 13C NMR (75 MHz, CDCl3):
195.5, 155.6, 152.1, 128.1, 127.1, 123.8, 123.2, 112.8, 112.5, 36.7, 18.8 ppm.
CH3 O
CH3
CH3

2-Methyl-1-(o-tolyl)butan-1-one (8). General procedure C was employed using o-toluoyl
chloride (46 mg, 0.3 mmol) and 5-(sec-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane (104 mg,
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0.33 mmol). A yellow liquid (47 mg, 89%) was isolated by column chromatography (99:1
hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.54-7.22 (m, 4H), 3.25-3.14 (hex, J = 6.6 Hz,
1H), 2.44 (s, 3H), 1.89-1.75 (m, 1H), 1.53-1.39 (m, 1H), 1.18 (d, J = 6 Hz, 3H), 0.95 (t, J = 7.5
Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 209.3, 139.3, 137.8, 130.9, 127.8, 125.7, 45.8, 26.4,
21.0, 16.4, 12.0 ppm. HRMS (ES+): Calcd (M-Na)+ 199.1099; Found 199.1113.
CH3 O
CH3
CH3

(S)-2-Methyl-1-(o-tolyl)butan-1-one (22). General procedure C was employed using o-toluoyl
chloride (31 mg, 0.2 mmol) and 5-(sec-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane (68 mg,
0.22 mmol, 99% ee). A yellow liquid (27.5 mg, 78%, 99% ee) was isolated by column
chromatography. [a]20D (c 1.00, CHCl3) = +12.4º. % ee was determined using an OJ-RH
(150x4.6) HPLC column with a 55%:45% methanol:water eluent.

O
Me
CH 3

3-Methyl-1-phenylheptan-4-one (9). General procedure B was employed using butyryl
chloride (32 mg, 0.3 mmol) and 5-(4-phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane
(129 mg, 0.33 mmol). A colorless oil (48 mg, 79%) was isolated by column chromatography
(94:6 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.31-7.15 (m, 5H), 2.60-2.37 (m, 5H), 2.00
(m, 1H), 1.69-1.53 (m, 3H), 1.13-1.10 (d, J = 9 Hz, 3H), 0.91 (t, J = 7.5 Hz, 3H) ppm. 13C NMR
(75 MHz, CDCl3): 214.7, 142.0, 128.61, 128.58, 126.1, 45.9, 43.3, 34.7, 33.7, 17.3, 16.7, 14.0
ppm. HRMS (ES+): Calcd (M-Na)+ 227.1412; Found 227.1416.

O
H 3C
CH3 CH3

2,4-Dimethyl-6-phenylhexan-3-one (10). General procedure B was employed using isobutyryl
chloride (32 mg, 0.3 mmol) and 5-(4-phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane
(129 mg, 0.33 mmol). A yellow oil (55 mg, 89%) was isolated by column chromatography (94:6
hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.31-7.15 (m, 5H), 2.76-2.67 (m, 2H), 2.59-2.53
(m, 2H), 2.06-1.94 (m, 1H), 1.68-1.55 (m, 1H), 1.12-1.05 (m, 9H) ppm. 13C NMR (75 MHz,
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CDCl3): 218.3, 142.1, 128.61, 128.55, 126.1, 44.1, 39.8, 34.8, 33.8, 18.62, 18.59, 17.10 ppm.
HRMS (ES+): Calcd (M-H)+ 205.1592; Found 205.1594.
O
H 3C
CH3 CH3

(S)-2,4-Dimethyl-6-phenylhexan-3-one (25). General procedure B was employed using
isobutyryl chloride (21.3 mg, 0.2 mmol) and (S)-5-(4-phenylbutan-2-yl)-1-aza-5stannabicyclo[3.3.3]undecane (86 mg, 0.22 mmol, 98% ee). A yellow oil (35 mg, 85%, 91% ee)
was isolated by column chromatography (94:6 hexanes/ether). [a]20D (c 1.00, CHCl3) = +15.7º.
% ee was determined using an IA (250x4.6) HPLC column with a 65%:35% [19:1 v/v
methanol/acetonitrile]:water eluent.
O
Cl

CH 3
CH 3

1-(3-Chlorophenyl)-2-methylpropan-1-one (11).8 General procedure B was employed using 3chlorobenzoyl
chloride
(53
mg,
0.3
mmol)
and
5-(iso-propyl)-1-aza-5stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol). A yellow liquid (47 mg, 86%) was isolated
by column chromatography (95:5 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.92 (t, J = 1.8
Hz, 1H), 7.83-7.80 (m, 1H), 7.53-7.52 (m, 1H), 7.41 (t, J = 8.0 Hz, 1H), 3.49 (sept, J = 6.8 Hz,
1H), 1.21 (d, J = 6.8 Hz, 6H) ppm. 13C NMR (75 MHz, CDCl3): 203.3, 138.0, 135.0, 132.8,
130.0, 128.5, 126.4, 35.7, 19.1 ppm.
O
CH 3
CH 3

Cl

1-(4-Chlorophenyl)-2-methylpropan-1-one (12).12 General procedure B was employed using
4-chlorobenzoyl
chloride
(53
mg,
0.3
mmol)
and
5-(iso-propyl)-1-aza-5stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol). A yellow liquid (44 mg, 81%) was isolated
by column chromatography (94:6 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.89 (d, J = 9
Hz, 2H), 7.43 (d, J = 9 Hz, 2H), 3.50 (septet, J = 7 Hz, 1H), 1.21 (d, J = 9 Hz, 6H) ppm. 13C
NMR (75 MHz, CDCl3): 203.2, 139.2, 134.5, 129.7, 128.9, 35.4, 19.1 ppm.
O
O
O

CH 3
CH 3
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1-(Benzo[d][1,3]dioxol-5-yl)-2-methylpropan-1-one (13).8 General procedure B was employed
using piperonyloyl chloride (55 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol). A yellow liquid (55.3 mg, 96%) was
isolated by column chromatography (90:10 pentane/MTBE). 1H NMR (300 MHz, CDCl3): δ 7.49
(dd, J = 8.1, 1.7 Hz, 1H), 7.37 (d, J = 1.7 Hz, 1H), 6.78 (d, J = 8.3 Hz, 1H), 5.97 (s, 2H), 3.39
(sept, J = 6.8 Hz, 1H), 1.12 (d, J = 6.9 Hz, 6H); ppm. 13C NMR (75 MHz, CDCl3): δ 202.6,
151.5, 148.2, 131.0, 124.3, 108.3, 107.9, 101.8, 35.1, 19.4 ppm.
O
O

S

Benzo[b]thiophen-2-yl(tetrahydro-2H-pyran-4-yl)methanone (14). General procedure C was
employed using benzo[b]thiophene-2-carbonyl chloride (55 mg, 0.3 mmol) and 5-(tetrahydro2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (113 mg, 0.33 mmol). A pale yellow solid
(51 mg, 69%) was isolated by column chromatography (97:3 hexanes/ether). 1H NMR (300
MHz, CDCl3): δ 7.99 (s, 1H), 7.91-7.87 (m, 2H), 7.51-7.39 (m, 2H), 4.13-4.07 (m, 2H), 3.633.44 (m, 3H), 2.06-1.84 (m, 4H) ppm. 13C NMR (75 MHz, CDCl3): 196.2, 142.6, 142.5, 139.1,
128.80, 127.5, 125.9, 125.1, 123.0, 67.2, 44.2, 29.3 ppm. HRMS (ES+): Calcd (M-Na)+
269.0612; Found 269.0615.
O

tBu
MeO

1-(4-Methoxyphenyl)-2,2-dimethylpropan-1-one (15).14 General procedure D was employed
using 4-methoxybenzoyl chloride (51 mg, 0.3 mmol) and 5-(tert-butyl)-1-aza-5stannabicyclo[3.3.3]undecane (104 mg, 0.33 mmol). A colorless liquid (24 mg, 42%) was
isolated by column chromatography (90:10 hexanes/ether). 1H NMR (500 MHz, CDCl3): δ 7.85
(d, J = 9.0 Hz, 2H), 6.90 (d, J = 9.0 Hz, 2H), 3.85 (s, 3H) 1.37 (s, 9H) ppm. 13C NMR (75 MHz,
CDCl3): 206.3, 162.0, 131.0, 130.1, 113.2, 55.4, 43.9, 28.4 ppm.
O
CH3
CH3

2-Methyl-1-(naphthalen-2-yl)butan-1-one (16).10 General procedure B was employed using 2naphthoyl chloride (57 mg, 0.3 mmol) and 5-(sec-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane
(104 mg, 0.33 mmol). An orange liquid (48 mg, 75%) was isolated by column chromatography
(93:7 hexanes/EtOAc). 1H NMR (300 MHz, CDCl3): δ 8.47 (s, 1H), 8.06-7.87 (m, 4H), 7.57
(quintet. d, J = 3, 7.5 Hz, 2H), 3.58 (sextet, J = 7.2 Hz, 1H), 1.97-1.83 (m, 1H), 1.63–1.50 (m,
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1H), 1.26 (d, J = 6 Hz, 3H), 0.96 (t, J = 6 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 204.7,
135.7, 134.4, 132.8, 129.8, 129.7, 128.7, 128.5, 128.0, 126.9, 124.5, 42.4, 27.1, 17.2, 12.1 ppm.
O

tBu

2,2-Dimethyl-1-(naphthalen-2-yl)propan-1-one (17).12 General procedure D was employed
using 2-naphthoyl chloride (57 mg, 0.3 mmol) and 5-(tert-butyl)-1-aza-5stannabicyclo[3.3.3]undecane (104 mg, 0.33 mmol). A pale yellow solid (44 mg, 69%) was
isolated by column chromatography (95:5 hexanes/EtOAc). 1H NMR (300 MHz, CDCl3): δ 8.24
(s, 1H), 7.93-7.77 (m, 4H), 7.59-7.51 (m, 2H), 1.43 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3):
209.2, 136.0, 134.5, 132.6, 129.3, 128.7, 128.0, 127.9, 126.8, 125.1, 124.22, 44.6, 28.4 ppm.
O
CH3
O

CH 3

1-(Benzofuran-2-yl)-2-phenylbutan-1-one (23). General procedure C was employed using
benzofuran-2-carbonyl chloride (36 mg, 0.2 mmol) and (S)-5-(sec-butyl)-1-aza-5stannabicyclo[3.3.3]undecane (68 mg, 0.22mmol, 91% ee). A colorless oil (27 mg, 67%, 88%
ee) was isolated by column chromatography (99:1 hexanes/ether). [a]20D (c 1.00, CHCl3) =
+3.2º. % ee was determined using an IA (250x4.6) HPLC column with a 60%:40%
methanol:water eluent. 1H NMR (300 MHz, CDCl3): δ 7.71 (d, J = 7.5 Hz, 1H), 7.60-7.44 (m,
3H), 7.31 (dt, J = 3, 7.5 Hz, 1H), 3.32 (sextet, J = 6.6 Hz, 1H), 1.94-1.82 (m, 1H), 1.63-1.49 (m,
1H), 1.25 (d, J = 6 Hz, 3H), 0.96 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 195.50,
155.63, 152.11, 128.07, 127.10, 123.83, 123.20, 112.80, 112.45, 36.70, 18.79 ppm. HRMS
(ES+): Calcd (M-H)+ 203.1072; Found 203.1072.

O
CH3

1,4-Diphenyl-2-methyl-1-butanone (24).15 General procedure B (acyl chloride) was employed
using benzoyl chloride (17 mg, 0.1 mmol) and (S)-5-(4-phenylbutan-2-yl)-1-aza-5stannabicyclo[3.3.3]undecane (43 mg, 0.11mmol, 99% ee). A colorless oil (18.5 mg, 78%, 99%
ee) was isolated by column chromatography (95:5 hexanes/ether). [a]20D (c 1.00, CHCl3) =
+27.8º. % ee was determined using an IA (250x4.6) HPLC column with a 80%:20% [19:1 v/v
methanol/acetonitrile]:sodium phosphate buffer (25mM, pH 7.8) eluent. 1H NMR (300 MHz,
CDCl3): δ 7.88-7.85 (m, 2H), 7.58-7.52 (m, 1H), 7.46-7.41 (m, 2H), 7.31-7.16 (m, 5H), 3.47
(sextet, J = 6.6 Hz, 1H), 2.65 (t, J = 7.5 Hz, 2H), 2.24-2.12 (m, 1H), 1.81-1.70 (m, 1H), 1.24 (d, J
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= 6.8 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 204.3, 142.0, 136.8, 133.1, 128.8, 128.7, 128.6,
128.5, 126.1, 39.9, 35.4, 33.7, 17.5 ppm.
General procedure E (thioester) was employed using Pd(PPh3)4 (2 mol %), CuCl (2 equiv), Sphenyl benzothioate (42.8 mg, 0.2 mmol) and (S)-5-(4-phenylbutan-2-yl)-1-aza-5stannabicyclo[3.3.3]undecane (86 mg, 0.22 mmol, 91% ee). A colorless oil (38.5 mg, 81%, 90%
ee) was isolated by column chromatography (95:5 hexanes/ether). % ee was determined using an
IA (250x4.6) HPLC column with a 75%:25% methanol:sodium phosphate buffer (25mM, pH
7.8) eluent.

O
N

O
CH3

1-(Isoxazol-5-yl)-2-methyl-4-phenylbutan-1-one (26). General procedure C was employed
using isoxazole-5-carbonyl chloride (26.3 mg, 0.2 mmol) and 5-(4-phenylbutan-2-yl)-1-aza-5stannabicyclo[3.3.3]undecane (86 mg, 0.22 mmol, 95% ee). A colorless oil (34.4 mg, 75%, 99%
ee) was isolated by column chromatography (75:25 hexanes/ether). [a]20D (c 1.00, CHCl3) =
+18.0º. % ee was determined using an OJ-RH (150x4.6) HPLC column with a 70%:30% [19:1
v/v methanol/acetonitrile]:water eluent. 1H NMR (300 MHz, CDCl3): δ 8.34 (d, J = 3.0 Hz, 1H),
7.27-7.14 (m, 1H), 6.85 (d, J = 3Hz, 5H), 3.38 (sextet, J = 7.2 Hz, 1H), 2.65 (t, J = 6 Hz, 2H),
2.25-2.12 (m, 1H), 1.88-1.73 (m, 1H), 1.28 (d, J = 6 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3):
193.0, 166.0, 150.9, 141.5, 128.7, 128.6, 126.3, 107.4, 42.9, 34.4, 33.6, 16.5 ppm. HRMS (ES+):
Calcd (M-H)+ 230.1181; Found 230.1155.

O
OEt
CH 3 O

Ethyl 3-methyl-4-(naphthalen-2-yl)-4-oxobutanoate (29). General procedure B was employed
using
2-naphthoyl
chloride
(57
mg,
0.3
mmol)
and
ethyl
3-(1-aza-5stannabicyclo[3.3.3]undecan-5-yl)butanoate (123 mg, 0.33 mmol). A colorless oil (49 mg, 71%)
was isolated by column chromatography (90:10 hexanes/ether). For the enantioenriched
carbastannatrane variant, general procedure B was employed using 2-naphthoyl chloride (0.05
mmol) and ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate (0.055 mmol, 97% ee).
The product yield (75%, 96% ee) was determined by calibrated gas chromatography. % ee was
determined using an OJ-RH (150x4.6) HPLC column with a 70%:30% [19:1 v/v
methanol/acetonitrile]:sodium phosphate buffer (25mM, pH 7.8) eluent. 1H NMR (300 MHz,
CDCl3): δ 8.53 (br s, 1H), 8.06-7.87 (m, 4H), 7.58 (dquintet, J = 1.8, 7.5 Hz, 2H), 4.16-4.07 (m,
3H), 3.06-2.97 (dd, J = 9, 18 Hz, 1H), 2.55-2.47 (dd, J = 6, 18 Hz, 1H), 1.29 (d, J = 6.0 Hz, 3H),
1.21 (t, J = 6.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 203.0, 172.6, 135.8, 133.5, 132.8,
130.2, 129.8, 128.8, 128.7, 128.0, 127.0, 124.5, 60.8, 37.9, 37.5, 18.3, 14.4 ppm. HRMS (ES+):
Calcd (M-H)+ 271.1334; Found 271.1335.
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O
O

OEt
CH 3 O

Ethyl 4-(furan-2-yl)-3-methyl-4-oxobutanoate (27). General procedure C was employed using
2-furoyl chloride (39 mg, 0.3 mmol) and ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5yl)butanoate (123 mg, 0.33 mmol). A colorless oil (50 mg, 79%) was isolated by column
chromatography (80:20 hexanes/EtOAc). For the enantioenriched carbastannatrane variant,
general procedure C was employed using 2-furoyl chloride (0.05 mmol) and ethyl 3-(1-aza-5stannabicyclo[3.3.3]undecan-5-yl)butanoate (0.055 mmol, 97% ee). The product yield (78%,
96% ee) was determined by calibrated gas chromatography. % ee was determined using an IA
(250x4.6) HPLC column with a 50%:50% [19:1 v/v methanol/acetonitrile]:sodium phosphate
buffer (25mM, pH 7.8) eluent. 1H NMR (300 MHz, CDCl3): δ 7.60 (br s, 1H), 7.24 (d, J = 3
Hz, 1H), 6.55-6.53 (dd, J = 3, 3 Hz, 1H), 4.09(q, J = 6.0 Hz, 2H), 3.72 (sextet, J = 6.6 Hz, 1H),
2.95-2.87 (dd, J = 9, 15 Hz, 1H), 2.46-2.38 (dd, J = 6, 18 Hz, 1H), 1.25-1.17 (m, 6H) ppm. 13C
NMR (75 MHz, CDCl3): 203.0, 172.6, 135.8, 133.5, 132.8, 130.2, 129.8, 128.8, 128.7, 128.0,
127.0, 124.5, 60.8, 37.9, 37.5, 18.3, 14.4 ppm. 13C NMR (125 MHz, CDCl3): 191.8, 172.3,
152.2, 146.7, 117.8, 112.5, 60.8, 38.1, 37.3, 17.8, 14.3 ppm. HRMS (ES+): Calcd (M-H)+
211.0970; Found 211.0960.
O
OEt
Cl

CH 3 O

Ethyl 4-(4-chlorophenyl)-3-methyl-4-oxobutanoate (28).16
General procedure C was
employed using 4-chlorobenzoyl chloride (53 mg, 0.3 mmol) and ethyl 3-(1-aza-5stannabicyclo[3.3.3]undecan-5-yl)butanoate (123 mg, 0.33 mmol). A colorless oil (71 mg, 93%)
was isolated by column chromatography (90:10 hexanes/ether). For the enantioenriched
carbastannatrane variant, general procedure C was employed using 4-chlorobenzoyl chloride
(0.05 mmol) and ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate (0.055 mmol,
99% ee). The product yield (93%, 99% ee) was determined by calibrated gas chromatography. %
ee was determined using an IA (250x4.6) HPLC column with a 70%:30% methanol:sodium
phosphate buffer (25mM, pH 7.8) eluent. 1H NMR (300 MHz, CDCl3): δ 7.94 (d, J = 9.0 Hz,
2H), 7.46 (d, J = 9.0 Hz, 2H), 4.12 (q, J = 7.0 Hz, 2H), 3.89 (sextet, J = 7.2 Hz, 1H), 3.00-2.91
(dd, J = 9, 18 Hz, 1H), 2.49-2.41 (dd, J = 6, 18 Hz, 1H), 1.23-1.18 (m, 6H) ppm. 13C NMR (75
MHz, CDCl3): 201.9, 172.4, 139.7, 134.5, 130.1, 129.2, 60.8, 37.7, 37.4, 18.0, 14.3 ppm.
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O

O

CH3

1-(Benzofuran-2-yl)-2-phenylbutan-1-one (30). General procedure C was employed using
benzofuran-2-carbonyl chloride (54 mg, 0.3 mmol) and 5-(1-phenylpropyl)-1-aza-5stannabicyclo[3.3.3]undecane (125 mg, 0.33 mmol). A yellow oil (63 mg, 80%) was isolated by
column chromatography (95:5 hexanes/ether). For the enantioenriched carbastannatrane variant,
general procedure C was employed using benzofuran-2-carbonyl chloride (0.05 mmol) and 5-(1phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.055 mmol, 99% ee). The product yield
(78%, 97% ee) was determined by calibrated gas chromatography. % ee was determined using
an OJ-RH (150x4.6) HPLC column with a 80%:20% [19:1 v/v methanol/acetonitrile]:sodium
phosphate buffer (25mM, pH 7.8) eluent. 1H NMR (300 MHz, CDCl3): δ 7.66-7.22 (m, 10H),
4.40 (t, J = 7.5 Hz, 1H), 2.30-2.21 (m, 1H), 1.93-1.86 (m, 1H), 0.94 (t, J = 7.5 Hz, 3H) ppm. 13C
NMR (75 MHz, CDCl3): 191.3, 155.8, 152.7, 139.2, 129.02, 128.6, 128.4, 127.4, 127.3, 124.0,
123.5, 113.7, 112.7, 56.3, 26.5, 12.5 ppm. HRMS (ES+): Calcd (M-Na)+ 287.1048; Found
287.1067.

O

S

CH3

1-(Benzo[b]thiophen-2-yl)-2-phenylbutan-1-one (31). General procedure C was employed
using benzo[b]thiophene-2-carbonyl chloride (55 mg, 0.3 mmol) and 5-(1-phenylpropyl)-1-aza5-stannabicyclo[3.3.3]undecane (125 mg, 0.33 mmol). A pale yellow solid (51 mg, 69%) was
isolated by column chromatography (97:3 hexanes/ether).
For the enantioenriched
carbastannatrane variant, general procedure C was employed using benzo[b]thiophene-2carbonyl chloride (0.05 mmol) and 5-(1-phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane
(0.055 mmol, 99% ee). The product yield (71%, 99% ee) was determined by calibrated gas
chromatography. % ee was determined using an OJ-RH (150x4.6) HPLC column with a
80%:20% [19:1 v/v methanol/acetonitrile] : sodium phosphate buffer (25mM, pH 7.8) eluent. 1H
NMR (300 MHz, CDCl3): δ 7.66-7.22 (m, 10H), 4.40 (t, J = 7.5 Hz, 1H), 2.30-2.21 (m, 1H),
1.93-1.86 (m, 1H), 0.94 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 191.3, 155.8,
152.7, 139.2, 129.0, 128.6, 128.4, 127.4, 127.3, 124.0, 123.5, 113.7, 112.7, 56.3, 26.5, 12.5 ppm.
HRMS (ES+): Calcd (M-H)+ 281.1000; Found 281.0984.
CH3 CH3
CH3
H 3CO

O
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(2S,4R)-2-(6-methoxynaphthalen-2-yl)-4-methylhexan-3-one (syn-34). General procedure E
was employed using Pd(dba)2 (5 mol %), Jackiephos (7 mol %), CuCl (2 equiv), S-phenyl (S)-2(6-methoxynaphthalen-2-yl)propanethioate (64.5 mg, 0.2 mmol, >99% ee) and (R)-5-(sec-butyl)1-aza-5-stannabicyclo[3.3.3]undecane (80.4 mg, 0.26 mmol, 99% ee). A white solid (32.5 mg,
60%, 49:1 dr) was isolated by column chromatography (97:3 hexanes/ether). [a]20D (c 1.00,
CHCl3) = +183.9º. 1H NMR (300 MHz, CDCl3): δ 7.71-7.62 (m, 3H), 7.32-7.29 (dd, J = 3, 9 Hz
,1H), 7.17-7.11 (m, 2H), 4.03 (q, J = 6 Hz, 1H), 3.91 (s, 3H), 2.58 (app. sextet, J = 8.4 Hz, 1H),
1.61-1.44 (m, 4H), 1.22 (app. heptet, J = 6 Hz, 1H), 1.07 (d, J = 6 Hz, 1H), 0.89-0.79 (m, 1H),
0.55 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 214.49, 157.84, 135.64, 133.84,
129.38, 129.26, 127.51, 126.97, 126.85, 119.25, 106.81, 55.51, 51.56, 46.57, 25.63, 18.27, 17.48,
11.80 ppm. HRMS (ES+): Calcd (M-Na)+ 293.1517; Found 293.1515.
CH3 CH3
CH3
H 3CO

O

(2S,4S)-2-(6-methoxynaphthalen-2-yl)-4-methylhexan-3-one (anti-34). General procedure E
was employed using Pd(dba)2 (5 mol %), Jackiephos (7 mol %), CuCl (2 equiv), S-phenyl (S)-2(6-methoxynaphthalen-2-yl)propanethioate (64.5 mg, 0.2 mmol, >99% ee) and (S)-5-(sec-butyl)1-aza-5-stannabicyclo[3.3.3]undecane (80.4 mg, 0.26 mmol, 91% ee). A pale yellow solid (35
mg, 65%, 22:1 dr) was isolated by column chromatography (97:3 hexanes/ether. [a]20D (c 1.00,
CHCl3) = +160.9º. 1H NMR (300 MHz, CDCl3): δ 7.71-7.61 (m, 3H), 7.31-7.28 (dd, J = 3, 9 Hz
,1H), 7.17-7.11 (m, 2H), 3.98 (q, J = 5.25 Hz, 1H), 3.92 (s, 3H), 2,61 (sextet, J = 6.6 Hz, 1H),
1.65 (heptet, J = 7 Hz, 1H), 1.47-1.32 (m, 4H), 1.07 (d, J = 6 Hz, 1H), 0.89-0.84 (m, 6H) ppm.
13
C NMR (75 MHz, CDCl3): 215.03, 157.87, 135.91, 133.83, 129.38, 129.29, 127.59, 126.92,
126.82, 119.30, 106.81, 55.54, 52.65, 46.29, 27.13, 18.11, 16.30, 11.89 ppm. HRMS (ES+):
Calcd (M-Na)+ 293.1517; Found 293.1515.
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Sn
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>99% ee

IA-3mm 150x4.6
100 : 0.1 Hexane : IPA
0.6 mL/min
220nm
25°C
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Sn
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Sn
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99% ee
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Flow
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Chiralcel OJ-H 250x4.6
95 : 5 Methanol : Water
1.0 mL/min
215nm
25°C
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Sn
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N
Sn
CH3
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Mobile Phase
Flow
Detector
Temp

Chiralcel OJ-H 250x4.6
95 : 5 Methanol : Water
1.0 mL/min
290nm
25°C
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Sn
H 3C

CH3

CH3
H 3C
96% ee

OMe

CH3

H 3C

OMe

CH3
H 3C
96% ee

CONDITIONS
Column
m-Phase
Flow
Detector
Temp

IA 250x4.6
57% : 43% Methanol : Water
1.3 mL/min
210 nm
25°C
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90% ee (99% es)
(using thioester)
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Mobile Phase
Flow
Detector
Temp

IA 250x4.6
75% : 25% Methanol : Sodium phosphate buffer (25mM, pH 7.8)
1 mL/min
210 nm
25°C
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O
CH3
99% ee (100% es)
(using acyl chloride)
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Column
Mobile Phase
Flow
Detector
Temp

IA 250x4.6
80% : 20% [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate
buffer (25mM, pH 7.8)
1 mL/min
205 nm
25°C
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94% ee (99% es)
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Mobile Phase
Flow
Detector
Temp

OJ-RH 150x4.6
70% : 30% [19:1 v/v Methanol/Acetonitrile] : Water
1.0 mL/min
220 nm
25°C
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OEt
CH 3 O
96% ee (99% es)

CONDITIONS
Column
Mobile Phase
Flow
Detector
Temp

OJ-RH 150x4.6
70% : 30% [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate
buffer (25mM, pH 7.8)
0.8 mL/min
205 nm
25°C
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99% ee (100% es)
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Column
Mobile Phase
Flow
Detector
Temp

OJ-RH 150x4.6
80% : 20% [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate
buffer (25mM, pH 7.8)
1 mL/min
215, 254 nm
25°C
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Mobile Phase
Flow
Detector
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OJ-RH 150x4.6
80% : 20% [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate
buffer (25mM, pH 7.8)
0.4 mL/min
215 nm
25°C
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Mobile Phase
Flow
Detector
Temp

CH 3 O
99% ee, (100% es)

IA 250x4.6
70% : 30% Methanol : Sodium phosphate buffer (25mM, pH 7.8)
1.0 mL/min
210 nm
25°C
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CH3 CH3

O
H 3C
CH3 CH3
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Mobile Phase
Flow
Detector
Temp

IA 250x4.6
65% : 35% [19:1 v/v Methanol/Acetonitrile] : Water
1.0 mL/min
220 nm
25°C
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Mobile Phase
Flow
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IA 250x4.6
50% : 50% [19:1 v/v Methanol/Acetonitrile] : Water
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210 nm
25°C
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CH3

CH3 O
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CH3
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Mobile Phase
Flow
Detector
Temp

OJ-RH 150x4.6
55% : 45% Methanol : Water
1.2 mL/min
220 nm
25°C
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Mobile Phase
Flow
Detector
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IA 250x4.6
60% : 40% Methanol : Water
1.2 mL/min
215 nm
25°C
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210 nm
25°C
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VCD analysis of absolute stereochemistry of product from acylation of (R)-19
Ph
O
Cl
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+
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Sn

Pd(PPh 3)4 (2 mol %)
CuCl (2 equiv)

O
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CH 3CN, 60 ºC
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Absolute
Determination
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RESULTS

Absolute Configuration of PhenAcyl is (R).

Confidence Level: 90 %

MEASUREMENT PARAMETERS
Concentration
Solvent
Resolution
PEM setting
Number of scans/Measurement time
Sample cell
Path length

5.7 mg/0.15mL
CDCl3
-1
4 cm
–1
1400 cm
6 hours
BaF2
100 µm

CALCULATION DETAILS
Gaussian version
Total low-energy conformer used for Boltzmann sum
Methodology and basis set for DFT calculations
Enantiomer used for calculation
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13
B3LYP/6-31G(d)

Total calculated conformers

13
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Number of low-energy conformations shown in report
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Absolute Configuration Determination Report
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Table 1. Numerical comparison describing the similarity in the range of 1300-1800 cm between
the calculated IR and VCD spectra for the (R) enantiomer at the B3LYP/6-31G(d) level and the
observed IR and VCD spectra for PhenAcyl.
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spectra.
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1. General Reagent/Analytical Information
BDH brand ethyl ether was purchased from VWR. EMD brand Omnisolv THF (unstabilized)
was also purchased from VWR. These solvents were transferred to separate 20 L solventdelivery kegs and vigorously purged with argon for 2 h. The solvents were further purified by
passing them under argon pressure through two packed columns of neutral alumina. 5-chloro-1aza-5-stannabicyclo[3.3.3]undecane and Selectfluor I were purchased from Sigma-Aldrich.
Acetonitrile (Sigma-Aldrich) was purged with argon prior to use. Grignard reagents were
prepared from their corresponding alkyl chlorides or bromides using a literature procedure[1].
Molarities of Grignard reagents and zinc reagents were determined using iodine titration[2].
Optically active alkylcarbastannatranes were prepared via preparatory chiral HPLC of the
racemate or using a previously reported literature procedure.[3] Reagents and solvents were used
as received unless otherwise noted. Flash chromatography was performed using Silicycle silica
gel (ultra-pure grade).
All NMR spectra were obtained on a Varian 500 (500 MHz for 1H and 125 MHz for 13C), a
Varian 300 (282 MHz for 19F) or a Bruker 300 (300 MHz for 1H, 75 MHz for 13C and 282 MHz
for 19F). All previously unreported compounds were additionally characterized by high resolution
MS. All 1H NMR experiments are reported in δ units, parts per million (ppm), and were
measured relative to the signals for residual chloroform (7.26 ppm) unless otherwise noted. The
following abbreviations are used to express the multiplicities: s = singlet; d = doublet; t = triplet;
m = multiplet; br = broad, app = apparent. All 13C NMR spectra are reported in ppm relative to
deuterochloroform (77.23 ppm), and were obtained with 1H decoupling. High resolution MS
analyses were performed on an Agilent 6520 Q-TOF instrument. All GC analyses were
performed on a Shimadzu GC-2010 gas chromatograph with an FID detector using a 25 m x 0.20
mm capillary column with cross-linked methyl siloxane as the stationary phase, or using a 30 m
x 0.32 mm chiral column (Rt®-βDEXsm from RESTEK). All low boiling point fluoride
compounds were confirmed by GCMS on Shimadzu GC-MS QP2010S or high resolution MS.
All GC yields were calibrated using dodecane or tetradecane as an internal standard. Chiral
HPLC analyses were performed using a Shimadzu Prominence HPLC system with binary mobile
phase pumps and UV-vis detector (LC-20AB, SPD-20A) using an OJ-RH (dimensions: 4.6 mm
x 150 mm; particle size: 5 µm) chiral column (DAICEL CHEMICAL IND., LTD.), or an IA
(dimensions: 4.6 mm x 150 mm; particle size: 5 µm) chiral column (DAICEL CHEMICAL IND.,
LTD.)
2. General Procedure Information
Preparation of alkylcarbastannatranes:
General procedure A (preparation of achiral and racemic alkylcarbastannatranes):
Grignard reagents were prepared from the corresponding alkyl chlorides. All reactions were
performed in oven-dried glassware under an atmosphere of Ar. The alkylmagnesium reagent (or
alkylzinc reagent for ethyl butanoate nucleophile) (2.0-3.0 equiv) was added to a suspension of
5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane1 (1 equiv) in THF at -78 °C. The resulting
mixture was stirred at -78 °C for 3 h, allowed to warm to room temperature, and stirred
170

overnight. The reaction mixture was poured into a separatory funnel containing a mixture of
water and ether. The organic layer was separated, washed with brine, dried over Na2SO4, and
filtered. Solvent was removed under reduced pressure, and the remaining compound was dried in
vacuo to provide the crude product. The crude alkyltin reagents were used without purification,
or following purification via Kugelrohr distillation or C18 chromatography. Homocoupling from
Grignard formation constituted the major residual byproduct in the crude product.
General procedure B (preparation of enantioenriched alkylcarbastannatranes):
To an oven-dried round bottom flask containing a stirbar, 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (588 mg, 2 mmol) and naphthalene (128 mg, 1 mmol) were added. The
flask was evacuated (<100 mtorr) and backfilled with argon three times. With the flask under a
flow of argon, the septum was removed and lithium granules (free of oil) (250 mg, 35 mmol)
were added. This was followed by two additional evacuation/backfill cycles. Anhydrous THF
(40 mL) was added to the flask via syringe, and the mixture was stirred at room temperature. The
solution turned dark green/black within 30 min. Upon color change, the solution was stirred at
room temperature for an additional hour. In a separate 100 mL flask under argon, with stirbar
and rubber septum, the optically active alkyl mesylate (1.2–1.5 equiv) was dissolved in
anhydrous THF (20 mL). The mesylate solution was heated to 60 °C. The stannatrane lithium
mixture was removed from the excess lithium via cannula or needle/syringe, and transferred
dropwise to the mesylate solution over 5 mins. The reaction stirred at 60 °C for an additional
hour. The reaction mixture was extracted with ethyl ether (60 mL), followed by brine (100 mL),
and dried over Na2SO4. The reaction solution was filtered and concentrated to provide the crude
product. The crude product was purified (40–50% isolated yield) by C18 silica (80/20
acetonitrile/water to 100% acetonitrile), fractions analyzed using HPLC (220/254 nm) or reversephase TLC.
Halogenation of racemic alkylcarbastannatranes:
General procedure C:
To an oven-dried screw-top test tube equipped with a stirbar, alkylcarbastannatrane (0.25 mmol)
and halogenation reagent (1.5 equiv of Selectfluor I, trichloroisocyanuric acid, Nbromosuccinimide, or iodine) were added. The test tube was sealed with a screw-top septum and
electrical tape. The reaction tube was evacuated (ca. 100 mtorr) and backfilled with argon 3
times using a needle attached to a vacuum manifold. Acetonitrile (1 mL) was added via syringe,
and the reaction mixture was allowed to stir (5 min–1 h) at rt. Once the reaction was complete,
water (0.5 mL) was added to the reaction mixture. For fluorination reactions, the resulting
solution was additionally diluted by ethyl acetate (0.2 mL). Fluorobenzene (0.2 mmol) was
added as an internal 19F NMR standard, and the solution was analyzed by unlocked 19F NMR
spectroscopy and GCMS. For volatile alkyl fluorides, calibrated yields were obtained by 19F
NMR and GC to ensure accuracy of measurement. For other halogenation reactions, the reaction
mixture was diluted with ether and washed with brine. The organic layer was dried over Na2SO4,
filtered, and concentrated to provide the crude product. The crude reaction products were
purified by flash column chromatography (diethyl ether/pentane).
Fluorination of enantioenriched alkylcarbastannatranes:

171

General procedure D:
To an oven-dried screw-top test tube equipped with a stirbar, the enantioenriched
alkylcarbastannatrane (0.1 mmol) was added. The test tube was sealed with a screw-top septum
and electrical tape. The reaction tube was evacuated (ca. 100 mtorr) and backfilled with argon 3
times, anhydrous pyridine (0.5 equiv.) was added, and the reaction mixture was then cooled to -5
ºC in a NaCl/ice bath. A solution of Selectfluor I (1.5 equiv) in acetonitrile (1.1 mL) and styrene
(1 equiv) was added via syringe. After the reaction stirred for 2 h at -5 ºC, water (0.2 mL) was
added. Fluorobenzene (0.05 mmol) was added as an internal standard, and the solution was
analyzed by unlocked 19F NMR spectroscopy. The ee value was determined by HPLC or chiral
GC analysis.
Halogenation (Cl, Br and I) of enantioenriched alkylcarbastannatranes:
General procedure E:
To an oven-dried screw-top test tube equipped with a stirbar, the enantioenriched
alkylcarbastannatrane (0.1 mmol) was added. The test tube was sealed with a screw-top septum
and electrical tape. The reaction tube was evacuated (ca. 100 mtorr) and backfilled with argon 3
times, then cooled to -5 ºC in a NaCl/ice bath. A solution containing the halogenation reagent
[trichloroisocyanuric acid (0.15 mmol) in CH3CN (1 mL), N-bromosuccinimide (0.15 mmol) in
CH3CN (1 mL), or N-iodosuccinimide (0.15 mmol) in 1 mL THF] was added dropwise via
syringe. After the reaction stirred for 3 h at -5 ºC, water (0.2 mL) was added. The organic layer
was used for GC and HPLC analysis. The GC yield was determined using tetradecane as an
internal calibration standard. The ee value was determined by HPLC or chiral GC analysis.
3. Compound Characterization Data
N
Sn
CH3

1-(4-Phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (5).[1] General procedure A
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.35 mmol) and (4phenylbutan-2-yl)magnesium chloride (4 mmol). A yellow liquid (0.413 g, 78%) was isolated.
1
H NMR (500 MHz, CDCl3): δ 7.25-7.28 (m, 2H), 7.16-7.19 (m, 3H), 2.50-2.65 (m, 2H), 2.36 (t,
J = 6.0 Hz, 6H), 1.68-1.81 (m, 2H), 1.65 (quint, J = 6.0 Hz, 6H), 1.13 (d, J = 7.5 Hz, 3H), 0.79
(quart, J = 7.5 Hz, 1H), 0.67 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 143.9,
128.6, 128.3, 125.5, 55.0, 39.0, 36.5, 24.2, 23.6, 18.6, 5.6 ppm.
N
Sn
H 3C

8

CH3
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1-(Dodecan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane. General procedure A was employed
using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.5 mmol) and dodecan-2-ylmagnesium
chloride (4.4 mmol). A yellow liquid (0.482 g, 75%) was isolated. 1H NMR (500 MHz, CDCl3):
d 2.34 (t, J = 5.75 Hz, 6H), 1.63 (app. quint, J = 6.6 Hz, 6H), 1.45-1.13 (m, 18H), 1.04 (d, J =
1.51, 3H), 0.88 (t, J = 6.6 Hz, 3H), 0.72 (m, 1H), 0.62 (t, J = 6.7 Hz, 6H) ppm; 13C NMR (125
MHz, CDCl3): δ 54.9, 36.6, 32.2, 30.2, 30.1, 29.98, 29.90, 29.6, 24.2, 23.65, 23.55, 22.94, 18.9,
14.4, 5.6 ppm. HRMS (ES+): Calcd (M-Na)+ 444.2341; Found 444.2332.
N
O
EtO

Sn
CH3

Ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate.[1] General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (3 mmol) and (4-ethoxy-4oxobutan-2-yl)zinc iodide (6.1 mmol). An yellow oil (509 mg, 45%) was isolated. 1H NMR
(500 MHz, CDCl3): δ 4.09 (quart, J = 7.0 Hz, 2H), 2.40 (m, 1H), 2.35 (t, J = 6.0 Hz, 6H), 2.25
(m, 1H), 1.64 (app. quint, J = 6 Hz, 6H), 1.24 (t, J = 7.0 Hz, 3H), 1.02-1.13 (m, 4H), 0.65 (t, J =
6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 175.5, 60.0, 54.9, 40.7, 23.5, 19.8, 18.4, 14.6,
5.2 ppm.
The ester derivative could also be prepared using a zincated stannatrane nucleophile via the
following process: Under argon, stannatrane lithium (1 equiv) (prepared via general procedure
B) was added to a 2 M solution of Et2Zn in ether (1 equiv) at 0 ºC. This mixture was allow to stir
at 0 ºC for 30 min. It was then added to a solution of ethyl 3-((methylsulfonyl)oxy)butanoate in
hexanes, and allowed to stir overnight at rt. The reaction mixture was washed with water, and
extracted with ether three times. The combined organic layers were dried over Na2SO4, filtered,
concentrated under reduced pressure, and purified by reverse phase flash chromatography (100%
CH3CN). A yellow liquid was isolated (32% yield).

N

Sn

O

5-(Tetrahydro-2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane.[1] General procedure A
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.42 mmol) and
(tetrahydro-2H-pyran-4-yl)magnesium chloride (1.26 mmol). A pale yellow solid (121 mg, 84%)
was isolated. 1H NMR (500 MHz, CDCl3): δ 3.87 (m, 2H), 3.33 (dt, J = 11.0, 2.0 Hz, 2H), 2.36
(t, J = 6 Hz, 6H), 1.64 (app. quint, J = 6.0 Hz, 6H), 1.50-1.65 (m, 4H), 0.90 (tt, J = 12.5, 4.0 Hz,
1H), 0.64 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 71.0, 54.8, 31.3, 26.0, 23.4,
4.6 ppm.

N

Sn

CH3
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5-(1-Phenylethyl)-1-aza-5-stannabicyclo[3.3.3]undecane.[1] General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.3 mmol) and (1phenylethyl)magnesium chloride (1.5 mmol). A yellow oil (90 mg, 82%) was isolated. 1H NMR
(500 MHz, CDCl3): δ 7.15 (t, J = 7.5 Hz, 2H), 6.90-7.00 (m, 3H), 2.30 (t, J = 6.0 Hz, 6H), 2.21
(quart, J = 7.5 Hz, 1H), 1.61 (app. quint, J = 6.0 Hz, 6H), 1.44 (d, J = 7.5 Hz, 3H), 0.61 (dt, J =
6.5, 3 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 151.5, 128.0, 124.9, 121.7, 54.7, 32.7, 23.5,
16.7, 5.3 ppm.
N
Sn
H

1-(3-Phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane.[3] General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.88 mmol) and (3phenylpropyl)magnesium chloride (2.5 mmol). A yellow liquid (274 mg, 82%) was isolated. 1H
NMR (500 MHz, CDCl3) δ: 7.27-7.14 (m, 5H), 2.53 (t, J = 7.5 Hz, 2H), 2.36 (t, J = 6.2 Hz, 6H),
1.69 (app. quint, J = 6 Hz, 2H), 1.62 (app. quint, J = 6 Hz, 6H), 0.64 (t, J = 6 Hz, 6H), 0.48 (t, J
= 6.0 Hz, 2H) ppm. 13C NMR (125 MHz, CDCl3) δ: 143.6, 128.7, 128.3, 125.5, 54.9, 41.5, 29.9,
23.6, 16.4, 6.8 ppm.

N

Sn n-C10H21

1-Decyl-5-aza-1-stanna-bicyclo[3.3.3]undecane (4). General procedure A was employed using
5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (2 mmol) decylmagnesium chloride (5 mmol). A
pale yellow solid (538 mg, 67%) was isolated. 1H NMR (500 MHz, CDCl3): δ 2.36 (t, J = 5.5
Hz, 6H), 1.63 (app. quint, J = 6.2 Hz, 6H), 1.26 (m, 16H), 0.88 (t, J = 6.8 Hz, 3H), 0.62 (t, J =
6.6 Hz, 6H); 0.40 (t, J = 8 Hz, 2H) ppm; 13C NMR (125 MHz, CDCl3): δ 55.0, 34.9, 32.2, 29.96,
29.95, 29.7, 29.6, 27.4, 23.6, 22.9, 16.4, 14.4, 6.8 ppm. HRMS (ES+): Calcd (M-Na)+ 416.2028;
Found 416.2021.

N

Sn

t-Bu

1-(4-tert-Butylbenzyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane. General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.5 mmol) and (4-tertbutylbenzyl)magnesium chloride (1.42 mmol). A pale yellow solid (172 mg, 85%) was isolated.
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1

H NMR (500 MHz, CDCl3): δ 7.11 (d, J = 8.3 Hz, 2H), 6.81 (d, J = 8.1 Hz, 2H), 2.33 (t, J = 5.7
Hz, 6H), 1.90 (s, 2H), 1.62 (app. quint, J = 6.6 Hz, 6H), 1.27 (s, 9H), 0.64 (t, J = 6.7 Hz, 6H)
ppm. 13C NMR (125 MHz, CDCl3): δ 144.0, 143.3, 128.2, 126.0, 125.4, 124.9, 54.8, 34.3, 31.8,
26.3, 23.5, 6.7 ppm. HRMS (ES+): Calcd (M-Na)+ 422.1559; Found 422.1557.
N
Sn
H 3C

CH2

5-(Pent-4-en-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure B was employed
using (1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)lithium (9 mmol, 1.5 equiv.) and pent-4-en-2-yl
methanesulfonate (6 mmol, 1 equiv.). The reaction stirred at 25 °C for 3 hours. The reaction
mixture was extracted with ethyl ether (60 mL), followed by brine (100 mL), and dried over
Na2SO4. The reaction solution was filtered and concentrated to provide the crude product. The
crude product was purified by C18 silica (100% acetonitrile). A colorless liquid (305 mg, 15%)
was isolated. 1H NMR (300 MHz, CDCl3): 5.83-5.69 (m, 1H), 4.96-4.86 (m, 2H), 2.35 (t, J = 5.8
Hz, 6H), 2.27-2.05 (m, 2H), 1.68- 1.60 (m, 6H), 1.04 (d, J = 7.5 Hz, 3H), 0.82-0.69 (m, 1H),
0.64 (t, J = 6.5 Hz, 6H) ppm; 13C NMR (75 MHz, CDCl3): 140.8, 113.7, 77.43, 54.9, 40.7, 23.6,
18.3, 5.66 ppm. LCMS Calcd (M-H)+ 330.1240; Found 330.1239.
N
Sn
H 3C

BPin
BPin

5-(4,5-bis(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane. To an oven-dried test tube with screw-top septum, 5-(pent-4-en-2yl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.4 mmol, 1 equiv.), K2CO3 (1.6 mmol, 4 equiv.) and
(Bpin)2 (1.2 mmol, 3 equiv.) was added. The reaction tube was evacuated and backfilled with
argon three times. With the tube under a positive pressure of argon, t-BuOH (anhydrous, 1 mL)
and H2O (degassed, 25 µL) were added. The reaction mixture was stirred at 60 oC for 12 h,
washed with water and extracted with ether 3 times. The combined organic layers were dried
over Na2SO4, filtered, concentrated under reduced pressure, and purified by reverse phase flash
column chromatography (100% CH3CN). A colorless liquid (165 mg, 71%) was isolated. The dr
for the product is 1:1.2. 1H NMR (300 MHz, CDCl3): 2.33 (t, J = 5.4 Hz, 6 H), 1.66-1.61 (m,
7H), 1.51-1.34 (m, 1H), 1.22 (d, J = 1.3 Hz, 24H), 1.06 -0.98 (m, 3H), 0.83-0.72 (m, 4H), 0.650.61 (m, 6H) ppm; 13C NMR (75 MHz, toluene- d8): δ 82.6, 82.5, 54.93 (minor), 54.92 (major),
40.8, 40.3, 25.13, 25.11, 25.09, 25.05, 25.03, 24.98, 24.96, 24.94, 24.08, 23.94 (minor), 23.92
(major), 23.7, 22.5, 19.0, 18.7, 5.45 (minor), 5.39 (major) ppm. HRMS (ESI): Calcd (M-Na)+
606.2932; Found 606.2934.
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N
Sn
H 3C

OH

3-(5-Aza-1-stanna-bicyclo[3.3.3]undecan-1-yl)butan-1-ol. To an oven-dried vial with a
stirbar, ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate (0.5 mmol) and LiAlH4 (4
mmol) were added. The vial was sealed with a screw-top septum and electrical tape. The reaction
vessel was evacuated (ca. 100 mtorr) and backfilled with argon 3 times. Then, dry ether (2 mL)
was added via syringe. The reaction was stirred overnight at room temperature. The reaction was
quenched with an aqueous solution of NaH2PO4 solution and extracted with hexane 3 times. The
combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure.
A colorless liquid (141 mg, 85%) was isolated. 1H NMR (500 MHz, CDCl3): δ 3.61 (q, J = 5.6
Hz, 2H), 2.36 (t, J = 5.5 Hz, 6H), 1.75 (m, 1H), 1.65 (quint, J = 5.9 Hz, 6H), 1.16 (m, 1H), 1.07
(d, J = 7.5 Hz, 3H), 0.76 (m, 1H), 0.65 (t, J = 6.6 Hz, 6H) ppm. 13C NMR(125 MHz, CDCl3): δ
63.3, 54.9, 39.2, 23.6, 19.1, 18.2, 5.4 ppm. HRMS (ES+): Calcd (M-H)+ 326.1219; Found
326.1219.
(S)-3-(5-Aza-1-stanna-bicyclo[3.3.3]undecan-1-yl)butan-1-ol The preceding procedure was
employed using (S)-3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl) butanoate (0.15 equiv) and
LiAlH4 (1.2 mmol). A colorless liquid (44 mg, 88%) was isolated.
Preparation of racemic and enantioenriched alkylcarbastannatranes S1, S2, and S3.
OH
H 3C

OMs

OH
OH

H 3C

OSiMe2t-Bu

H 3C

OSiMe2t-Bu

N

N

N

Sn

Sn

Sn

H 3C

OSiMe2t-Bu
(S1)

H 3C

OH
(S2)

H 3C

O
O

Ph

(S3)

OH
H 3C

OSiMe2t-Bu

(R)-4-((tert-Butyldimethylsilyl)oxy)butan-2-ol.[4]
To a round bottom flask, 4-(dimethylamino)pyridine (DMAP, 0.5 mmol, 10 mol %), tertbutyldimethylsilyl chloride (TBDMSCl, 6 mmol, 1.2 equiv), triethylamine (TEA, 10 mmol, 2
equiv), (R)-butane-1,3-diol (5 mmol, or butane-1,3-diol for racemic reaction), and
dichloromethane (DCM, 30 mL) were added. The reaction was stirred overnight at room
temperature. The reaction was quenched by water and extracted with DCM three times. The
combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure,
and purified by purified by flash column chromatography using ethyl acetate/dichloromethane
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(1:9). A colorless liquid (868 mg, 85%) was isolated. 1H NMR (300 MHz, CDCl3): δ 4.02 (m,
1H), 3.85 (m, 2H), 3.36 (br s, 1H), 1.65 (m, 2H), 1.19 (d, J = 6.3 Hz, 3H), 0.90 (s, 9H), 0.08 (s,
6H) ppm. 13C NMR (75 MHz, CDCl3): δ 68.5, 63.0, 40.2, 26.1, 23.6, 18.3, -5.31, -5.36 ppm.
OMs
H 3C

OSiMe2t-Bu

(R)-4-((tert-Butyldimethylsilyl)oxy)butan-2-yl methanesulfonate.[5]
To a round bottom flask, (R)-4-((tert-butyldimethylsilyl)oxy)butan-2-ol (3 mmol, 4-((tertbutyldimethylsilyl)oxy)butan-2-ol for racemic reaction), TEA (6 mmol, 2 equiv), and anhydrous
diethyl ether (20 mL) were added. The reaction flask was cooled to 0 ºC and mesyl chloride (4.5
mmol, 1.5 equiv) was added. The reaction was allowed to warm to room temperature and stirred
overnight. The reaction was quenched by water and extracted with ether three times. The
combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure,
and purified by purified by flash column chromatography (ethyl acetate/hexane = 1:9). A
colorless liquid (771 mg, 91%) was isolated. 1H NMR (300 MHz, CDCl3): δ 4.95 (m, 1H), 3.71
(m, 2H), 3.0 (s, 3H), 1.84 (m, 2H), 1.47 (d, J = 6.3 Hz, 3H), 0.89 (s, 9H), 0.06 (s, 6H) ppm. 13C
NMR (75 MHz, CDCl3): δ 77.7, 58.7, 39.7, 38.4, 26.1, 21.9, 18.4, -5.18, -5.19 ppm.
N
Sn
H 3C

OSiMe2t-Bu

(S)-5-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane
(S1).
General procedure B was followed.[3] The mixture was purified by reverse phase flash column
chromatography (DCM/CH3CN = 1:9). A light yellow oil was isolated (Yield: 40%). The ee
value (97% ee) was determined after deprotection to 3-(5-aza-1-stanna-bicyclo[3.3.3]undecan-1yl)butan-1-ol. 1H NMR (300 MHz, CDCl3): δ 3.56 (m, 2H), 2.35 (t, J = 5.7 Hz, 6H), 1.65 (m,
8H), 1.06 (d, J = 7.2 Hz, 2H), 0.89 (s, 10H), 0.64 (t, J = 6.7 Hz, 6H), 0.049 (s, 6H) ppm. 13C
NMR (75 MHz, CDCl3): δ 64.1, 54.9, 39.5, 26.3, 26.3, 26.2, 23.6, 19.6, 18.7, 18.6, 5.4, -4.8, -4.8
ppm. HRMS (ES+): Calcd (M-Na)+ 470.1880; Found 470.1868.
N
Sn
H 3C

OH

(S)-3-(5-Aza-1-stanna-bicyclo[3.3.3]undecan-1-yl)butan-1-ol (S2).
(S)-5-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo[3.3.3] undecane (0.01
mmol) and THF (0.2 mL) were combined in a 3 mL vial. The vial was cooled to 0 ºC, and TBAF
(1.2 equiv, 1M in THF) was added dropwise. The reaction was allowed to stir at 0 ºC for 30 min,
and then at room temperature for 3 h. The reaction was quenched with water and extracted with
ether three times. The combined organic layers were dried over Na2SO4, filtered, concentrated
under reduced pressure. The ee value (97% ee) was determined by HPLC analysis. The NMR
spectra of the isolated compound matched that of the racemic sample.
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O
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(S)-3-(1-Aza-5-stannabicyclo[3.3.3]undecan-5-yl)butyl benzoate (S3).
(S)-5-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.2
mmol) (or (5-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza- 5-stannabicyclo[3.3.3]undecane
for the racemic reaction) and THF (0.5 mL) were combined in a 3 mL vial. Tetra-nbutylammonium fluoride (TBAF 0.24 mmol, 1.2 equiv, 1M in THF) was added dropwise to the
vial at rt. The reaction was stirred for 30 min at 0 ºC, and then for 3 h at room temperature.
Triethylamine (0.8 mmol, 4 equiv) and benzoyl chloride (0.8 mmol, 4 equiv) were then added to
the reaction, which was allowed to stir overnight at rt. The reaction was washed by NaHCO3
(aq.) and extracted with ether three times. The combined organic layers were dried over Na2SO4,
filtered, concentrated under reduced pressure, and purified by purified by reverse phase flash
column chromatography (100% CH3CN). A colorless liquid (77 mg, 88%) was isolated. The ee
value (97% ee) was determined following hydrolysis to 3-(5-aza-1-stannabicyclo[3.3.3]undecan-1-yl)butan-1-ol. 1H NMR (300 MHz, CDCl3): δ 8.05 (m, 2H), 7.54 (m,
1H), 7.43 (m, 2H), 4.30 (t, J = 6.7Hz, 2H), 2.36 (t, J = 5.9 Hz, 6H), 2.0-1.81 (m, 2H), 1.65 (m,
6H), 1.13 (d, J = 7.5 Hz, 3H), 0.89-0.80 (m, 1H), 0.68 (t, J = 6.7 Hz, 6H) ppm. 13C NMR (75
MHz, CDCl3): δ 167.0, 132.8, 131.0, 129.8, 128.5, 65.8, 54.9, 35.0, 23.6, 19.8, 18.4, 5.3 ppm.
HRMS (ES+): Calcd (M-Na)+ 452.1301; Found 452.1315.
F
CH3

(3-Fluorobutyl)benzene (10). General procedure C was performed using 1-(4-phenylbutan-2yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 mmol). The
fluorinated product was formed in 64% yield as determined by 19F NMR spectroscopic analysis
of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -173.0 (m). 19F
NMR spectra are referenced based on the internal standard fluorobenzene, which is set at –113.6
ppm. The identity of the product was further confirmed by GCMS analysis. EIMS: m/z (%) =
152.10 (31.02), 132.05 (1.26), 117.05 (13.84), 105.05 (9.18), 91.05 (100). 92.05 (60.77),
77.05 (7.86), 65.05 (13.11), 51.05 (5.37), 39.05 (5.6).
(R)-(3-Fluorobutyl)benzene (29). General procedure D was performed using enantioenriched 1(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.1 mmol) and Selectfluor I (0.15
mmol). Water was added to quench the reaction. The organic layer was run on HPLC to
determine ee value. The fluorinated product was formed in 56% yield as determined by 19F NMR
spectroscopic analysis of the crude reaction mixture.
F
CH3

(1-Fluoroethyl)benzene (11). General procedure C was performed using 5-(1-Phenylethyl)-1aza-5-stannabicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 mmol). The
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fluorinated product was formed in 55% yield as determined by 19F NMR spectroscopic analysis
of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -166.9 (m). 19F
NMR spectra are referenced based on the internal standard fluorobenzene, which is set at –113.6
ppm. The identity of the product was further confirmed by GCMS analysis. m/z (%) = 124.1
(36.53), 109.05 (100), 103.05 (8.69), 83.5 (8.94), 77.05 (8.44), 63.05 (2.77), 51.05 (9.8), 39.05
(3.55).
F
H 3C

8

CH3

2-Fluorododecane (12). General procedure C was performed using 1-(dodecan-2- yl)-5-aza-1stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 mmol). The fluorinated
product was formed in 60% yield as determined by 19F NMR spectroscopic analysis of the crude
reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -171.6 (m). 19F NMR spectra
are referenced based on the internal standard fluorobenzene, which is set at –113.6 ppm. The
identity of the product was further confirmed by GCMS analysis. m/z (%) = 180.1 (0.02),
168.15 (2.36), 140.1 (5.13), 125.1 (8.24), 111.1 (20.55), 98.1 (17.43), 97.1 (49.9), 84.1 (38), 83.1
(63.93), 82.1 (18.45) 71.1 (24.14), 70.1 (66.43), 69.1 (79.52), 57.1 (73.51), 56.1 (64.51), 55.1
(88.1), 43.1 (100), 42.1 (24.14), 41.1 (72.35).
O
EtO

F
CH3

Ethyl 3-fluorobutanoate (13). General procedure C was performed using ethyl 3-(1-aza-5stannabicyclo[3.3.3]undecan-5-yl) butanoate (0.25 mmol) Selectfluor I (0.375 mmol). The
fluorinated product was formed in 64% yield as determined by 19F NMR spectroscopic analysis
of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -172.0 (m). 19F
NMR spectra are referenced based on the internal standard fluorobenzene, which is set at –113.6
ppm. The identity of the product was further confirmed by GCMS analysis. m/z (%) = 134.05
(0.19), 114.05 (5.07), 107.05 (19.46), 99.05 (7.99), 89.05 (100), 87.05 (11.65), 86.05 (9.53),
73.05 (7.52), 69.05 (12.68), 61.05 (42.88), 60 (15.83), 55.1 (5.68), 47.05 (17.48), 45.1 (26.38),
43.5 (20.87), 42.1 (42.33), 41.1 (22.66), 39.05 (6.4), 35.1 (0.01).
(R)-Ethyl-3-fluorobutanoate (31). General procedure D was performed using enantioenriched
ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl) butanoate (0.1 mmol) and Selectfluor I (0.15
mmol). Water was added to quench the reaction. The organic layer was run on chiral GC to
determine ee value. The fluorinated product was formed in 49% yield as determined by 19F NMR
spectroscopic analysis of the crude reaction mixture.
F
H 3C

OH

3-Fluorobutan-1-ol (14). General procedure C was performed using 3-(5-aza-1-stannabicyclo[3.3.3]undecan-1-yl)butan-1-ol (0.25 mmol) Selectfluor I (0.375 mmol). After the
reaction was complete, triethylamine (2 mmol, 8 equiv) and benzoyl chloride (1 mmol, 4 equiv)
were added to the reaction. The reaction mixture was stirred overnight. The 3-fluorobutyl
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benzoate was formed in 50% yield as determined by 19F NMR spectroscopic analysis of the
crude reaction mixture. The reaction was washed by water and extracted with ether 3 times. The
combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure,
and purified by purified by flash column chromatography. 3-Fluorobutyl benzoate (20) is
isolated as a colorless liquid. See characterization data for 20 below.
(R)-3-Fluorobutan-1-ol (30). General procedure D was performed using enantioenriched 3-(5aza-1-stanna-bicyclo[3.3.3]undecan-1-yl) butan-1-ol (0.1 mmol) and Selectfluor I (0.15 mmol).
After the reaction was complete, triethylamine (0.8 mmol, 8 equiv) and benzoyl chloride (0.4
mmol, 4 equiv) were added to the reaction. It was stirred overnight. The reaction was washed by
water and extracted with ether 3 times. The combined organic layers were dried over Na2SO4,
filtered, concentrated under reduced pressure and purified by purified by flash column
chromatography. 3-Fluorobutylbenzoate was isolated as the colorless liquid and run on HPLC to
determine ee value. The fluorinated product was formed in 59% yield as determined by 19F NMR
spectroscopic analysis of the crude reaction mixture.
F
H 3C

BPin
BPin

2,2'-(4-fluoropentane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (15). General
procedure C was employed using 5-(4,5- bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan2-yl)-1-aza-5-stanna-bicyclo[3.3.3]undecane (0.1 mmol) and Selectfluor I (0.15 mmol) in
acetonitrile (0.5 mL). The reaction was washed by water and extracted with ether 3 times. The
combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure
and purified by purified by flash column chromatography (ether/hexane = 15:85). A colorless
liquid (20 mg, 58%) was isolated. 1H NMR (300 MHz, CDCl3): δ 4.86-4.75 (m, 0.45H) and
4.69-4.59 (m, 0.55H) indicates a diastereomeric ratio of 1:1.2, 1.95-1.40 (m, 2H), 1.31 (m, 3H),
1.22 (s, 24H), 1.01-0.75 (m, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 91.7 (d, J = 21.4 Hz,
major), 89.6 (d, J = 21.8 Hz, minor), 83.2, 77.4, 41.24, 41.13, 40.97, 40.86, 25.11, 25.10, 25.05,
25.03, 25.02, 25, 24.97, 24.93, 21.65 (minor), 21.35 (major) ppm. . 19F NMR (282 MHz, CDCl3):
δ -170.63(minor), -172.18 (major) ppm (1F). HRMS (ESI): Calcd (M-Na)+ 365.2447; Found
365.2449.

(3-Fluoropropyl)benzene (16). General procedure C was performed using 1- (3- phenylpropyl)5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 mmol). The
fluorinated product was formed in 52% yield as determined by 19F NMR spectroscopic analysis
of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -219.5 (m). 19F
NMR spectra are referenced based on the internal standard fluorobenzene, which is set at -113.6
ppm. The identity of the product was further confirmed by GCMS analysis. m/z (%) = 138.1
(31.04), 105.05 (3.52), 92.1 (19.94), 91.05 (100), 77 (4.38), 65 (11.29), 51 (4.79), 39.05 (4.97).
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H 3C

7

F

1-Fluorodecane (17). General procedure C was performed using 1-decyl-5-aza-1-stannabicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 mmol). The fluorinated product
was formed in 66% yield as determined by 19F NMR spectroscopic analysis of the crude reaction
mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -217.8 (m). 19F NMR spectra are
referenced based on the internal standard fluorobenzene, which is set at -113.6 ppm. The identity
of the product was further confirmed by GCMS analysis. m/z (%) = 160.10 (0.18), 111.10
(10.15), 97.10 (18.91), 85.10 (15.39), 75 (5.51), 69.05 (35.52), 57.10 (68.19), 55.05 (51.08),
61.05 (10.30), 43.1 (100), 41.1 (56.9), 39.05 (9.93).
t-Bu
F

1-(tert-Butyl)-4-(fluoromethyl)benzene
(18). General procedure C was performed using 1(4-tert-butylbenzyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375
mmol). The fluorinated product was formed in 56% yield as determined by 19F NMR
spectroscopic analysis of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282
MHz): δ -204.2 (m). 19F NMR spectra are referenced based on the internal standard
fluorobenzene, which is set at -113.6 ppm. The identity of the product was further confirmed by
GCMS analysis. m/z (%) = 166.1 (21.51), 152.1 (11.14), 151.1 (100),
135.05 (4.28), 123.05 (38.56), 116.05 (2.52), 103.05 (4.8), 91.05 (21.99), 77(4.39), 63 (2.19),
57 (2.55), 51.05 (2.90), 41.05 (14.34), 39 (5.66).

4-Fluorotetrahydro-2H-pyran (19). General procedure C was performed using 5-(tetrahydro2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375
mmol). The fluorinated product was formed in 53% yield as determined by 19F NMR
spectroscopic analysis of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282
MHz): δ -176.5 (m). 19F NMR spectra are referenced based on the internal standard
fluorobenzene, which is set at -113.6 ppm. The identity of the product was further confirmed by
HRMS analysis. HRMS (ES+): Calcd (M)+ 104.0637; Found 104.0640.
F
H 3C

O
O

3-Fluorobutyl benzoate (20).[6] General procedure C was performed using 3-(1-aza-5stannabicyclo[3.3.3]undecan-5-yl) butyl benzoate (0.25 mmol) and Selectfluor I (0.375 mmol).
A colorless liquid (34 mg, 70%) was isolated. 1H NMR (500 MHz, CDCl3): δ 8.04 (d, J = 9.5
Hz, 2H), 7.58-7.55 (m, 1H), 7.46-7.43 (m, 2H), 4.90 (dm, J = 47.9 Hz, 1H), δ 4.51 – 4.41 (m,
2H), 2.15 – 1.97 (m, 2H), 1.42 (dd, J = 23.9, 6.2 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ
166.6, 133.2, 130.4, 129.7, 128.6, 88.0 (d, J = 146.9 Hz), 61.2, 36.3 (d, J = 12.3 Hz), 21.3 (d, J =
12.8 Hz) ppm. 19F NMR (282 MHz, CDCl3): δ -175.51 (1F) ppm.
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(R)-3-Fluorobutyl benzoate (32). General procedure D was performed using enantioenriched 3(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl) butyl benzoate (0.1 mmol) Selectfluor I (0.15
mmol). After the reaction was done, water was added to quench the reaction. The combined
organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure, and
purified by purified by flash column chromatography. 3-fluorobutyl benzoate is isolated as the
colorless liquid and run on HPLC to determine ee value.
F
H 3C

OSiMe2t-Bu

tert-Butyl(3-fluorobutoxy)dimethylsilane (21). General procedure C was performed using 5-(4((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo [3.3.3]undecane (0.25 mmol)
and Selectfluor I (0.375 mmol). The fluorinated product was formed in 62% yield as determined
by 19F NMR spectroscopic analysis of the crude reaction mixture. The reaction was washed by
water and extracted with ether 3 times. The combined organic layers were dried over Na2SO4,
filtered, concentrated under reduced pressure, and purified by flash column chromatography.
tert-Butyl(3-fluorobutoxy)dimethylsilane is isolated as the colorless liquid. 1H NMR (300 MHz,
CDCl3): δ 4.97-4.70 (m, 1H), 3.72 (m, 2H), 1.93-1.62 (m, 2H), 1.34 (dd, J = 24.1, 6.2 Hz, 3H),
0.93(s, 9H), 0.059 (s, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 88.2 (d, J = 162.3 Hz) 58.2 (d, J
= 5.5 Hz), 40.3 (d, J = 20.4 Hz), 26.1, 21.4 (d, J = 22.3 Hz), 18.5, -5.19, -5.20 ppm. 19F NMR
(282 MHz, CDCl3): δ -175.66 ppm (1F). HRMS (ES+): Calcd (M-Na)+ 229.1400; Found
229.1405.
(R)-tert-Butyl(3-fluorobutoxy)dimethylsilane (33). General procedure D was performed using enantioenriched 5(4-((tert-butyldimethylsilyl) oxy) butan-2-yl)-1- aza-5-stannabicyclo[3.3.3]undecane (0.1 mmol) and Selectfluor I
(0.15 mmol). After the reaction was done, TBAF (0.12 mmol, 1.2 equiv) was added to the reaction vial at 0 ºC. It
was stirred for 30 min at 0 ºC, then 3h at room temperature. Triethylamine (0.8 mmol, 8 equiv) and benzoyl chloride
(0.4 mmol, 4 equiv) were added to the reaction. It was stirred overnight. The reaction was washed by water and
extracted with ether 3 times. The combined organic layers were dried over Na2SO4, filtered, concentrated under
reduced pressure and purified by purified by flash column chromatography. 3-fluorobutyl benzoate was isolated as
the colorless liquid and run on HPLC to determine ee value. The fluorinated product was formed in 59% yield as
determined by 19F NMR spectroscopic analysis of the crude reaction mixture.

1-(3-Chloropropyl)benzene (22).[7] General procedure C was employed using 1-(3phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and trichloroisocyanuric acid
(0.375 mmol). A colorless liquid (25 mg, 65%) was isolated. 1H NMR (500 MHz, CDCl3): δ
7.31-7.28 (m, 2H), 7.22-7.19 (m, 3H), 3.54-3.52 (t, J = 6.5 Hz, 2H), 2.80-2.77 (t, J = 7.4 Hz,
2H), 2.11-2.07 (quint, J = 7.4, 6.7 Hz, 2H) ppm. 13C NMR (125 MHz, CDCl3): δ 140.9, 128.7,
128.6, 126.3, 44.5, 34.2, 33.0 ppm.
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1-(3-bromopropyl)benzene (23).[7] General procedure C was employed using 1-(3phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and N-bromosuccinimide
(0.375mmol). A colorless liquid (41 mg, 82%) was isolated. 1H NMR (500 MHz, CDCl3): δ
7.31-7.28 (m, 2H), 7.22- 7.19 (m, 3H), 3.38 (t, J = 6.6 Hz, 2H), 2.78 (t, J = 7.3 Hz, 2H), 2.202.15 (m, 2H) ppm. 13C NMR (125 MHz, CDCl3): δ 140.7, 128.75, 128.7, 126.4, 34.4, 34.2, 33.3
ppm.

1-(3-iodopropyl)benzene (24).[7] General procedure C was employed using 1-(3phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and iodine (0.375 mmol). A
colorless liquid (42 mg, 68%) was isolated. 1H NMR (500 MHz, CDCl3): δ 7.31- 7.28 (m, 2H),
7.22- 7.19(m, 3H), 3.17 (t, J = 6.8 Hz, 2H), 2.73 (t, J = 7.2 Hz, 2H), 2.16- 2.22 (m, 2H) ppm. 13C
NMR (125 MHz, CDCl3): δ 140.6, 128.77, 128.71, 126.4, 36.4, 35.1, 6.5 ppm.
Cl
CH3

1-(3-Chlorobutyl)benzene (25).[8] General procedure C was employed using compound 1-(4phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3] undecane (0.25 mmol) and trichloroisocyanuric
acid (0.375 mmol). A colorless liquid (26 mg, 62%) was isolated. 1H NMR (500 MHz, CDCl3): δ
7.31-7.28 (m, 2H), 7.21-7.20 (m, 3H), 4.03-3.96 (m, 1H), 2.88-2.83 (m, 1H), 2.77-2.71 (m, 1H),
2.06-1.95 (m, 2H), 1.54(d, J = 6.6 Hz, 3H) ppm. 13C NMR(125 MHz, CDCl3): δ 141.3, 128.7,
128.6, 126.2, 58.1, 42.1, 33.0, 25.6 ppm.
(R)-(3-Chlorobutyl)benzene (34). General procedure E was performed using enantioenriched 1(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3] undecane (0.1 mmol) and
trichloroisocyanuric acid (0.15 mmol). After the reaction was done, water was added to quench
the reaction. The ee value (93% ee) was determined by HPLC analysis of the organic layer. The
yield (81%) was determined by calibrated gas chromatography.
Br
CH3

1-(3-Bromobutyl)benzene (26).[9] General procedure C was employed using compound
enantioenriched 1-(4-phenylbutan-2-yl) -5-aza-1-stanna-bicyclo[3.3.3] undecane (0.25 mmol)
and N-bromosuccinimide (0.375 mmol). A colorless liquid (32 mg, 60%) was isolated. 1H NMR
(500 MHz, CDCl3): δ 7.32-7.28 (m, 2 H), 7.22-7.18 (m, 3 H), 4.11-4.05 (dqd, J = 9.0, 6.5, 4.5
Hz, 1 H), 2.87 (ddd, J = 14.0, 9.0, 5.5 Hz, 1 H), 2.74 (ddd, J = 14.0, 9.0, 7.0 Hz), 2.17-2.02 (m, 2
H), 1.73 (d, J = 6.7 Hz, 3 H) ppm. 13C NMR (125 MHz, CDCl3): δ 141.1, 128.7, 128.6, 126.2,
51.0, 42.9, 34.2, 26.7 ppm.
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(R)-(3-Bromobutyl)benzene (35). General procedure E was performed using enantioenriched 1(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3] undecane (0.1 mmol) and Nbromosuccinimide (0.15 mmol). After the reaction was done, water was added to quench the
reaction. The ee value (97% ee) was determined by HPLC analysis of the organic layer. The
yield (71%) was determined by calibrated gas chromatography.
I
CH3

1-(3-Iodobutyl)benzene (27).[9] General procedure C was employed using compound 1-(4phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and iodine (0.375 mmol).
A colorless liquid (41 mg, 63%) was isolated. 1H NMR (500 MHz, CDCl3): δ 7.31-7.28 (m, 2
H), 7.22-7.21 (m, 3 H), 4.15-4.08 (dqd, J = 9.0, 7.0, 4.5 Hz, 1 H), 2.88-2.82 (ddd, J = 14.0, 9.0,
5.0 Hz, 1 H), 2.73-2.67 (ddd, J = 14.0, 9.0, 7.0 Hz, 1 H), 2.18-2.12 (dtd, J = 14.5, 9.0, 5.0 Hz, 1
H), 1.95 (d, J = 6.9 Hz, 3 H), 1.92-1.85 (dddd, J = 14.5, 9.0, 7.0, 5.0 Hz, 1 H) ppm. 13C NMR
(125 MHz, CDCl3): δ 140.7, 128.7, 128.6, 126.2, 44.6, 36.0, 29.8, 29.2 ppm.
(R)-(3-Iodobutyl)benzene (36). General procedure E was performed using enantioenriched 1-(4phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.1 mmol) and N-iodosuccinimide
(0.15 mmol). After the reaction was done, water was added to quench the reaction. The ee value
(92% ee) was determined by HPLC analysis of the organic layer. The yield (52%) was
determined by calibrated gas chromatography.
Use of enantioenriched benzylcarbastannatrane in fluorination reaction:
N

Cl
N
N
2BF4
F
1

Sn
Ph

CH3
99% ee

F

styrene (1 equiv)
pyridine (1 equiv)

CH3
Ph
50% yield
53% ee

CH3CN, -5 ºC, 5 min

4. Investigation of the Stereochemical Course of the Fluorination Reaction.
OH

F

DAST

CH3

CH3
(S4)
[10]

(S)-1-(3-Fluorobutyl)benzene (S4) At -78 ºC, to the vial with (R)-4-phenylbutan-2-ol (1
mmol) in DCM (5 mL) was added diethylaminosulfur trifluoride (DAST, 1.2 mmol, 1.2 equiv.)
under Ar. The reaction was warmed to room temperature slowly and stirred overnight. The
reaction was quenched by water and extracted with ether 3 times. The combined organic layers
were dried over Na2SO4, filtered, concentrated under reduced pressure and purified by purified
by flash column chromatography. A colorless liquid (80.6 mg, 53%) was isolated. 1H NMR (300
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MHz, CDCl3): 7.33-7.26 (m, 2H), 7.23-7.17 (m, 3H), 4.66 (dm, J = 49.1Hz, 1H), 2.86-2.64 (m,
2H), 2.08-1.71 (m, 2H), 1.35 (dd, J = 24.0 Hz, 6.18 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ
141.7, 128.6, 126.1, 90.3 (d, J = 162.8 Hz), 38.9 (d, J = 22.5 Hz), 31.6 (d, J = 4.8 Hz), 21.2 (d, J
= 22.5 Hz) ppm; 19F NMR (282 MHz, CDCl3) δ -174.2 (1F).
N
Sn

F

Selectfluor I

CH3

CH3
(S5)

(R)-(3-Fluorobutyl)benzene (S5). General procedure D was employed using (S)-5-(4phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3] undecane (0.025 mmol, prepared from (R)-4phenylbutan-2-yl methanesulfonate[3]). After the reaction was complete, water was added to
quench the reaction. The ee value (84% ee) was determined by HPLC analysis of the organic
layer. The yield (54%) was determined by calibrated gas chromatography.

F
CH3

F
CH3
(S2)

F
CH3
(S1)
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Conditions:
Column
Mobile phase
Flow rate
Detector
Temperature

IA 250x4.6
[19:1 v/v Methanol/Acetonitrile]:H2O = 61%: 39%
0.8 mL/min
254 nm
25 ºC
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6. GC Data Supporting Absence of Protodestannylation
N
Sn
5

F

1 (1.5 equiv)

CH3

CH3 CH3CN, rt, 5 min

tetradecane internal standard
F

CH3

1.972 min

from crude reaction

CH3

1.813 min

Sigma-Aldrich

N
Sn
CH3
and GC decomposition products
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7. Chiral HPLC and GC Data

N
O

Sn

EtO

CH3

N
O
EtO

Sn

CH3
>99% ee

Conditions and results:
Column
IA-3mm 150x4.6
Mobile Phase
Hexane : IPA = 100 : 0.1
Flow
0.6 mL/min
Detector
220 nm
Temp
25°C
Result
>99% ee
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N
Sn
CH3

N
Sn
CH3
99% ee

Conditions and results:
Column
Chiralcel OJ-H 250x4.6
Mobile Phase
Methanol : Water = 95% : 5%
Flow
1.0 mL/min
Detector
215 nm
Temp
25°C
Result
99% ee
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Compound S2

N
Sn
H 3C

OH

N
Sn
H 3C

OH

Conditions and results
Column
IA 250x4.6
Mobile phase
Hexane : IPA = 90% : 10%
Flow rate
0.3 mL/min
Detector
210 nm
Temperature
25 ºC
Result
97% ee
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Scheme 6, compound 29

Conditions and results:
Column
IA 250x4.6
Mobile phase
[19:1 v/v Methanol/Acetonitrile] : H2O = 61% : 39%
Flow rate
0.8 mL/min
Detector
254 nm
Temperature
25 ºC
Result
82 % ee, 85% es
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Scheme 6, compound 30

89% ee, 90% es

Conditions and results:
Column
IA 250x4.6
Mobile phase
[19:1 v/v Methanol/Acetonitrile]:Sodium phosphate buffer
(25mM, pH 7.8) = 60%: 40%
Flow rate
0.8 mL/min
Detector
254 nm
Temperature
25 ºC
Result
89% ee, 90% es
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Scheme 6, compound 32

86% ee, 89% es

Column
Mobile phase
Flow rate
Detector
Temperature
Result

IA 250x4.6
[19:1 v/v Methanol/Acetonitrile]:Sodium phosphate buffer
(25mM, pH 7.8) = 60% : 40%
0.8 mL/min
254 nm
25 ºC
86% ee, 89% es

Scheme 6, compound 33

Conditions and results:
Column
IA 250x4.6
Mobile phase
[19:1 v/v Methanol/Acetonitrile]:Sodium phosphate buffer
(25mM, pH 7.8) = 60% : 40%
Flow rate
0.8 mL/min
Detector
254 nm
Temperature
25 ºC
Result
80% ee, 83% es
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Scheme 6, compound 31

Scheme 6, entry 31
87% ee (88% es)

194

Scheme 6, compound 34

Conditions and results:
Column
IA 250x4.6
Mobile phase
[19:1 v/v Methanol/Acetonitrile]:H2O = 60% : 40%
Flow rate
0.9 mL/min
Detector
210 nm
Temperature
25 ºC
Result
93% ee (95% es)
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Scheme 6, compound 35

Scheme 6, entry 35
97% ee (98% es)
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Scheme 6, compound 36

Conditions and results:
Column
IA 250x4.6
Mobile phase
[19:1 v/v Methanol/Acetonitrile]:H2O = 70% : 30%
Flow rate
0.8 mL/min
Detector
254 nm
Temperature
25 ºC
Result
92% ee, 94% es
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8. 1H and 13C NMR spectra
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General reagent/analytical information
General reagent information
BDH brand ethyl ether was purchased from VWR. EMD brand Omnisolv THF (unstabilized)
was also purchased from VWR. These solvents were transferred to separate 20 L solventdelivery kegs and vigorously purged with argon for 2 h. The solvents were further purified by
passing them under argon pressure through two packed columns of neutral alumina. Pd(dba)2 and
JackiePhos were purchased from Strem. Acetonitrile (Sigma-Aldrich) was purged with argon
prior to use. 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane was purchased from SigmaAldrich, and purified through silica gel with 100% DCM prior to use. Reagents and solvents
were used as received unless otherwise noted. Normal phase flash chromatography was
performed using Silicylcle silica gel (ultra pure grade). Reversed phase flash chromatography
was performed using C18 silica gel, 17%C, 40-63 µm (Acros).

General analytical information
All NMR spectra were obtained on a Bruker 300 (300 MHz for 1H and 75 MHz for 13C). All 1H
NMR experiments are reported in δ units, parts per million (ppm), and were measured relative to
the signals for residual chloroform (7.26 ppm) unless otherwise noted. The following
abbreviations are used to express the multiplicities: s = singlet; d = doublet; t = triplet; m =
multiplet. All 13C NMR spectra are reported in ppm relative to deuterochloroform (77.16 ppm),
and were obtained with 1H decoupling. All GC analyses were performed on a Shimadzu GC2010 gas chromatograph with an FID detector using a 25 m x 0.20 mm capillary column with
cross-linked methyl siloxane as the stationary phase. Chiral HPLC analyses were performed
using a Shimadzu Prominence HPLC system with binary mobile phase pumps and UV-vis
detector (LC-20AB, SPD-20A) using an OJ-RH (dimensions: 4.6 mm x 150 mm; particle size: 5
µm) chiral column (DAICEL CHEMICAL IND., LTD.), or an IA (dimensions: 4.6 mm x 150
mm; particle size: 5 µm) chiral column (DAICEL CHEMICAL IND., LTD.).
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General procedure information
Preparation of stannatrane-lithium solution:
To an empty 50mL flame dried one neck RBF was added lithium granules (47.3mg, 2.5eq),
stannatrane chloride (802mg, 1.0 eq), and naphthalene (35mg, 0.1eq) under a strict argon
atmosphere. Without a stirbar, the RBF was sealed with a rubber stopper. THF (9mL, 0.3M)
was injected through the rubber stopper, and the RBF was sonnicated at 40-45 °C until lithium
was almost completely consumed, confirmed by visual inspection, after 4-6 hours of heated
sonication. The dark green/black opaque solution was then transferred under argon to a sealed
vessel for storage at -20 °C, at 5-10% decomposition per day.

Preparation of additional stannatrane-anions:
To a 50mL flame dried one neck RBF sealed with a rubber stopper was added 1.0 eq stannatrane
lithium solution and a glass magnetic stirbar under a strict argon atmosphere. The solution was
cooled to 0°C, and an appropriate amount of attenuating agent was added as a liquid, or as a
solid under positive argon pressure. The mixture was stirred at 0°C for one hour.
Preparation of 2° alkyl mesylate (3-octyl mesylate)
To a 200mL RBF with magnetic stirbar was added the commercially available 2° alkyl alcohol
(2g, 1.0eq), triethylamine (4.3mL, 2.0eq), and dichloromethane (150mL, 0.1M). The RBF was
sealed with a rubber stopper. At room temperature, methanesulfonyl chloride (1.31mL, 1.1eq)
was added slowly over 5 minutes.

The solution was allowed to stir at room temperature

overnight. TLC with potassium permanganate was used to confirm reaction completion. The
organic layer was washed with water, 2x with saturated bicarbonate, dried with sodium sulfate,
and condensed. The resulting oil was then purified via flash chromatography using 100% DCM
as the mobile phase.
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General procedure A for the preparation of racemic alkylstannatrane via stannatrane anion:
To a 50mL flame dried one neck RBF sealed with a rubber stopper was added 1.0eq alkyl
mesylate and a glass stirbar. The flask was evacuated and backfilled 3x with argon. THF (0.1M)
was added with stirring, followed by a slow addition of stannatrane anion (1.5 eq). The reaction
was allowed to stir overnight. Water was added, and extracted with hexane 3 times. The organic
layers were combined, dried with sodium sulfate, and condensed. The thick oil was purified with
reversed phase column chromatography (100% acetonitrile to 15% DCM in acetonitrile),
fractions were monitored by reversed phase HPLC with a c18 column or reversed phase TLC.
General procedure B for the preparation of enantioenriched alkylstannatrane via stannatrane
anion:
To a 50mL flame dried one neck RBF sealed with a rubber stopper was added 1.0eq alkyl
mesylate and a glass stirbar. The flask was evacuated and backfilled 3x with argon. n-Hexane
(0.1M) was added with stirring, followed by a slow addition of stannatrane anion (1.5 eq). The
reaction was allowed to stir overnight. Water was added, and extracted with hexane 3 times.
The organic layers were combined, dried with sodium sulfate, and condensed. The thick oil was
purified with reversed phase column chromatography, fractions monitored by reversed phase
HPLC with a c18 column.

General procedure C for cross-coupling arylation reactions with aryl-bromides
Pd(dba)2 (5 mol %, 14.4 mg for 0.5 mmol scale and 28.8 mg for 1.0 mmol scale), JackiePhos (610 mol %), CuCl (2 equiv, 100 mg for 0.5 mmol scale and 200 mg for 1.0 mmol scale) and KF
(2 equiv, 58 mg for 0.5 mmol scale and 116 mg for 1.0 mmol scale) were weighed out on the
benchtop, and transferred to an oven-dried screwtop vial with stir bar. With stirring begun, the
Sealed vial was evacuated (50 mTorr) and backfilled three times with argon using a needle
attached to a vacuum manifold. The tin reagent (1.1-2.0 equiv) and aryl halide/triflate (1 equiv)
was then added to the screwtop vial via microsyringe, followed by degassed CH3CN (3 mL for
0.5-1.0 mmol scale). If the aryl halide/triflate or the tin reagent was a solid, it was weighed out
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on the benchtop alongside the other solids. The vial was then heated to 60 °C for 6-12h. The
reaction mixture was cooled to rt, diluted with ether, washed sequentially with saturated aqueous
KF and brine, and dried over Na2SO4. The reaction solution was filtered and concentrated to
provide the crude product. The crude product was purified by column chromatography.

Compound characterization data:

N

Sn

5-(6-methyl-5-hepten-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure A was
employed using stannatrane lithium (9mL, 2.73mmol) and racemic 6-methyl-5-hepten-2-yl
mesylate (375mg, 1.82mmol). A pale yellow oil was obtained (365mg, 54% yield). 1H NMR
(300 MHz, CDCl3) δ: 5.12 (m, 1H), 2.35 (m, 6H), 1.92 (m, 2H), 1.80-1.25 (m, 14H), 1.06 (d, J =
7.5 Hz, 3H), 0.65 (m, 7H) ppm.

13

C NMR (75MHz, CDCl3) δ: 130.6, 125.8, 54.9, 36.8, 28.6,

25.9, 24.1, 23.6, 18.6, 17.8, 5.5 ppm. Racemates were separated by derivatization via crosscoupling with 4-bromo-2H-1,4-benzoxazin-3(4H)-one.

N

Sn

(S) 5-(6-methyl-5-hepten-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure B
was employed using stannatrane lithium (9.5mL, 2.90mmol) and (R)-6-methyl-5-hepten-2-yl
mesylate (400mg, 1.93mmol). A pale yellow oil was obtained (362mg, 51% yield). 1H NMR
(300 MHz, CDCl3) δ: 5.12 (m, 1H), 2.35 (m, 6H), 1.92 (m, 2H), 1.80-1.25 (m, 14H), 1.06 (d, J =
7.5 Hz, 3H), 0.65 (m, 7H) ppm.

13

C NMR (75MHz, CDCl3) δ: 130.6, 125.8, 54.9, 36.8, 28.6,

25.9, 24.1, 23.6, 18.6, 17.8, 5.5 ppm. Enantiopurity of 98.7% ee obtained by derivatization via
cross-coupling with 4-bromo-2H-1,4-benzoxazin-3(4H)-one. Total es% from starting alcohol =
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99.5% es.

N

Sn

5-(3-octyl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure A was employed using
stannatrane lithium (13.5mL, 4.11mmol) and racemic 3-octyl mesylate (521mg, 2.5mmol). A
pale yellow oil was obtained (478mg, 51% yield). 1H NMR (300 MHz, CDCl3) δ: 2.35 (m, 6H),
1.63 (m, 6H), 1.53- 1.15 (m 10H), 0.83 (m, 6H), 0.63 (m, 7H) ppm. 13C NMR (75MHz, CDCl3)
δ: 55.0, 33.9, 33.2, 29.8, 26.2, 23.7, 23.0, 14.6, 14.4, 6.8 ppm.

O
O

1-(octan-3-yl)-3,4-(methylenedioxy)benzene. General procedure C was employed using 5-(3octyl)-1-aza-5-stannabicyclo[3.3.3]undecane and 1-bromo-3,4-(methylenedioxy)benzene on a
0.04 mmol scale. A colorless oil was obtained (9mg, 60% yield) after column chromatography
0% to 50% DCM in hexane. 1H NMR (300 MHz, CDCl3) δ: 6.72 (d, J = 7.8 Hz, 1H), 6.58 (m,
2H), 2.30 (m, 1H), 1.51 (m, 4H), 1.71 (m, 6H), 0.84 (t, 3H), 0.75 (t, 3H) ppm.

13

C NMR

(75MHz, CDCl3) δ: 147.6, 145.5, 140.2, 121.0, 108.0, 107.7, 100.8, 47.8, 36.9, 32.1, 30.0, 27.4,
22.7, 14.2, 12.3 ppm.

O

4-(octan-3-yl)-acetophenone. General procedure C was employed using 5-(3-octyl)-1-aza-5stannabicyclo[3.3.3]undecane and 4-bromoacetophenone on a 0.04 mmol scale. A colorless oil
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was obtained (13.4mg, 90% yield) after column chromatography 50% DCM in hexane to 100%
DCM. 1H NMR (300 MHz, CDCl3) δ: 7.87 (d, J = 8.1Hz, 2H), 7.23 (d, J = 9Hz, 2H), 2.59 (s,
3H), 2.47 (m, 1H), 1.60 (m, 4H), 1.20 (m, 6H), 0.82 (t, 3H), 0.76 (t, 3H) ppm.

13

C NMR

(75MHz, CDCl3) δ: 198.1, 152.3, 135.3, 128.6, 128.1, 48.1, 36.4, 32.0, 29.7, 27.4, 26.7, 22.7
ppm.

O
HN
O

6-(octan-3-yl)-2H-1,4-benzoxazin-3(4H)-one. General procedure C was employed using 5-(3octyl)-1-aza-5-stannabicyclo[3.3.3]undecane and 4-bromo-2H-1,4-benzoxazin-3(4H)-one on a
0.04 mmol scale. A white crystalline solid was obtained (6.3mg, 59% yield) after column
chromatography 100% DCM to 10% ethylacetate in DCM. 1H NMR (300 MHz, CDCl3) δ: 7.65
(s, 1H), 6.89 (d, J = 8.4 Hz, 1H), 6.74 (d, J = 9 Hz, 1H), 6.52, (d, J = 2.1Hz, 1H), 4.60 (s, 2H),
2.32 (m, 1H), 1.61 (m, 4H), 1.21 (m, 6H), 0.84 (t, 3H), 0.76 (t, 3H) ppm.

13

C NMR (75MHz,

CDCl3) δ: 141.8, 141.2, 125.9, 123.5, 116.6, 115.1, 67.5, 47.4, 36.7, 32.1, 29.9, 27.4, 22.7, 31.2,
14.2, 12.3 ppm.

O
TBDMSO

4(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-acetophenone. General procedure C was
employed using 5-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5stannabicyclo[3.3.3]undecane and 4-bromoacetophenone on a 0.04 mmol scale. A white
crystalline solid was obtained (12.1mg, 94% yield) after column chromatography 90% DCM in
hexane. 1H NMR (300 MHz, CDCl3) δ: 7.89 (d, J = 8.4, 2H), 7.28 (d, J = 8.4, 2H), 3.50 (m, 2H),
2.97 (m, 1H), 2.59 (s, 3H), 1.80 (q, J = 4.2 Hz, 2H), 1.26 (d, J = 6.9 Hz, 3H), 0.88 (s, 9H), -0.01
(s, 6H) ppm. 13C NMR (75MHz, CDCl3) δ: 198.0, 153.3, 135.4, 128.7, 127.5, 61.0, 41.0, 36.3,
26.7, 26.1, 22.1, 18.4, -5.2 ppm. Analytical resolution of the racemate can be achieved by
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reversed phase chiral-HPLC implementing an OJ-RH column, 70% acetonitrile in water, 1.2
mL/min, 254nm (tR = 35, 39min)

TBDMSO

O
O

1-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-3,4-(methylenedioxy)benzene. General
procedure C was employed using 5-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5stannabicyclo[3.3.3]undecane and 1-bromo-3,4-(methylenedioxy)benzene on a 0.04 mmol scale.
A white crystalline solid was obtained (9mg, 71% yield) after column chromatography 50%
DCM in hexane. 1H NMR (300 MHz, CDCl3) δ: 6.68 (m, 3H), 5.92 (s, 2H), 3.50 (m, 2H), 2.81
(m, 1H), 1.73 (q, J = 6.6Hz, 2H), 1.20 (d, J = 8.4 Hz, 3H), 0.88 (s, 9H), 0.00 (s, 6H) ppm. 13C
NMR (75MHz, CDCl3) δ: 147.7, 145.7, 141.5, 120.1, 108.2, 107.4, 100.9, 61.3, 41.5, 36.1, 26.1,
22.7, 18.4, -5.1 ppm. Analytical resolution of the racemate can be achieved by reversed phase
chiral-HPLC implementing an IA column, 1.0 mL/min, acetonitrile and water at the following
method, 40%B for 10 minutes, gradient to 60%B at 50 minutes, 254nm (tR = 43, 46min).

TBDMSO

2-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)naphthalene. General procedure C was
employed using 5-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo[3.3.3]
undecane and 2-bromonaphthalene on a 0.04 mmol scale. A white crystalline solid was obtained
(9.5mg, 73% yield) after column chromatography 10% to 50% DCM in hexane. 1H NMR (300
MHz, CDCl3) δ: 7.80 (m, 3H), 7.62 (s, 1H), 7.35 (m, 3H), 3.53 (m, 2H), 3.07 (m, 1H), 1.89 (q, J
= 6.9Hz, 2H), 1.34 (d, J = 6.9 Hz, 3H), 0.89 (s, 9H), 0.00 (s, 6H) ppm. 13C NMR (75MHz,
CDCl3) δ: 144.8, 133.8, 132.3, 128.1, 127.7, 127.6, 126.0, 125.9, 125.4, 125.2, 61.4, 41.2, 36.4,
26.1, 22.5, 18.4, 5.2 ppm. Analytical resolution of the racemate can be achieved by reversed
phase chiral-HPLC implementing an OJ-RH column, 70% acetonitrile in water, 1.2 mL/min,
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254nm (tR = 9.2, 12.2 min).

O
HN
O

6-(6-methyl-5-hepten-2-yl)-2H-1,4-benzoxazin-3(4H)-one. General procedure C was
employed using 5-(6-methyl-5-hepten-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane and 4-bromo2H-1,4-benzoxazin-3(4H)-one on a 0.04 mmol scale. A white crystalline solid was obtained
(7mg, 63% yield) after column chromatography 0% to 25% ethylacetate in DCM. 1H NMR (300
MHz, CDCl3) δ: 8.25 (s, 1H), 6.89 (d, J = 8.4 Hz, 1H), 6.79 (d, J = 6.3, 1H), 6.60 (d, J = 2.0 Hz,
1H), 5.07 (m, 1H), 4.60 (s, 2H), 2.63 (m, 1H), 1.86 (m, 2H), 1.57 (t, 2H), 1.52 (s, 3H), 1.19 (d, J
= 6.9 Hz, 3H) ppm. 13C NMR (75MHz, CDCl3) δ:166.1, 142.8, 141.8, 131.8, 126.0, 124.4,
122.8, 116.7, 114.5, 67.5, 39.0, 38.5, 26.1, 25.9, 22.6, 17.8 ppm. Analytical resolution of the
racemate can be achieved by normal phase chiral-HPLC implementing an IA column, 5%
isopropanol in hexanes, 0.3 mL/min, 254nm (tR = 26.7, 27.7 min).
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Chiral-HPLC data
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